ประสบการณ์อาการ การจัดการอาการและผลลัพธ์การจัดการอาการในผู้ป่วยที่รอผ่าตัดบางเบี่ยงหลอดเลือดหัวใจ by Sukanda Bunkong
ii 
 
Symptom Experiences, Symptom Management, and Symptom Outcomes in 
Patients Waiting for Coronary Artery Bypass Graft 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of 
Master of Nursing Science (International Program) 
Prince of Songkla University 
2009 
Copyright of Prince of Songkla University 
Sukanda  Bunkong 
i 
ii 
Thesis Title Symptom Experiences, Symptom Management, and Symptom 
Outcomes in Patients Waiting for Coronary Artery Bypass Graft  
Author  Miss Sukanda  Bunkong 
Major Program Nursing Science (International Program) 
 
 
Major Advisor: Examining Committee: 
 
……………………………………………… ……………………….………...Chairperson 
(Assoc. Prof. Dr. Praneed  Songwathana) (Assist. Prof. Dr. Wongchan  Petpichetchian) 
 
 ……………………….……………………... 
Co-advisor: (Assoc. Prof. Dr. Praneed  Songwathana) 
 
……………………………………………… ……………………….……………………… 
(Dr. Luppana  Kitrungrote) (Dr. Luppana  Kitrungrote) 
 
 ……………………….……………………… 
 (Assist. Prof. Dr. Kittikorn  Nilmanat) 
 
                                                                           ……………………………………………… 
(Somchai  Waikittipong, MD.)  
      
  
The Graduate School, Prince of Songkla University, has approved this thesis as 
partial fulfillment of the requirements for the Master of Nursing Science (International 
Program) 
 
 
 
 ………………………………………… 
      (Assoc. Prof. Dr. Krerkchai  Thongnoo) 
                 Dean of Graduate School  
 iii 
 
ชื่อวิทยานิพนธ ประสบการณอาการ การจัดการอาการ และผลลัพธการจัดการอาการใน
ผูปวยท่ีรอผาตัดทางเบ่ียงหลอดเลือดหัวใจ 
ผูเขียน   นางสาวสุกานดา บุญคง 
สาขาวิชา  พยาบาลศาสตร (นานาชาติ) 
ปการศึกษา  2552 
บทคัดยอ 
การวิจัยคร้ังนี้มีวัตถุประสงค เพื่ออธิบายประสบการณอาการ การจัดการอาการ และ 
ผลลัพธการจัดการอาการในผูปวยท่ีรอผาตัดทางเบ่ียงหลอดเลือดหัวใจ โดยคัดเลือกกลุมตัวอยาง
แบบเฉพาะเจาะจงตามคุณสมบัติท่ีกําหนดจํานวน 60 ราย จากทะเบียนผูปวยท่ีรอผาตัดทางเบ่ียง
หลอดเลือดหัวใจที่มารับบริการในโรงพยาบาลสงขลานครินทร เคร่ืองมือวิจัยท่ีใชประกอบดวย 
แบบบันทึกขอมูลสวนบุคคลและขอมูลเกี่ยวกับความเจ็บปวย แบบประเมินประสบการณอาการ 
แบบสัมภาษณการจัดการอาการ และผลลัพธของการจัดการอาการ แบบสอบถามผานการ
ตรวจสอบคุณภาพของเคร่ืองมือ วิเคราะหขอมูลโดยใชสถิติบรรยาย และวิเคราะหขอมูลเชิงคุณภาพ
เกี่ยวกับการจัดการอาการในผูปวยท่ีรอผาตัดทางเบ่ียงหลอดเลือดหัวใจ โดยใชวิธีวิเคราะหเนื้อหา
อยางงาย ผลการวิจัยพบวา 
 1. ในประสบการณอาการที่เกิดข้ึน พบวาอาการท่ีพบบอย ไดแก เจ็บหนาอก/แนนหนาอก 
เจ็บหนาอกรวมกับปวดราวไปอวัยวะตางๆ เหนื่อยลา/ออนเพลีย อาหารไมยอย/ทองอืด หอบ
เหนื่อย/หายใจลําบาก/หายใจขัด กลัว/ตกใจกลัว เครียด/วิตกกังวล และรูสึกไมแนนอน/ไมม่ันคง 
แตอาการเหลานี้เกิดข้ึนไมบอยนัก รวมท้ังผูปวยรับรูวาไมรุนแรง 
 2. ผูปวยใชวิธีการจัดการจัดการกับอาการท่ีหลากหลาย ไดแก (1) การจัดการโดยใชยา 
เชน ยาอมใตล้ิน ยาพน/ยาดม ยาระบาย ยาลดกรด และยาสมุนไพร (2) การจัดการโดยไมใชยา เชน 
การพัก การนวด การทุบอก การกดทอง การจัดทา การหลีกเล่ียงอาหารที่มีแกส การใชเทคนิกการ
ผอนคลาย และวิธีทางศาสนา และ (3) การจัดการโดยใชยารวมกับการจัดการโดยไมใชยา ซ่ึงกลุม
ตัวอยางสวนใหญจะเปนผูจัดการกับอาการของโรคดวยตนเองที่บานกอนท่ีจะขอความชวยเหลือ
จากคนอ่ืน  
3. ผลลัพธของการจัดการอาการพบวา ผูปวยสวนใหญมีอาการดีข้ึนหลังใชวิธีจัดการกับ
อาการดังกลาว และภาวะสุขภาพโดยรวมและรายดาน อยูในระดับปานกลาง ยกเวนดานสุขภาพจิต
อยูในระดับสูง 
 iv 
 
ผลการศึกษา สามารถใชเปนแนวทางสําหรับพยาบาลในการวางแผนการดูแลท่ีตอเนื่อง 
เพื่อสงเสริมการจัดการกับอาการท่ีเกิดข้ึนของผูปวยขณะรอผาตัดทางเบ่ียงหลอดเลือดหัวใจ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 v 
 
Thesis Title  Symptom Experiences, Symptom Management, and Symptom  
Outcomes in Patients Waiting for Coronary Artery Bypass  
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Author  Miss Sukanda Bunkong 
Major Program Nursing Science (International Program) 
Academic Year 2009 
Abstract 
The purposes of this study were to describe the symptom experiences,  
symptom management strategies, and symptom outcomes in patients waiting for 
coronary artery bypass graft (CABG). Sixty patients purposively selected from 
waiting lists for CABG and attending at the university hospital, in southern Thailand 
were interviewed. Data were collected using demographic and health-related data 
form, symptom experience, symptom management, and symptom outcome 
questionnaires. The questionnaires were developed based on the literature review and 
the Symptom Management Model (Dodd et al., 2001). Data were analysed using 
descriptive statistics and simple content analysis for some open-ended questions. The 
results were as follows: 
1. The  most common  symptoms of patients waiting for CABG were chest  
pain/chest discomfort, chest pain with referred pain, fatigue/weakness, 
indigestion/abdominal distension, dyspnea/shortness of breath/difficult breathing, 
fear/fright, stress/anxiety, and uncertainty. Those symptoms were reported as being 
infrequent and their severity perceived as being mild. 
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2. The strategies used to manage symptoms were various, and included: (1)  
using pharmacology such as isosorbide dinitrate, inhalant, laxative, antacid, and 
herbs, (2) using non-pharmacological strategies such as resting, massaging, chest 
thumbing, abdominal compressing, positioning, avoiding gas-inducing diet, using 
relaxation and religious coping, and (3) combining both methods.  The symptoms 
were primarily managed by patients at home rather than asking for help from other 
persons.  
3. Most subjects reported that the outcomes after their symptom management  
were improved. Their overall health status and all dimensions were reported at a 
moderate level, except mental health which was reported at a high level. 
 The results of this study can be used to guide nurses in assessing and planning 
a continuing care to enhance the effective strategies of symptom management in 
patients waiting for CABG.  
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CHAPTER 1 
INTRODUCTION 
Significance of the Problem 
Coronary artery bypass graft (CABG) is an important intervention which is 
applied on the patients with coronary artery disease (CAD) to relieve angina and 
myocardial ischemia (MI) (McHugh, Hankey, & Belcher, 2000; Rihal, Raco, Gersh, 
& Yusuf, 2003). In Thailand, the incidences of CABG have been increasing every 
year. According to the Medical Statistic Office of the Songklanagarind Hospital, Hat 
Yai, Thailand (2008), the incidences of CABG have increased; in the past five years 
there were 6 cases reported in 2002 and this number increased up to 105 cases in 
2007.  
The number of patients who require CABG is increasing and at the same time 
the available facilities are limited. This situation makes the patients to wait for long 
time to undergo CABG. Some patients wait for CABG for more than one year (V. 
Chittitaworn, personal communication, July 9, 2008). Further, the long waiting time 
for CABG is partly due to the shortage of surgical or financial resources, the shortage 
of critical care beds and the severity of patients’ condition (Cesena, Favarato, Cesar, 
de Oliveira, & da Luz, 2004; Fox, O’Dea & Parfrey, 1998; Rexius, Brandrup, Oden, 
& Jeppsson, 2004). According to Songklanagarind Hospital, patients’ condition is the 
priority for CABG. For example, some patients do not show the severity of symptoms 
like unstable angina, so the CABG surgery is usually postponed until their conditions  
    
 
2
are severe enough. But, some cardiac surgeons decide to perform surgery, if the 
disease threatens the life of patient (V. Chittitaworn).  
Waiting for CABG surgery had an impact on patient’s health which includes 
physical, psychological, and social dimensions (Cesena et al., 2004; Fitzsimons, 
Parahoo, Dip, & Stringer, 2000; McCormick, Naimark, & Tate, 2006). Studies on 
patients waiting for CABG surgery have been conducted in many developed 
countries. They found the impacts of waiting for CABG surgery on patients’ health 
such as cardiac complications, morbidity, and mortality (Cesena et al.; Fitzsimons et 
al., 2000; Koomen et al., 2001; Legare, MacLean, Buth, & Sullivan, 2005; Rexius et 
al., 2004; Sampalis, Boukas, Liberman, Reid, & Dupuis, 2001). Many symptoms are 
presented as cardiac symptoms such as chest pain or discomfort, fatigue, upper 
gastrointestinal pain, debility, aerodigestion, and neuropsychological symptoms 
(Chen, Woods, Wilkie, & Puntillo, 2005; Fitzsimons et al.; Granot, Goldstein-Ferber, 
& Azzam, 2004; Lovlien, Schei, & Gjengedal, 2006; Perry, Petrie, Ellis, Horne, & 
Moss-Morris, 2001). Chest pain is the common symptom found in patients waiting for 
CABG (Bengtson, Herlitz, Karlsson, Hjalmarson, 1996). Bengtson et al. (1996) found 
that most of patients waiting for CABG complaint about the chest pain. Even though 
chest pain is the common symptom, different genders may perceive the symptom in 
different ways. According to Granot et al. (2004), women reported chest pain more 
often than men. In addition, the severity of chest pain affects the sleeping pattern of 
the patients.  
Moreover, the severity of symptom is associated with various psychological 
symptoms such as anxiety, depression and stress that will worsen the condition of 
patient (Bengtson et al., 1996; Jonsdottir & Baldursdottir, 1998). The common 
symptoms are uncertainty and fear about the future (Bengtson et al.). Similarly, 
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Fitzsimons et al. (2000) who conducted the qualitative study to describe the thoughts 
and feelings regarding the experience of patients waiting for CABG found that 
uncertainty and anxiety emerge as the dominant themes among the patients. In 
addition, the social problems were found in the patients when their physical capacity 
and functioning were decreased such as the ability to perform working, usual 
household chores, and self-care ability (Fitzsimons et al.). Jonsdottir and Baldursdottir 
(1998) found that most of the patients in waiting period have negative effects on the 
daily lives and jobs. The conditions of patients waiting for CABG also affect the 
relationship with family and friends and cause dissatisfaction about work and sexual 
life (Jonsdottir & Baldursdottir).  
There are many factors that trigger the occurrence of symptoms, which 
emerged from both patients’ conditions and environment. According to patients’ 
condition, pain location and the symptom occurrences are related to infarction 
location (Culic et al. as cited in Chen et al., 2005). Moreover, the severity of the 
disease, such as severe left ventricular dysfunction and heart failure cause the sudden 
or cardiac death while waiting for CABG (Cesena et al., 2004). Lallukka et al. (2006) 
found that the working condition such as work-fatigue, physical and mental strain at 
work, lack of social support, health behaviors such as smoking, binge drinking, and 
increased body mass index, low socio-economic status and menopause are associated 
with occurrence of symptoms. Moreover, co-morbidity such as diabetes and 
hypertension affect the patients’ symptoms, particularly chest pain (Patel, Black, & 
Markides, 2003). Therefore, controlling these factors is necessary in order to prevent 
and manage patients’ symptom severity.  
For relieving symptoms, in western countries, patients waiting for CABG use 
several management strategies to deal with their symptoms. The management 
    
 
4
strategies includes taking anti-anginal medications (Jackson, Doogue, & Elliott, 
1999), analgesic muscular rubs, rest, position changes, drinking spirits (Foster & 
Mallik, 1998), and lifestyle modification (McHugh et al., 2001). Moreover, some 
patients contact a physician, family, and friends about the action to be taken when 
they experienced cardiac symptoms (Finnegan et al., 2000). The experience and 
interpretation of symptoms are the important factors in symptom management to 
encourage the patients for seeking help (Horne, James, Petrie, Weinman, & Vincent, 
2000). For instance, the severe physical symptom stimulates the patients to seek help 
(Kearney as cited in McSweeney, Cody, & Crane, 2001). As male and female patients 
perceive the symptoms in the different ways, they need different symptom 
management strategies (DeVon, Ryan, Ochs, & Shapiro, 2008). Granot et al. (2004) 
found that women use the self-management practice to reduce their chest pain by 
resting. Women do not associate their chest pain with heart disease because they think 
it is a problem found in men. There is no need to consult a doctor about this, and they 
are also less directed by family or by friends to seek medical care (Finnegan et al., 
2000; Lefler, 2002; Richards, Reid, & Watt, 2002). Moreover, in Thailand, the 
symptom management strategies related heart disease include asking for help, using 
self-management practice (e.g., self-medication, resting, changing position, pre-
cordial thumb, relaxation, acupressure, and massage), waiting and seeing, and 
enduring (Dej-adisai, 2006). Proper symptom management reduces the number of 
hospital visits or readmissions. On the contrary, if the patients do not use proper 
symptom management, the negative outcome can occur (Perry et al., 2001).  
The study regarding symptom outcomes in patients waiting for CABG has not 
been reported yet by any researcher. It has been reported in only one study conducted 
by Dej-adisai (2006), who found that the symptom outcome of each patient with acute 
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myocardial infarction (AMI) is different, and it depends on many dimensions. In 
addition, she also found that some symptom management strategies are effective but 
some are not. In her study, symptom outcomes were reported as symptom status, 
including getting worse, no change, and getting better. Her findings showed that more 
than half of AMI patients reported their symptom status as getting worse.  
The previous studies regarding patients with CABG have been conducted in 
western countries, but those studies were conducted on symptom experiences and 
symptom management. Moreover, no study about patients waiting for CABG has 
been conducted in Thailand. Since, Thailand is one of the Asian countries, where the 
culture is different from western countries. The culture difference may influence how 
patients perceive health/illness, which related to their symptom management and 
symptom outcomes (Dodd et al., 2001). Moreover, although one study was conducted 
in 125 Thai patients with AMI regarding symptom clusters and its management. 
However, it was unclear, that whether the patients who participated included the 
patients who were waiting for CABG (Dej-adisai, 2006). The condition between 
patients with AMI and patients waiting for CABG may be different, in terms of 
frequency and severity of the physical symptoms and psychosocial impacts. During 
the waiting period of CABG, the patients’ conditions are usually severe and many 
cardiac complications always develops (Cesena et al.). Therefore, the symptom 
experiences, symptom management, and symptom outcomes among Thai patients 
waiting for CABG are worth to investigate.  
To describe symptom experiences, symptom management, and symptom 
outcomes of patients waiting for CABG, Symptom Management Model developed by 
Dodd et al. (2001) was used in this study.  This study focused on managing symptoms 
by the patients at home rather than curing the disease which is directly related to the 
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nursing profession. The findings of this study can assist nurses and other health care 
providers to provide better advice and services for patients waiting for CABG which 
they can use at home.   
Objectives  
The objectives of this study were as follows: 
1. To describe the symptom experiences of patients waiting for CABG 
2. To describe the symptom management strategies used by patients waiting 
for CABG 
3. To describe the symptom outcomes of patients waiting for CABG 
Research Questions 
The research questions of this study were as follows: 
1. What are the symptom experiences of patients waiting for CABG? 
2. What symptom management strategies are used by patients waiting for 
    CABG? 
 3. What are the symptom outcomes of patients waiting for CABG? 
Conceptual Framework 
To understand symptom experiences, symptom management and symptom 
outcomes of patients waiting for CABG, the Symptom Management Model developed 
by Dodd et al. (2001) was applied in this study. This model is composed of three 
dimensions and three nursing domains. Three dimensions include (1) symptom 
experience, (2) symptom management strategies, and (3) symptom outcomes. Each 
dimension is interrelated and three nursing domains include (1) person domain, (2) 
environment domain, and (3) health and illness domain. 
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Symptom experience is a dynamic, which involve the interaction of three 
subconcepts including the patients’ perception of symptoms, evaluation of symptoms, 
and response to symptoms. Perception of symptoms refers to the perception of an 
individual regarding a change from the way that the patients usually feel or behave. 
Evaluation of symptoms refers to the judgment of the patients to characterize the 
symptom experience. Response to symptoms refers to the patients’ responses to the 
symptoms. Dodd et al. (2001) were also interested in the presentation of several 
concurrent symptoms or coexistent symptoms that may be occurred as a symptom 
cluster. In this model, the dynamic nature of symptom expression means that the 
primary symptom within a cluster may be subjected to rapid change (Dodd et al.).  
 Symptom management strategies are defined as the management of symptoms 
through biomedical, professional, and self-care strategies to manage or prevent the 
symptoms. They include the specifications of what, when, where, why, how much, to 
whom, and how (Dodd et al., 2001).  
 Symptom outcomes are defined as the outcomes that emerged from symptom 
experience and symptom management strategies to evaluate and verify the 
effectiveness of symptom management strategies (Dodd et al., 2001). The indicators 
of the outcomes consist of eight indicators that include functional status, self care, 
costs, quality of life, morbidity and co-morbidity, mortality, and emotional status 
(Dodd et al.).  
 In this study, the symptom experiences, symptom managements, and symptom 
outcomes of patients waiting for CABG were explored. Symptom experiences are 
composed of symptom perception and symptom evaluation. The patients waiting for 
CABG perceived their symptoms including physical and psychological symptoms and 
evaluated their symptoms in terms of frequency and severity. Their symptoms were 
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managed depending on what, when, where, why, how much, to whom, and how. The 
symptom outcomes were evaluated as symptom status and health status. The 
conceptual framework of this study was presented in Figure 1. 
Operational Definition  
 Symptom experiences are defined as several symptom occurrences that change 
the feelings and behaviors of patients waiting for CABG over the last month from the 
way they usually feel or behave. Symptom experiences include symptom perception 
and symptom evaluation. The symptom perception is the recognition of having 
symptom occurrences. The symptom evaluation is the way in which patient 
characterizes the frequency and severity of symptom. These symptom experiences 
were measured by using the Symptom Experiences Questionnaire that was developed 
by the researcher based on the previous study (Dej-adisai, 2006). 
Symptom management is defined as performances, behaviors and coping of 
the patients waiting for CABG to relieve their symptom experiences at home over the 
last month including what, when, where, why, how much, to whom, and how. Patients 
waiting for CABG were interviewed by the researcher by using the Symptom 
Management Questionnaire which was developed by the researcher. 
Symptom outcomes are defined as the perception of patients waiting for 
CABG regarding the symptom status including getting better, no change, and getting 
worse and health status resulting from symptom management which is managed by 
patients in the last month. Symptom outcomes were measured into two parts. In part 
one, the symptom status was assessed by using checklist. Part two, the health status 
was assessed by using the Short Form-36 Health Survey Version 2 (SF-36 V2) (Ware, 
2000).  
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Figure1. Conceptual framework of symptom experiences, symptom management, and symptom outcomes of patients waiting for CABG
Symptom experiences of 
patients waiting for CABG   
1. Symptom perception  
   - Symptom occurrence 
2. Symptom evaluation     
   - Frequency 
   - Severity 
 
 
Symptom management of  
patients waiting for CABG 
-What, When, Where, Why,  
  How much, To whom, and How 
Symptom outcomes of 
patients waiting for CABG 
- Symptom status 
- Health status 
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Scope of the Study 
This study is a descriptive research, which aimed to investigate the symptom 
experiences, symptom management, and symptom outcomes of patients waiting for 
CABG. The subjects were outpatients who were waiting for CABG at the 
Songklanagarind Hospital from January 2009 to May 2009. 
Significance of the Study  
The findings of this study can contribute knowledge to the nursing profession 
in the following aspects: 
1. They can help nurses to understand symptom experiences, symptom  
management, and symptom outcomes of patients waiting for CABG and develop 
teaching appropriate symptom management for these patients. 
2. They can provide valuable information for nurses to develop some  
interventions to prevent negative outcomes or complications of patients waiting for 
CABG. 
3. They can be used as baseline data for further research related to symptom  
experiences, symptom management, and symptom outcomes of patients waiting for 
CABG. 
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CHAPTER 2 
LITERATURE REVIEW 
This chapter is a review of literature relevant to the present study. The 
literature review is grouped and presented in four different parts as follows: 
1. Overview of patients waiting for CABG 
    1.1 Coronary artery disease (CAD) 
          1.1.1 Pathophysiology of CAD 
          1.1.2 Treatments for CAD 
    1.2 Indications for CABG and pre-surgical conditions 
    1.3 Definition of waiting for CABG 
    1.4 Patients perception and impacts on patients waiting for CABG 
2. Symptom management model 
3. Symptom experiences, symptom management, and symptom outcomes of  
                patients waiting for CABG 
    3.1 Symptom experiences of patients waiting for CABG 
    3.2 Symptom management of patients waiting for CABG 
    3.3 Symptom outcome of patients waiting for CABG  
4. Factors associated with symptom experiences, symptom management and  
                symptom outcomes of patients waiting for CABG 
 5. Conclusion 
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Overview of Patients Waiting for CABG 
The presence of waiting list and lengthy waiting time for CABG has raised 
concerns regarding the number of CAD among Thai population which increases 
yearly, particularly the occurrence of ischemic heart disease. In 2006, there were 
132,500 patients who were suffering from CAD (National Statistic Office of 
Thailand, 2006). Additionally, waiting for CABG is a situation of much professional 
and public attention (Ray, Buth, Sullivan, Johnstone, & Hirsch, 2001).  
Mostly, the priority group of patients waiting for CABG is based on the 
severity of symptom (Jonsdottir & Baldursdottir, 1998; Koomen et al., 2001). Rexius 
et al. (2004) categorized the priority group in patients waiting for CABG based 
mainly on the severity of symptom, the extent of CAD, and left ventricular function. 
In addition, Seddon et al. (1999) prioritized the waiting list into four categories viz 
emergency in hospital, emergency while waiting at home, semi-emergency, and 
routine. The last three categories were defined as waiting on the outpatient list for 
cardiac surgery (Seddon et al.). Moreover, Koomen et al. categorized the priority 
categories in waiting list based mainly on the severity of condition as imperative, 
urgent, and routine. In case of imperative, surgery is intended within one week, which 
includes patients with left main and/or severe three vessel disease with angina at rest 
and/or ST-T segment changes in the electrocardiogram (ECG); in case of urgent, 
surgery is intended between one and six weeks, patients with left main or three-vessel 
disease with angina on exertion despite adequate anti-anginal medication but without 
complaints at rest and/or ST-T segment changes on the ECG; and in case of routine, 
surgery is intended within three months. Many studies showed that the priority 
categories in waiting for CABG is based mainly on the severity of patients condition 
(Levy et al., 2005; Sampalis et al., 2001; Schofield, 2003), but there are some 
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differences in term of duration of waiting time. The duration of waiting time might be 
different and depends on institutional policy. 
In fact, CABG surgery should be offered within a week after diagnostic 
coronary angiography (CAG), because the complications always occurred within four 
weeks after diagnostic catheterization or early in the queuing process (Ray et al., 
2001; Stott, 2002). Similarly, a previous study found that the incidence of waiting list 
of CABG related deaths appears higher in the initial few weeks compared to several 
weeks (Plomp et al., 1999). The incidence of death within the first month was 1.19 
per 1,000 patient-weeks while the incidence of death after the first month was 0.76 
per 1,000 patient-weeks (Plomp et al.).  
Many studies showed that the patients who need CABG still have to wait for 
more than one year (Haddad et al., 2002; Seddon et al., 1999). Haddad et al. found 
that the waiting time for CABG ranges from 3 days to 77 months. Moreover, 
Tryfonidis, Prendergast, and Curzen (2002) found that the average waiting time from 
CAG to CABG surgery is 18.7 months and the mean delay from CAG to CABG 
surgery is 13.5 months. The consequence of long waiting time may cause death at 
mortality rate of 4-5% per year that is greater than the CABG itself (Large, 2002). 
Coronary Artery Disease 
CAD is a chronic disease in which the coronary arteries gradually harden and 
narrowed (atherosclerosis). This condition is also referred as coronary heart disease 
(Elhendy, Prewitt, & Weitzman, n.d.). CAD is the leading cause of death in both 
sexes, accounting for about one-third of all deaths (Warnica, 2007). CAD is a 
complex disease that causes reduced or no blood flow in one or more of the arteries 
that encircle and supply the heart. The disease may be focal or diffuse. Apart from 
rare congenital anomalies (birth defects), CAD is usually a degenerative disease. It is 
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uncommon as a clinical problem before the age of 30 years and common by the age of 
60 years (Pearlman, Lin, Newell, Krasny, & Coombs, 2007). 
Pathophysiology of CAD 
CAD is a chronic disease in which blood flow is obstructed through the  
coronary arteries that supply the heart with oxygen-rich blood. This obstruction is 
caused by a disease known as atherosclerosis, which is sometimes called hardening 
of the arteries. Atherosclerosis leads a person to danger of cardiovascular problems. 
First, the inner lining of the artery (e.g. the endothelium) is damaged. This causes 
white blood cells (WBC) to gather at the site of injury. This provokes an 
inflammatory immune response that causes further damage to the artery wall. WBC 
and cholesterol combine to form lipid foam. In the early stages of atherosclerosis, 
these fatty streaks are presented on the arterial wall as plaque deposits. Over time, the 
plaque may calcify, or form a hardened shell. This reduces the arterys ability to 
contract and expand and thus narrows the artery and reduced the amount of blood that 
can flow through it. If the plaque deposit ruptures, a blood clot can form at the site of 
the rupture, or pieces of the plaque can travel through the arteries until they eventually 
cause a blockage (Elhendy et al., n.d.). This interrupts coronary blood flow and causes 
some degree of myocardial ischemia. The consequences of acute ischemia are 
collectively referred as acute coronary syndromes depending on the location and 
degree of obstruction and range from unstable angina to transmural infarction 
(Warnica, 2007).  
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Treatments of CAD 
Treatment for CAD varies according to the severity of the disease, the  
location of blockages in the blood vessels, the presence of any risk factors (e.g. 
abnormal cholesterol profile or high blood pressure) and the overall health of the 
patient. Treatment options include medications, medical procedure, and risk factors 
modification (Elhendy et al., n.d.). 
1) Medications 
Medicines used to treat CAD include statins, beta-blockers, calcium-channel  
blockers, nitrates, antiplatelets, and angiotensin-converting enzyme (ACE) inhibitors. 
1.1) Statins. These medications decreases the amount of cholesterol in  
the blood, especially low-density lipoprotein or bad cholesterol to decrease the 
production of primary material that deposits on the coronary arteries (Grogan, 2008), 
and they also block the production of specific enzymes which used by the body to 
make cholesterol (Elhendy et al., n.d.). 
1.2) Beta-blockers (β-blockers). These medications block the effect of  
the sympathetic nervous system on the heart (Elhendy et al., n.d.). These agents slow 
down the heart beat rate and decrease blood pressure, which decreases the hearts 
demand for oxygen. Moreover, they reduce the risk of future heart attacks (Grogan, 
2008). 
1.3) Calcium-channel blockers. These medications relax the muscles  
that surround the coronary arteries and cause the vessels to open, in order to increase 
the blood flow to the heart. Moreover, they control high blood pressure (Grogan, 
2008). Some calcium-channel blockers also decrease the workload of the heart and 
some also decrease the heart beat rate as well (Columbia University Medical Center, 
Department of Surgery, New York, 2007).  
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1.4) Nitrates (e.g. nitroglycerin). These medications cause arteries to  
relax or dilate and improve blood flow to the heart (Elhendy et al., n.d.). 
1.5) Antiplatelets (e.g. aspirin, clopidogrel). These medications can   
inhibit the formation of blood clots by decreasing the ability of platelets (a clotting 
component of the blood) to bind together and form a blood clot (Grogan, 2008).  
1.6) ACE inhibitors. These medications decreases blood pressure and  
may help to prevent progression of CAD. Moreover, ACE inhibitors can also reduce 
the risk of future heart attacks (Grogan, 2008). 
2) Medical procedure 
Medical procedure demonstrate as revascularization procedure that composed  
of interventional cardiology, cardiovascular surgery, and medications including, 
thrombolysis and heparinization. 
2.1) Angioplasty and stent placement (percutaneous coronary  
revascularization). In this procedure, a long thin catheter is inserted into the narrowed 
part of artery. A wire with a deflated balloon is passed through the catheter to the 
narrowed area. The balloon is then inflated, compressing the deposits against the 
artery walls, thus allowing more blood to flow through the widened vessel (Grogan, 
2008). A major problem with this approach is the gradual re-closure of the vessel 
(restenosis) (Elhendy et al., n.d.). The recent introduction of stents has somewhat 
helped in solving this problem. These stents are implanted in the artery after 
angioplasty. They hold the plaque against the wall and help to prevent the vessel from 
closing again (Elhendy et al.). Latest stents, known as drug eluting stents which have 
been coated with special drugs can also help to reduce restenosis (Grogan, 2008). 
 2.2) Atherectomy. It is another catheter-based procedure, in this  
procedure a special catheter is guided into the blocked coronary artery. This catheter 
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is equipped with a blade that cuts away the soft plaque deposits, or grinding burr that 
pulverizes harder, calcified plaque (Elhendy et al., n.d.).  
2.3) CABG. It is a surgery that increases blood flow to the heart by  
creating a detour and re-routing the blood flow around the blocked portion of the 
artery. A section of a blood vessel from another part of the body (e.g. the leg-
saphenous vein or chest-internal mammary artery) is relocated and grafted above and 
below the damaged portion of the coronary artery to form an open channel around the 
blockage (Elhendy et al., n.d.). 
2.4) Minimally invasive coronary artery bypass (MICAB). It is a less 
invasive by-pass surgery technique. The incision is smaller, and may be done while 
the heart is still beating to reduce the risk of complications (American Heart 
Association, 2008). MICAB is effective in some situations, such as patients who have 
limited disease in one or two main coronary arteries but it is not commonly used. 
MICAB is sometimes used in conjunction with coronary angioplasty to treat multi-
vessel disease (Elhendy et al., n.d.).   
2.5) Transmyocardial laser revascularization (TMLR). This procedure  
involves the use of a laser to create tiny channels in the lower left chamber of the 
heart (the left ventricle), which may increase blood flow within the heart. While the 
heart is still beating, the surgeons use the laser to make 20 to 40 tiny (one-millimeter-
wide) channels through the oxygen-deprived heart muscle and into left ventricle. 
These channels give a new route for blood to flow into the heart muscle, which may 
reduce pain of angina. TMLR is only used for the patients who do not respond to 
other treatments such as medicines, angioplasty, or CABG (American Heart 
Association {AHA}, 2008).  
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2.6) Thrombolysis. Thrombolysis is the breakdown of blood clot, by  
pharmacological means. It works by stimulating fibrinolysis by plasmin through 
infusion of tissue plasminogen activator, a protein that normally activates plasmin. 
Thrombolytic agents actively reduce the size of clot. This makes the clot soluble and 
subject to further proteolysis by other enzymes, and restores blood flow over occluded 
blood vessels (Wardlaw, Berge, del Zoppo, & Yamaguchi, 2004).    
2.7) Heparinization. Heparin is an antithrombotic agent in patients with  
CAD. Heparin prevents the formation of clots and extension of existing clots within 
the blood. Its administration is known to increase circulating free fatty acids, which 
may adversely affect myocardial energetics, especially during ischemia (Fragasso et 
al., 2002). 
3) Risk factor modification 
Risk factors are traits related to the development and progression of CAD. 
Decreasing risk factors improves the long term survival and quality of life of CAD 
patients. Risk factor modifications include: 
3.1) Stop smoking. Smoking is directly related to an increased risk of  
the heart attack and its complication. CAD patients who keep on smoking have a 43% 
greater chance of dying from a heart attack than those who stop smoking (Goldenberg 
et al., 2003). 
3.2) Decrease lipid and cholesterol intake. A high-fat diet can contribute  
to increased fat content in the blood, thus leading to heart attack. 
3.3) Control high blood pressure. High blood pressure can damage the  
lining of coronary arteries and lead to coronary artery disease. Blood pressure should 
be checked on a regular basis. A healthy diet, exercise, medications and controlling 
sodium in diet can control high blood pressure. 
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3.4) Control blood sugar. High blood sugar are linked to the progression  
of CAD. High blood sugar can be controlled through monitoring blood sugar, diet, 
exercise, and medications. 
3.5) Increase physical activity. Regular physical activity can lower many  
CAD risk factors, including LDL cholesterol, high blood pressure, and excess weight. 
Physical activity also can lower risk for diabetes and raised the levels of HDL 
cholesterol. 
3.6) Maintain ideal body weight. When the patients are overweight, the 
heart has to do more work, and thus increases the risk of high blood pressure, high 
cholesterol levels and diabetes. 
3.7) Reduce stress. An emotionally upsetting event is the common trigger 
for a heart attack, particularly anger. Also, some of the ways patients cope up with 
stress, such as drinking, smoking, or overeating, are harmful to healthy heart. Physical 
activity can help to relieve stress and reduce other CAD risk factors.  
 Many treatments were used to manage with CAD, including medications, 
medical procedure, and risk factors modification. However, this study focuses on 
CABG procedure, particularly patients waiting for CABG.  
Indications for CABG and Pre-Surgical Conditions 
In recent years, there has been a progressive increase in the number of patients 
undergoing revascularization (Schofield, 2003). Patients who present the symptoms of 
CAD are referred to the cardiologist to assess the need for surgical revascularization 
(Sobolev, Levy, Hayden, & Kuramoto, 2006). Patients who have persistent symptoms 
and a diminished quality of life while receiving optimal medical therapy are generally 
considered for revascularization. CABG is the most commonly used method of 
revascularization for symptomatic CAD (Hamm et al., 1994; Herlitz, Brorsson, & 
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Werko, 1999). This intervention has been proved to be safe and effective in relieving 
medically uncontrolled angina pectoris in most patients (Urden, Stacy, & Lough, 
2002). The objectives of CABG are the improvement of anginal status, symptoms and 
quality of life and to prolong life expectancy (Jelinek, 2002; Urden, Stacy, & Lough, 
2002).  
There is a team to perform procedure of patient selection for CABG. It 
consists of at least one cardiologist who evaluates the results of CAG and decides on 
treatment (Grech, 2003; Tryfonidis et al., 2002) and one cardiac surgeon who assesses 
the patients need and suitability for CABG (Sobolev, Levy, Hayden, & Kuramoto, 
2006). This team decides between medical therapy, angioplasty, or cardiac surgery on 
the basis of history, non-invasive tests and cine-angiograms for coronary anatomy and 
left ventricular function (Koomen et al., 2001).  
There are two indications for CABG including, symptomatic and prognostic. 
The first indication involves patients whose angina is not adequately controlled by 
medical treatment and the second indication is the presence of CAD which has been 
shown to probably a better prognosis with surgery than with medical treatment 
(Schofield, 2003). Such diseases which are indication of CABG includes (1) 
significant (more than 50%) stenosis of the left main stem, (2) significant proximal 
stenosis of the three major coronary arteries, and (3) significant stenosis of two major 
coronary arteries including high grade stenosis of the proximal left anterior 
descending artery (LAD). In addition, the impaired left ventricular function increases 
the prognostic advantage of surgery over medical treatment in all categories 
(Schofield). 
 Mostly, indications for CABG depend on consensus opinion in accordance 
with institutional guidelines for anatomy, stress test, and symptom burden (Cox et al, 
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1996 as cited in Ray et al., 2001). In particular, patients with CAD are prioritized 
according to angina symptoms, coronary anatomy, and left ventricular function 
impairment to facilitate them to access the surgical revascularization (Levy et al., 
2005). Sampalis et al. (2001) reported that the events before CABG include, 
myocardial infarction (MI) that is determined by the clinical ischemic pain, new 
appearance of Q-waves or left bundle branch block, elevated creatine kinase (CK) 
level or elevated creatine kinase-MB (CK-MB) fraction, new unstable angina that is 
determined by decreased threshold and increased intensity, frequency or duration of 
pain, and by rest pain with ST-segment elevation, and ST-segment depression or T-
wave inversion. 
A study about priority setting and cardiac surgery found that the priority 
setting decisions for cardiac surgery were based on a complex set of interrelated 
clinical and non-clinical reasons (Koomen et al., 2001). Clinical reasons that cardiac 
surgeon considers in decision-making includes, coronary anatomy, left ventricular 
(LV) function, symptoms, co-morbidities, special urgent situations such as tight aortic 
stenosis or high left main coronary artery (LMCA) disease and goals of cardiac 
surgery. Left ventricular function is classified in four categories including normal, 
slightly diminished, diminished, and poor (Koomen et al.). In regard to coronary 
anatomy, it is divided into five categories that consist of left main disease, multi-
vessel including proximal anterior descendent artery stenosis, three-vessel without 
anterior descendent artery stenosis, single-vessel proximal anterior descendent artery 
stenosis, and one or two-vessel disease without anterior descendent artery lesion 
(Cesena et al., 2004). Moreover, non-clinical reasons that cardiac surgeon uses in 
decision-making includes, patients social situations, lifestyle choices, occupation, 
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mental state (high level of anxiety), advanced age, and obesity (Walton, Martin, Peter, 
Pringle, & Singer, 2007).  
The CABG surgery is used both for the relief of symptoms and prolongation 
of life (Urden et al., 2002). The conditions of symptoms are classified into four sub-
classes including, (1) class I: conditions for which there is evidence and/or general 
agreement that a given procedure/treatment is useful and effective, (2) class IIa: 
weight of evidence/opinion is in favor of usefulness/efficacy, (3) class IIb: 
usefulness/efficacy is less established by evidence/opinion, and (4) class III: 
conditions for which there is evidence and/or general agreement that the 
procedure/treatment is not useful/effective and in some cases may be harmful. In 
addition, indications of clinical subsets for CABG which are currently in practice are 
mentioned in Table 1 (Camp & Mentzer, 2004). 
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Table 1  
Indications of clinical subsets for CABG 
Indication Class I Class IIa Class IIb Class III 
1. Asymptomatic or mild angina 
 
 
 
 
 
 
 
 
 
2. Chronic stable angina  
- Significant (50% or greater 
reduction of lumen diameter) 
left main coronary artery 
stenosis. 
- Left main equivalent: 
significant (70%) stenosis of the 
proximal LAD and proximal left 
circumflex artery (Cx). 
- Three-vessel disease. 
 
- Significant left main coronary 
stenosis. 
- Left main equivalent: 
significant (70%) stenosis of the 
proximal LAD and proximal left 
Cx artery. 
- Three-vessel disease. 
- Two-vessel disease with 
significant proximal LAD  
- Proximal LAD stenosis with 
one or two vessel disease. 
 
 
 
 
 
 
 
 
- Proximal LAD stenosis with 
one vessel disease. 
- One or two vessel CAD 
without significant proximal 
LAD stenosis, but with a 
moderate area of viable 
myocardium and demonstrable 
ischemic on noninvasive testing. 
 
- One or two vessel disease not 
involving the proximal LAD. 
 
 
 
 
 
 
 
 
- None 
- None 
 
 
 
 
 
 
 
 
 
- One or two vessel disease not 
involving significant proximal. 
LAD stenosis. 
- Borderline coronary stenosis 
(50% to 60% diameter in 
locations other than the left 
main coronary artery) and no 
demonstrable ischemia on 
noninvasive testing. 
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Table 1 (Continued) 
 
Indication Class I Class IIa Class IIb Class III 
 
 
 
 
 
 
 
 
 
 
 
3. Unstable angina/Non-Q wave 
MI 
stenosis and either ejection 
fraction (EF) < 0.50 or 
demonstable ischemic on non-
invasive testing. 
- One or two vessel CAD 
without significant proximal 
LAD stenosis, but with a large 
area of viable myocardium and 
high-risk criteria on non-
invasive testing. 
 
- Disabling angina despite 
maximal non-invasive therapy. 
- Significant left main coronary 
artery stenosis. 
- Left main equivalent: 
significant (70%) stenosis of the 
proximal LAD and proximal left 
Cx artery. 
- Ongoing ischemia not 
responsive to maximal  
 
 
 
 
 
 
 
 
 
 
 
- Proximal LAD stenosis with 
one or two vessel disease. 
 
 
 
 
 
 
 
 
 
 
 
 
- One or two vessel disease not 
involving the proximal LAD.  
- Insignificant coronary stenosis 
(<50% diameter reduction). 
 
 
 
 
 
 
 
 
 
- None 
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Table 1 (Continued) 
 
Indication Class I Class IIa Class IIb Class III 
 
 
4. ST-segment elevation (Q-
wave) MI  
 
 
 
 
 
 
 
 
5. Poor LV function 
 
 
 
 
 
 
 
 
non-surgical therapy. 
 
- None 
 
 
 
 
 
 
 
 
 
- Significant left main coronary 
artery stenosis. 
- Left main equivalent: 
significant (70%) stenosis of the 
proximal LAD and proximal left 
Cx artery. 
- Proximal LAD stenosis with 
two or three vessel disease. 
stenosis. 
 
 
- Ongoing ischemia/ infarction 
not responsive to maximal non-
surgical therapy. 
 
 
 
 
 
 
 
- Poor LV function, with 
significant viable non-
contracting revascularizable 
myocardium and without any of 
the above anatomic patterns. 
 
 
 
 
 
 
- Progressive LV pump failure 
with coronary stenosis 
compromising viable 
myocardium outside the initial 
infarct area. 
- Primary reperfusion in the 
early hours (6 to 12 hours) of an 
evolving ST-segment elevation 
MI. 
 
- None 
 
 
 
 
 
 
 
 
 
- Primary reperfusion late (12 
hours) in an evolving ST-
segment elevation MI without 
ongoing ischemia. 
 
 
 
 
 
 
- Poor LV function, without 
evidence of intermittent 
ischemia and without evidence 
of significant revascularizable 
viable myocardium. 
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Table 1 (Continued) 
 
Indication Class I Class IIa Class IIb Class III 
6. Life-threatening ventricular 
arrhythmias 
 
 
 
 
7. CABG after failure PTCA 
 
 
 
 
 
 
8. Patients with previous CABG 
- Left main coronary artery  
- Three vessel coronary disease. 
 
 
 
 
- Ongoing ischemia or 
threatened occlusion with 
significant myocardium at risk. 
- Hemodynamic compromise. 
 
 
 
- Disabling angina despite 
maximal non-invasive therapy. 
 
- By-passable one or two vessel 
disease causing life-threatening 
ventricular arrhythmia.  
- Proximal LAD disease with 
one or two vessel disease.  
 
- Foreign body in crucial 
anatomic position. 
- Hemodynamic compromise in 
patients with impairment of the 
coagulation system and  
without previous sternotomy. 
 
- By-passable distal vessel with 
a large area of threatens 
myocardium. 
 
 
- None 
 
 
 
 
 
 
 
 
 
 
 
 
- Ischemia in the non-LAD 
distribution with a patent IMA 
graft to the LAD supplying 
functioning myocardium, 
without an aggressive attempt at 
medical management and/or 
percutaneous revascularization.   
- Ventricular tachycardia with 
scar and no evidence of 
ischemia. 
 
 
 
- Absence of ischemia. 
- Inability to revascularization 
due to target anatomy or no-
reflow state. 
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Definition of Waiting for CABG 
Many studies defined the waiting time for CABG in various ways which are as 
follows: 
The waiting time for CABG is defined as the time that patient is enrolled onto 
the waiting list for CABG surgery by a cardiac surgeon to the time the patients gets 
CABG (Morgan et al., 1998; Naylor, Szalai, & Katic, 2000; Rexius et al., 2004; 
Rexius, Brandrup-Wongsen, Oden, & Jeppsson, 2005; Seddon et al., 1999). But 
another definition defines the waiting time for CABG as the time that patient is 
emrolled onto the waiting list for CAG by a cardiologist to the time the patients gets 
CABG (Bengtson, Karlsson, & Herlitz, 2000; Ray et al., 2001). There are many 
reasons related to waiting time for CABG. The reasons for postponement of cardiac 
surgery are categorized into three groups (Dagmar as cited in Ivarsson, Larsson, & 
Sjoberg, 2004) as follows: 
1) Patients related reasons: The patients do not keep the appointment or  
suddenly refuse the cardiac surgery because they feel that they are not ready for it at 
the time it is offered (National Health Service Trust, 2008).  
2) Medical reasons: Sometime the patients health deteriorates, or the pre-
operative investigations are not completed. Some patients do not present the severity 
of symptoms, such as unstable angina. Thus, the cardiac surgery is postponed until the 
patients conditions become severe (Dagmar as cited in Ivarsson et al., 2004).  
3) Organizational reasons: There are many reasons for the postponement  
of cardiac surgery, for instance, shortage of surgeon, lack of operating room for 
cardiac surgery, the shortage of intensive care unit (ICU) beds, lack of operating 
equipment, and lack of time because of previous cardiac surgeries exceeding the 
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scheduled time (Cesena et al., 2004; Fox et al., 1998; Jonsdottir & Baldursdottir, 
1998). 
In summary, the waiting time for CABG is defined as the starting time when 
patient is assessed for CABG surgery by a cardiac surgeon, after getting CAG by a 
cardiologist unto the waiting list to the time the patients gets CABG. Moreover, the 
waiting time includes the delay and/or postponement which is associated with patient 
related reasons, medical reasons, and organizational reasons. 
Patients’ Perception and Impacts of Waiting for CABG 
Waiting time is both positive, as it gives patients enough time to prepare 
themselves before intervention, and negative, as it is a virtue of the stress encountered 
by waiting an indeterminate length of time (Jonsen, Athlin, & Suhr, 2000). However, 
the long waiting time may cause several problems for the patients, their families, and 
society (Haddad et al., 2002). In regard to patients, who are delayed for cardiac 
surgery faces the increased risks of worsening symptoms (Ray et al., 2001). They may 
experience a high degree of dependency (Lindsay, Smith, Hanlon, & Wheatley, 
2000). Moreover, most of the patients are not satisfied with their health status, due to 
the major symptoms, such as fatigue, dyspnea, chest pain, anxiety, and depression 
(Jonsdottir & Baldursdottir, 1998). The length of waiting time is a contributing factor 
and it also heightens the perceptions of risk for myocardial infarction (MI) of patients 
waiting for CABG (McHugh et al., 2001). The co-morbid medical condition may 
increase the amount of time in waiting for CABG. Death may even occur, resulting in 
psychological problems and repercussions for their families (Fitzsimons et al., 2000). 
Patients waiting for CABG have three times more chances to die than members of the 
general population (Naylor et al., 2000). Mostly, the death occurs within four weeks 
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after diagnostic catheterization, so CABG should be offered within a week after 
diagnosis of CAG (Silber et al., 1996). 
During the time of waiting for CABG, a comorbid condition can be developed 
(Levy, Sobolev, Kuramoto, Hayden, & MacLeod, 2007). A previous study showed 
that the effect of the waiting list of the patients for CABG is finally death and it also 
upgrades the need of more urgent intervention due to worsening of symptoms or 
adverse events, such as unstable angina occurring while the patients waiting for 
CABG that induced the patients to undergo hospitalization before surgery (Ray et al., 
2001). This fact was supported by a study of Jackson, Doogue, and Elliott (1999), 
who reported that while waiting for CABG, 44% of patients had cardiac events 
including, death (4%), non-fatal MI (6%), and readmission with unstable angina 
(34%). Being in the waiting period indicates a risk of death and cardiac readmission 
can also take place while waiting for CABG (Ray et al., 2001; Seddon et al., 1999). 
However, one study showed that the waiting time was not associated with both 
mortality and morbidity outcome among patients waiting for CABG (Legare et al., 
2005).  
In addition, the quality of life of patients waiting for CABG is affected. Teo et 
al. (1998) conducted a study in 102 patients with CAD who have been on the waiting 
list for CABG surgery for more than six weeks to assess the quality of life perceived 
by these patients. The result showed that approximately 87% of patients reported that 
their quality of life is worsen since they have been placed on the waiting list, mainly 
in regard to issues related to work, income, stress, social support, and frustration. 
Regarding psychosocial aspect, living with CAD during the waiting time has 
negative effects mostly on the daily lives and jobs (Jonsdottir & Baldursdottir, 1998). 
Some patients are unable to work due to illness which results in a decreased 
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productivity and an increased cost of health insurance due to physical incapability 
(Fitzsimons, Parahoo, Richardson, & Stringer, 2003; Haddad et al., 2002). These 
situations cause economic burdens and worries (Jonsdottir & Baldursdottir; Naylor et 
al., 2000). In addition, the family relationships (sexual life) are altered because of the 
patients illness (Fitzsimons et al., 2000). The major symptoms of patients also have a 
negative repercussion on their spouse and families, particularly on their emotional 
conditions (Jonsdottir & Baldursdottir).  
In conclusion, waiting time for CABG is an important period that can produce 
adverse events and death. Patients waiting for CABG experienced a wide range of 
physical, psychological, and economic difficulties that disrupt their lives and affect 
their quality of life and their families as a holistic.  
Symptom Management Model 
In order to describe the symptom experiences, symptom management, and 
symptom outcomes in patients waiting for CABG in this study, the Symptom 
Management Model developed by Dodd et al. (2001) was used. This model focuses 
on nursing domains and managing symptoms at home rather than curing the disease 
which is directly related to nursing profession.  
Symptom management is a strategy that patients uses through biomedical, 
professional and self-care ways for managing symptom occurrence with a goal to 
avert or delay a negative outcome (Dodd et al., 2001). In general, it is clear that 
symptom management can be applied to get rid of a disease or minimizing the impact 
of symptoms. The Symptom Management Model of Dodd et al. assumes that the 
symptom management is a dynamic process. It is modified by individual outcomes 
and the influences of the nursing domains.  
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 Dodd et al. (2001) had identified three domains of nursing profession which 
are related to Symptom Management Model including (1) person, (2) health and 
illness, and (3) environment. The three domains of nursing science are described as 
follows: 
1) Person domain. It consists of demography, psychology, and physiology of a  
person. This domain can interfere with an individuals view and responses to the 
symptom experiences. 
2) Health and illness domain. It comprises of variables which are unique to the  
health or illness state of an individual and includes risk factors, injuries, or 
disabilities. This domain has direct and indirect effects on symptom experiences, 
symptom management strategies, and symptom outcomes. 
3) Environment domain. It includes physical, social, and cultural variables of 
the patient. The physical environment may encompass home, work, and hospital. The 
social environment includes social support network and interpersonal relationships. 
Cultural aspects of the environment are beliefs, values, and practices that are unique 
to ones identified ethnic, racial, and religious group. 
These three domains are contextual variables which influences all three  
dimensions of the model including (1) symptom experiences, (2) symptom 
management strategies, and (3) symptom outcomes. 
1) Symptom experience. It includes perception of symptoms, evaluation of  
symptoms, and response to symptoms. Perception of symptoms refers to the change in 
individuals feeling and behavior from the way he or she usually used to feels or 
behaves. Evaluation of symptoms refers to making judgments about symptom 
severity, cause, treatability, and the effect of symptoms on the lives of individuals. 
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Response to symptoms refers to the change in individuals functioning including 
physiological, psychological, sociological, and behavioral components. 
2) Symptom management strategy. It is a dynamic process, often requiring  
change in strategies over time or in response to acceptance or lack of acceptance of 
the devised strategies. Symptom management begins with assessment of the symptom 
experiences from the individuals perspective, followed by identifying the focus for 
intervention strategies. The intervention strategies may be targeted at one or more 
components of the individuals symptom experience to achieve desired outcomes. 
Symptom management strategy include the specifications of what (the nature of the 
strategy), when, where, why, how much (intervention dose), to whom (recipient of 
intervention), and how (delivered). 
3) Symptom outcome. It is associated with symptom experience and symptom 
management strategies. Symptom outcome is conceptualized as eight indicators which 
include (1) symptom status, (2) functional status, (3) emotional status, (4) cost, (5) 
morbidity and co-morbidity, (6) mortality, (7) quality of life, and (8) self-care. 
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Figure2. Revised Symptom Management Conceptual Model 
Note from Revised Symptom Management Conceptual Model (p. 670), by M. Dodd et 
al., 2001, Journal of Advanced Nursing, 33(5). 
In summary, there are three different types of nursing domains that comprises 
of person domain, health and illness domain, and environment domain. These three 
domains are contextual variables influencing symptom experience including 
perception of symptoms, evaluation of symptoms, and response to symptoms; 
symptom management strategy and symptom outcomes.  
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Symptom Experiences, Symptom Management, and Symptom Outcomes of 
Patients Waiting for CABG 
Symptom Experiences of Patients Waiting for CABG 
Waiting for CABG surgery produces the impact on both physical and 
psychological aspects. For physical symptoms, the dominant physical symptom 
appearing among patients waiting for CABG is the chest pain (Arslanian-Engoren, 
2005; Canto et al., 2007; Horne et al., 2000; Jonsdottir & Baldursdottir, 1998; Omran 
& Al-Hassan, 2006). Even though, chest pain is regarded as the hallmark symptom of 
cardiac symptom, but not all patients experience chest pain (Canto et al.). Patients 
during waiting period also reported the other symptoms such as sweating or fever, 
arm pain, shoulder pain, radiating pain, fatigue, weakness, palpitation, 
tachyarrhythmia,  shortness of breath, indigestion, nausea/vomiting, fainting/ 
lightheadedness, dizziness, syncope, diaphoresis and sweating (Canto et al.; Horne et 
al.; Jonsdottir & Baldursdottir). 
While waiting for CABG, not only the physical symptoms occur, but also 
various psychological symptoms also occur. The psychological symptoms include 
uncertainty, fear, anxiety, stress, depression, disappointment and worry (Ivarsson et 
al., 2004). The patients are also afraid of dying of MI before cardiac surgery 
(Jonsdottir & Baldursdottir, 1998). The greatest problem among patients waiting for 
CABG is uncertainty and fear about what will happen next (Hawley, 1998). 
Moreover, some patients feel uncertainty due to their concern about whether or not 
their symptoms will be treated in time and their financial situation and the future of 
their families (Bengtson et al., 1996).  
Regarding the literature review, symptom occurrences reported by CAD 
patients seem to be similar to the symptom occurrences of patients waiting for CABG. 
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Most symptoms are related to heart disease. The symptom experienced in CAD 
patients is categorized into two groups including, typical and atypical symptoms 
(Horne et al., 2000). The typical symptom comprises the symptoms that are 
commonly perceived as associated with cardiac problems. Dej-adisai (2006) found 
that the most prominent symptom in typical symptom group of AMI patients is the 
chest pain. The typical symptoms also include radiating pain or numbness (arm, jaw, 
back, neck, shoulder, epigastria or other locations), collapse (fainting or loss of 
consciousness), and cardiac arrest (Horne et al.). Moreover, the atypical symptom 
comprises other symptoms that may occur during an acute cardiac event but the 
symptoms may be less likely associated with a cardiac origin. Atypical symptoms are 
described as mild, short termed, and non-standard in the symptom presentation (Canto 
et al., 2007). Atypical symptoms include unexplained shortness of breath, indigestion, 
epigastric pain, abdominal distension, nausea/vomiting, diarrhea, belching, hiccups, 
fainting/lightheadedness, dizziness, fatigue, weakness, palpitation, tachyarrhythmia, 
clammy limbs, fever, syncope, confusion, diaphoresis, and sweating (Canto et al.; 
Dej-adisai; Horne et al.). The most prominent symptom in atypical symptom group is 
epigastric pain (Dej-adisai).  
Comparing the symptoms of men and women, Ashton (1999) found that the 
atypical symptoms occur more frequently in women compared to men. Women 
experienced atypical symptoms, such as back and jaw pain, shoulder blade/upper back 
pain, nausea and vomiting, dyspnea, shortness of breathe, palpitation, indigestion, loss 
of appetite, dizziness, fatigue, syncope, tiredness, weakness, and sweating 
(McSweeney et al., 2001; Omran & Al-Hassan, 2006; Patel, Rosengren, & Ekman, 
2004). The presentation of fatigue is a prominent reported symptom by women 
(Lovlein et al., 2006).  
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On the contrary, men often experienced the typical symptoms, such as chest 
pain and diaphoresis (Patel et al., 2004). It may be due to the fact that men more likely 
attribute their symptoms as cardiac symptoms than women (Bengtson et al., 2000; 
Lovlien et al., 2006; Omran & Al-Hassan, 2006). Although chest pain is the most 
common symptom in both men and women, the absence of chest pain is noted more 
commonly in women (Canto et al., 2007). Women are less likely to report chest pain 
compared with men (Canto et al.).  
According to the literature review, the physical and psychological symptoms 
in patients waiting for CABG include are presented in Table 2 (Arslanian-Engoren, 
2005; Canto et al., 2007; Dej-adisai, 2006; DeVon et al., 2008; Hravnak et al., 2007; 
Ivarsson et al., 2004; Omran & Al-Hassan, 2006; Patel et al., 2004).  
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Table 2 
Symptom experiences of patients waiting for CABG 
Dimension Symptom occurrences 
1. Physical - chest pain/chest discomfort 
- radiating pain  
- upper extremity numbness, clammy limbs  
- sweating, diaphoresis, fever  
- tiredness, fatigue, weakness, loss of strength, collapse, confusion 
- shortness of breath, dyspnea, breathlessness, difficulty breathing, 
  coughing  
- tachyarrhythmia, irregular heartbeat, palpitation 
- lightheadedness, nausea/vomiting, dizziness 
- diarrhea, loss of appetite, indigestion, upset stomach, heartburn, 
  epigastric pain, abdominal distension, belching, hiccups 
2. Psychological - anxiety, stress, worry  
- uncertainty  
- fear, fright, afraid 
- disappointment 
- depression, sadness 
- sleep disturbance, restlessness 
Symptom Management of Patients Waiting for CABG 
Symptom management is defined as the strategy to avert or delay a negative 
outcome through biomedical, professional, and self-care strategies (Dodd et al., 
2001). It is a dynamic process, which always changes over time or in response to a 
patients acceptance (Dodd et al.). In addition, the Dictionary of Cancer Terms 
defines symptom management as the care given to patients to improve the quality of 
life that has a serious or life-threatening disease. The goal of symptom management is 
to prevent or to treat the symptoms of a disease, its side effects caused by the 
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treatment of a disease, and psychological, social, and spiritual problems related to a 
disease or its treatment as early as possible (National Cancer Institute, {NCI}, n.d.).  
The management of symptoms may differ from the management of an  
individual symptom (Barsevick, Beck, Whitmer, & Dudley, 2002). The experience 
and interpretation of symptoms is an important source of symptom management to 
encourage the patients for seeking help. When the symptoms become severe enough, 
the physical nature of the symptoms stimulates the patients to seek for a help (Horne 
et al., 2000). However, lack of knowledge about symptoms of CAD may influence the 
interpretation of symptoms (Kearney, 2000 as cited in McSweeney et al., 2001). Well-
educated patients are more likely to seek more information and to involve actively in 
decision making about their symptom management (Omran & Al-Hassan, 2006). 
In general, symptom management strategies of both patients waiting for 
CABG and CAD patients are quite similar. The symptom management is classified 
into two groups including, non-pharmacological and pharmacological management 
strategies.  
1) Non-pharmacological management  
Regarding the literature review, the non-pharmacological management  
strategies that the patients with heart disease used to manage their symptom 
experiences include (1) consultation or asking for help, (2) self-management, (3) 
waiting and seeing, (4) enduring (Dej-adisai, 2006), and (5) lifestyle modification 
(McHugh et al., 2001).  
1.1) Consultation or asking for help. It is one of the symptom  
management strategies that the patients always use to manage their symptoms before 
seeking medical treatment (Lovlien et al., 2006). Perception of symptom severity 
influences the symptom management of the patients by stimulating them to seek help 
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(Foster & Mallik, 1998). Mostly, after occurrence of symptom, the patients usually 
consult with someone, especially with their family or friends about their acute 
symptoms (Lovlien et al.). Some patients consult a physician before consulting 
hospital services (Perry et al., 2001). Especially, the patients who experienced cardiac 
symptoms are more likely to contact a physician, family, and friends about what 
actions to take (Asthon, 1999; Finnegan et al., 2000). But, if the patients perceive that 
their current symptoms match with prior symptoms, they would more likely prefer to 
help by themselves rather than to rely on others for help (Horne et al., 2000).  
1.2) Self-management. The patients use self-management to manage their 
symptoms because they do not realize the importance of symptoms, and they also do 
not appraise their symptoms as serious symptoms or symptoms originated from the 
heart related diseases (Kathleen & Debra, 1997; Moser et al., 2006). Normally, self-
management strategies that the patients always used are resting and self-medication 
before seeking help or making the decision to consult the hospital (Perry et al., 2001). 
Foster and Mallik (1998), found that the patients who delay to ask for help for longer 
than 24 hours perceived that their symptoms are sporadic and not too severe, and they 
believe that their chest pain is due to indigestion. Thus these patients used to take 
indigestion remedies at home to manage their symptoms. This perception may lead 
the patients to delay in seeking help which results in the development of more severe 
symptoms (McSweeney et al., 2001).  
Additionally, there are many self-management strategies that patients use 
to manage their symptoms, such as analgesic muscular rubs, drinking spirits, rest and 
position changes. Furthermore, Dej-adisai (2006) found that self-management that the 
patients use are effective which include, massage, acupressure, pre-cordial thumb, 
body straightening, position changes, and sponge. Moreover, to relieve symptoms, 
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meditation (focusing on breathing in and breathing out), praying, and chest 
compressing are self-management strategies that are also used to relieve the 
symptoms. But they are not effective enough in relieving the symptom occurrences 
(Dej-adisai). 
1.3) Waiting and seeing. Perception of symptom severity influences the  
symptom management (Foster & Mallik, 1998). When the patients perceive their 
symptoms as mild, they try to tolerate the symptoms or ignore them initially, or they 
try to manage them by waiting and watching until they disappear instead of going to a 
hospital (Sobolev et al., 2006). Dej-adisai (2006) found that most of AMI patients 
manage their symptoms by waiting and seeing. Mostly, the duration of waiting and 
seeing before seeking medical treatment is less than one hour. There are many reasons 
for using this strategy to manage the symptom, which includes waiting for symptoms 
to go away, perception of mildly severe symptoms, presentation of atypical 
symptoms, inconvenient transportation facility for going to health care service, and 
perception of non-cardiac symptoms. Similarly Miller (2002) found that the patients 
do not perceive the symptoms as serious symptoms and they also perceive symptoms 
as non-cardiac symptoms.  
1.4) Enduring. It is used when the patients perceive their symptoms as 
mildly severe (Dej-adisai, 2006). When patients perceive the symptoms as mildly 
severe, they try to tolerate or ignore them initially (Sobolev et al., 2006). Dej-adisai 
found that most of the AMI patients use enduring to manage their symptoms by 
providing several reasons which include (1) perception of mildly severe symptoms, 
(2) inconvenient transportation facility for going to health care service, (3) perception 
of common symptoms, (4) symptom presentation at night time, (5) perception of non-
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cardiac symptoms, (6) unwillingness for going to a hospital, and (7) having 
experience of cardiac symptoms before. 
1.5) Lifestyle modification. Not only four symptom management  
strategies as mentioned above are important for preventing or delaying the negative 
symptom outcome, but also lifestyle modification is important. Lifestyle modification 
may be more motivated for patients on the waiting list for CABG than others and it is 
also more effective to prevent the complications (McHugh et al., 2001; Stott, 2002). 
Lifestyle modification focuses on diet, smoking cessation, blood pressure monitoring, 
lipid management (body weight control), exercise, and stress or anxiety management 
(McHugh et al.).  
As far as the non-pharmacological management strategies are concerned,  
several symptom management strategies are used by the patients to manage their 
symptoms depending on their perception and evaluation of the symptoms. Some 
strategies may be effective, but some may be not. If chosen symptom management 
strategy is ineffective, then the symptoms will become worse instead of preventing or 
delaying them.  
2) Pharmacological management 
Pharmacological management strategies are the strategies that the patients use 
to manage their symptoms by taking prescribed medications or traditional 
medications. Mostly, patients with angina who are potential candidates for coronary 
revascularization are given chronic treatment with at least two to three anti-ischemic 
drugs which are used to manage chronic stable angina pectoris (Herlitz et al., 1999). 
The medication that can improve a chance of survival includes aspirin and other anti-
platelet drugs, nitrates, β-blockers, statins, and ACE inhibitors when left ventricular 
impairment is occurred (Aroney et al., 2006; Maynard, Scott, Ridell, & Adgey, 2000).  
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Pharmacological management continues to be the main stay for anti-anginal 
therapy in patients waiting for CABG. Whenever, the patients experience chest pain, 
they usually use self-treatment for relieving chest pain. The conventional anti-anginal 
medications (anti-ischemic drugs), include nitrates (nitroglycerine/isosorbide 
dinitrate), β-blockers, and calcium channel blockers (Herlitz et al., 1999; Jackson et 
al., 1999).  
While waiting for CABG, patients experience not only chest pain, but also 
other disturbing symptoms, especially sleep disturbance. Jonsdottir and Baldursdottir 
(1998) found that while waiting for CABG, patients experience sleeping difficulty and 
use sleeping medications. Similarly, Bengtson et al. (1996) found that the patients 
always use sedatives and sleeping medications to manage their sleep disturbance. 
Women use sleeping medications more frequently than men, because women 
frequently suffer from sleeping disorders, such as difficulty in going to sleep, 
difficulty waking up, repeated awakening, and insomnia (Bengtson et al.). Moreover, 
indigestion remedies are the predominant form of pharmacological management 
strategies in patients waiting for CABG, because the patients believe that their chest 
pain is due to indigestion (Foster & Mallik, 1998). Furthermore, taking soothing 
medication (Ya-Hom) is also used to manage the symptom occurrences (Dej-adisai, 
2006).    
In addition, the patients waiting for CABG may have co-morbidity, such as 
hypertension, diabetes, obesity or overweight, and dyslipidemia. So, anti-hypertensive 
drugs, oral hypoglycemic agent or insulin, and statins are used to control risk factors 
that can develop more severity of CAD (Cesena et al., 2004).  
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Symptom Outcomes of Patients Waiting for CABG 
Symptom outcomes emerge from symptom experiences and symptom  
management strategies. Symptom outcomes are conceptualized in the form of eight 
indicators which include, (1) symptom status, (2) functional status, (3) emotional 
status, (4) cost, (5) morbidity and co-morbidity, (6) mortality, (7) quality of life, and 
(8) self care (Dodd et al., 2001).  
According to the literature review, the study about symptom outcomes in 
patients waiting for CABG has not been reported yet. There is only one study 
conducted about symptom clusters and symptom cluster management in AMI 
patients, and in this study, symptom outcomes were evaluated as symptom status, 
including getting worse, no change, and getting better. The findings of this study 
showed that more than half of AMI patients reported their symptom status as getting 
worse (Dej-adisai, 2006). Regarding this study, symptom status and health status were 
used to evaluate the symptom outcomes of patients waiting for CABG. Health status 
and health-related quality of life are often used interchangeably, assuming that a fully 
healthy life results in a high quality of life (Suwanno, 2007).  
Health status 
Health status is chosen to represent the symptom outcomes of the Symptom 
Management Model (Dodd et al., 2001). Health status is conceptualized as a 
consequence of the symptom management, which is influenced by perception and 
evaluation of symptoms. In this study, the term health status was used to capture 
physical and psychological dimensions. Health is consistently considered as an 
important aspect of quality of life. Consequently, health-related quality of life 
(HRQoL) measures have been developed to assess aspects of an individuals 
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subjective experience that is related both directly and indirectly to health, disease, 
disability, and impairment (Cieza et al., 2002).  
In this study, health status of patients waiting for CABG was measured by 
using the Short Form-36 Health Survey (SF-36). SF-36 is widely used to measure 
health status in patients with cardiac disease and CABG surgery (Kiebzak, Pierson, 
Campbell, & Cook, 2002; Lindsay, Smith, Hanlon, & Wheatley, 2001; Vaccarino et 
al., 2003). Dempster and Donnelly (2000) compared the validity, reliability, and 
sensitivity of the SF-36 with other generic questionnaires such as the Nottingham 
health profile and the sickness impact profile for patients with CAD. They concluded 
that the SF-36 is the most appropriate generic instrument to assess HRQoL of cardiac 
patients.  
The Short Form-36 Health Survey 
The SF-36 is used to measure general health status of patients waiting for 
CABG. The original version was developed in England by J. E. Ware in the mid 
1980s (Ware & Gandek, 1998) with 36 items in 8 subscales of eight health concepts. 
The eight health concepts were selected from 40 concepts that were included in the 
Medical Outcomes Study (MOS) (Ware, 2000). SF-36 had already been tested and 
validated (Ware & Sherbourne, 1992). The SF-36 should be administrated within a 
one-month recall period in which participants perceive their health status (Ware & 
Gandek). SF-36 items also represent the multiple operational indicators of health, 
including behavioral functioning and dysfunction, distress and well-being, objective 
reports and subjective ratings, and both favorable and unfavorable self-evaluations of 
general health status (Ware). 
 The SF-36 contains 36 items in eight subscales that cover the domains of role 
limitations (physical), physical functioning, general health perceptions, bodily pain, 
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energy/vitality, social functioning, role limitations (emotional), and mental health. 
The subscales have been shown to have good internal consistency and reliability 
(Arthur, Daniels, McKelvie, Hirsh, & Rush, 2000). Likert-type scale response 
descriptors were designed to match the various subscale items. In this method, a score 
for each items is derived from a standardized set of response choice; scores for some 
items are needed to be recorded so that all item scores are then computed by simply 
summing the scores assigned to each item responses and by transforming scores to 0 -
100 (Ware & Gandek, 1998). All of the 36 items, except health transition (HT), are 
scored the eight SF-36 scales. Score of each subscale can range from 0 to 100 and the 
total score of SF-36 can range from 0 to 800 with a higher score indicating better 
general health status. 
 Recently, the SF-36 has been recommended as a novel psychometric property 
to measure health status, since it has been translated into more than 40 countries as 
part of the International Quality of Life Assessment (IQoLA) Project (Ware & 
Gandek, 1998). Most SF-36 items have their roots in instruments that have been in 
use since the 1970s and 1980s, including the General psychological Well-Being 
Inventory, various physical and role functioning measures, the Health Perceptions 
Questionnaire, and other measures that were useful during the Health Insurance 
Experiment (HIE) (Ware, 2000). The MOS researchers selected and adapted 
questionnaire items from these and other sources and developed new measures for a 
149-item Functioning and Well-Being Profile (FWBP) (Ware & Gandek). The FWBP 
was the source for questionnaire items and instructions that was adapted for use in the 
SF-36.  The SF-36 was first made available in a developmental form in 1988 and in 
standard form in 1990 (Ware & Sherbourne, 1992). 
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 Compared with the standard SF-36 version 1.0, improvements in version 2.0 
included simpler instructions and questionnaire items, an improved layout for 
questions and answers in the self-administered version, greater comparability with 
widely used translations and cultural adaptations, and five-level response choices 
instead of dichotomous response choices for items in the two role functioning scales 
(Ware, 2000). The SF-36 is a generic measure of general health status as opposed to 
one that targets a specific age, disease, or treatment group. 
 The content validity of the SF-36 has been compared with that of other widely 
used generic health surveys. Systematic comparisons indicates that the SF-36 include 
eight of the most frequently measured health concepts. Among the contents areas 
included in the SF-36, are: sleep adequacy, cognitive functioning, self-esteem, eating, 
recreation and hobbies, communication, and symptoms and problems that are specific 
to one condition. Symptoms and problems are not included in the SF-36, because the 
SF-36 is a generic measure (Ware, 2000). 
Most of the SF-36 scales were constructed to replace longer scales and 
attention was initially given to how well the short-form versions perform in empirical 
tests as compare with the full-length versions. The SF-36 scales have been shown to 
perform with about 80-90% empirical validity in the studies involving physical and 
mental health criteria. (McHorney, Ware, Rogers, Raczek, & Lu, 1992). This 
disadvantage of the SF-36 should be weighed against the fact that some of these long 
form measures require 5-10 times greater respondent burden. Empirical studies of this 
tradeoff suggested that the SF-36 provides a practical alternative to longer measures 
and that the eight scales and two summary scales rarely miss a noteworthy difference 
in physical or mental health status in the group level comparisons (Katz, Larson, 
Phillips, Fossel, & Liang, 1992).    
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Factors Associated With Symptom Experiences, Symptom Management, and 
Symptom Outcomes of Patient Waiting for CABG 
There are several factors that influence symptom experiences, symptom 
management, and symptom outcomes of patients waiting for CABG. These factors 
can have both directional and indirectional effects for these three dimensions. The 
predictive factors of symptom experiences, symptom management, and symptom 
outcomes of patients waiting for CABG are related to three domains of nursing 
science including person domain, health and illness domain, and environment domain 
(Dodd et al., 2001).  
Person Domain 
Person domain consists of age, gender, stress, and socio-economic status as 
follows: 
1) Age. The advanced age increases the risk for symptom severity (Cesena et  
al., 2004). Elderly patients perceive the symptoms, such as chest pain more often than 
younger patients. On the contrary, younger patients experience more psychological 
symptoms, such as anxiety, depression, vulnerability, impatience, and irritability than 
the elderly patients (Jonsdottir & Baldursdottir, 1998). Rankin, & Fofonoff (2001) 
used a chart audit of symptom differences in three age groups of 105 men and 48 
women to determine trends. The age groups included 35-64 years old, 65-75 years old 
and more than 75 years old patients. They reported that women in the age group 65-75 
years old had the highest percentage of atypical symptoms. On the other hand, 
psychosomatic symptoms were reported more frequently by younger patients than 
elderly patients (Bengtson et al., 1996). Moreover, advanced age is at significant risk 
factor for the death of patients waiting for CABG (p = .007) (Morgan et al., 1998). 
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2) Gender. Male gender is at significant risk factor of death while waiting for  
CABG (Rexius et al., 2004), because men have more risk behaviors, such as smoking 
than women (Koivula et al., 2002; Morgan et al., 1998). But, women perceive the 
severity and frequency of symptoms more than men (Bengtson et al., 2000; Lovlien et 
al., 2006; Omran & Al-Hassan, 2006). It may be due to the physiological and 
sociological differences between women and men (DeVon et al., 2008; Miller, 2002). 
Women typically have a smaller body surface area than men which in turn is 
associated with smaller size of heart and correspondingly diminutive coronary arteries 
(McLarty, Mann, Lawson, & Foster, 2003). In addition, women are more likely to 
have co-morbid disease such as hypertension, diabetes or obesity than men (Hassan, 
Chiasson, Buth, & Hirsch, 2005). These include higher risk factors for operative 
mortality in female than male gender (Levy et al., 2007). 
Even though, women perceive the severity and frequency of symptoms more 
than men (Bengtson et al., 2000; Lovlien et al., 2006; Omran & Al-Hassan, 2006), 
men are more likely to seek treatment than women as they are more ready to perceive 
their symptoms as cardiac experience than women (Lefler & Bondy, 2004). 
Additionally, women are less likely to seek treatment than men due to families and 
social responsibilities (Arslanian-Engoren, 2000). 
3) Stress. Patients waiting for CABG experience severe stress (Jonsdottir &  
Baldursdottir, 1998). Stress situations are associated with the severity of symptoms, 
especially chest pain (Bengtson et al., 2000; Canto, 2007; Jonsdottir & Baldursdottir, 
1998). Stress ultimately affects the coronary blood flow (Stone, 1990 as cited in 
Jonsdottir & Baldursdottir, 1998). Patients who reports CAD as life stressor have 1.3 
times increased exertional chest pain compared with the patients who do not reports 
CAD as life stressor (Canto et al., 2007). Therefore, effective stress management 
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should be paid more attention in patients waiting for CABG for preventing the 
undesirable symptoms, especially chest pain.  
4) Socioeconomic status. Socioeconomic status is associated with the health  
status of patients waiting for CABG. Patients who have higher education and receive 
higher incomes have higher self-management ability resulting in better health status 
(Suwanno, 2007). MacMahon and Lip (2002) found that patients belonging to low 
socio-economic classes are observed to have greater suffering from symptoms, poor 
psychosocial wellness, and poor health outcome. Patients with inappropriate personal 
resources have higher levels of depression, stress, hostility, anger, anxiety and 
uncertainty over time and take longer or fail to return to normal daily activities, work, 
and social activities.  
Health and Illness Domain 
Health and illness domain consists of smoking, severity of illness, and co-
morbid disease as follows: 
1) Smoking. Smoking is one of the most important risk factors which affect  
the genesis of CAD (Vartiainen et al. as cited in Koivula et al., 2002). It is the major 
risk factor for sudden death and angina pectoris because it produces vasospasm, 
especially coronary spasm (Sugiishi & Takatsu, 1993). The smokers compared with 
non-smokers are significantly more likely to report exertional chest pain (Patel et al., 
2003). Although patients know that smoking is a major cause of symptom severity, 
some patients waiting for CABG keep on smoking, because they do not perceive the 
symptoms as very severe (Jonsdottir & Baldursdottir, 1998). 
2) Severity of illness. The severity of illness is the major predictive factor for  
urgency and death in waiting time for CABG. Morgan et al. (1998), Ray et al. (2000), 
and Rexius et al. (2004) found that the risk factors for death includes left main stem 
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stenosis, impaired left ventricular function, and unstable angina pectoris. Regarding 
the severity of angina, it depends on the infarction size that is measured by CPK level 
(Omran & Al-Hassan, 2006). In addition, heart failure of class III or IV is risk factors 
for sudden death in waiting period of CABG (Cesena et al., 2004). 
3) Co-morbid disease. Common co-morbid diseases of patients with  
cardiovascular disease are such as hypertension, diabetes, dyslipidemia (cholesterol 
was higher than 240 mg/dl or 6.22 mmol/l), and obesity (Hassan et al., 2005). These 
co-morbid diseases are risk factors of death for the patients in the waiting period 
(Cesena et al., 2004; Rexius et al., 2004; Seddon et al., 1999). Moreover, patients 
having co-morbid disease perceived more severe chest pain than patients who do not 
have it (Bengtson et al., 1996). Similar to Patel et al. (2003), they revealed that 
diabetes and hypertension are associated with an increased likelihood of exertional 
chest pain.  
Environment Domain 
Environment domain includes social support and culture as follows: 
1) Social support.  Social network of patients waiting for CABG is an  
important factor to assist patients for managing their symptoms. Emotional support 
from social network, particularly from family members and relatives can be important 
source to reduce anxiety (Koivula et al., 2002). For example, men get help quickly 
when they experience symptoms because their wives feel anxious and take control, by 
promptly asking for help for their husbands, thus the patients can be assisted from 
health care provider or others timely (Foster & Mallik, 1998). 
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2) Culture. Culture aspects of the environment are beliefs, values and  
practices that are unique to ones identified ethnic, racial, or religious group (Dodd et 
al., 2001). Culture beliefs can influence the symptom perception, symptom 
evaluation, and symptom management (Kleinman, Eisenberg, & Good, 2006).     
Conclusion 
From the literature review, it can be concluded that patients waiting for CABG 
suffered from both physical and psychological symptoms, but how they can 
experience and interpret the symptoms in their lives may differ. From this situation, it 
is clarified that symptom management is related to how the symptoms are perceived 
by patients; whether they are bothered by symptoms or they are not active in decision 
making for the use of symptom management strategy. In this study, there are two 
types of symptom management strategies including pharmacological and non-
pharmacological management strategies that can help the patients to remove or 
minimize the adverse effect of symptoms, but some symptom management may not 
be effective to relieve the symptoms. The effectiveness of using symptom experience 
and symptom management can reduce the adverse events and mortality rate. 
Moreover, it also associated with general health status of patients waiting for CABG 
that is the indicator for evaluation of the symptom outcome in this study. However, 
based on the literature review up to date, the previous studies were done in the 
western countries that may not explain the symptom experiences, symptom 
management, and symptom outcomes of Thai patients waiting for CABG because of 
different cultural and social contexts. Therefore, this study was conducted to describe 
the symptom experiences, symptom management, and symptom outcomes of Thai 
patients who were waiting for CABG at home.  
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CHAPTER 3 
METHODOLOGY 
The descriptive study describes the symptom experiences, symptom 
management, and symptom outcomes in the patients waiting for CABG. 
Population and Setting 
 The target population was adult and elderly patients who were scheduled for 
CABG by the cardiac surgeon but were on waiting list, and attending the surgical and 
medical outpatient department (OPD) of Songklanagarind Hospital. The subjects were 
recruited from the surgical and medical OPD. From the waiting list registration 
records, the average admission rate of the patients from 2007 to 2008 ranged from 
100 to 105 cases (Waiting list for CABG, Songklanagarind Hospital, 2008). The 
subjects were patients who were waiting for CABG during 2007 to 2008.  
Sample 
Sample size 
The researcher proposed to collect 80 subjects based on the estimated 
population. However, the researcher was not able to collect the required number of 
subjects because of time limitations and fewer cases were on the waiting list during 
data collection period than expected. Sixty patients waiting for CABG participated in 
the study.  
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Sampling design 
Subjects were recruited using purposive sampling. The inclusion criteria for  
their recruitment were as follows: 
1) Be appointed for CABG by the cardiac surgeon and will be on the waiting  
list more than one month. 
2) Be fully conscious and able to communicate in Thai language. 
Instrumentation 
The instruments comprised of four parts to assess symptom experiences, 
symptom managements, and symptom outcomes in patients waiting for CABG 
(Appendix B). 
1)  Demographic and Health-Related Data Form   
The Demographic and Health-Related Data Form was developed by the 
researcher. It was composed of two parts. Part one was used to assess patients’ 
demographic data related to gender, age, marital status, religion, educational level, 
occupation, family income, medical payment, residential area, and number of family 
members. Part two was used to assess health related data including family history of 
CAD, smoking habits, drinking habits, co-morbidity, length of waiting for CABG, 
medication currently taken, and clinical examination. These data were obtained from 
interviews and medical records. 
2) Symptom Experiences Questionnaire (SEQ)  
The SEQ was developed by the researcher based on the Symptom 
Management Model (Dodd et al., 2001) and the literature review. Symptom 
experiences consisted of symptom perception and symptom evaluation. Symptom 
perception of patients waiting for CABG consisted of 22 most common symptom 
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occurrences including 17 physical symptoms that are chest pain/chest discomfort, 
chest pain with referred pain, epigastric pain, dyspnea/shortness of breath/difficulty 
breathing, dizziness/blackness/fainting/light-headedness, upper extremity numbness, 
edema of the extremities, sweating/diaphoresis, clammy limbs, heartburn, 
indigestion/abdominal distension, nausea/vomiting,  fatigue/weakness, palpitation, 
tachyarrhythmia, coughing, and bored with food  and 5 psychological symptoms are 
uncertainty, fear/fright, stress/anxiety, sad, and insomnia.  
Each symptom was assessed for its occurrence using a checklist (yes/no) 
format. If it was checked as “yes” then subjects were asked to rate its frequency and 
severity. Frequency of symptom occurrence was evaluated using a four-point Likert-
type scale ranging from rarely, sometime, almost all of the time, and all of the time. 
Severity of symptom occurrence was evaluated using a four-point Likert-type scale 
ranging from mildly severe, moderately severe, very severe, and extremely severe.  
3) Symptom Management Questionnaire (SMQ)   
The SMQ was used to assess the symptom management of the patients waiting 
for CABG. It was developed by the researcher based on the Symptom Management 
Model (Dodd et al., 2001) and the literature review.  The questionnaire was in the 
form of open-ended questions. If each symptom experience was answered then 
subjects were asked to describe the symptom management in the statements in terms 
of what, when, where, why, how much, to whom, and how related to each symptom 
occurrence. 
4) Symptom Outcomes Questionnaire (SOQ) 
The SOQ was used to assess the symptom outcomes of patients waiting for 
CABG. This tool consists of two parts. Part 1 was used to assess the symptom status 
of patients waiting for CABG. It was the checklist format which includes conditions 
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such as getting better, no change, and getting worse. Part 2 was SF-36 which was used 
to assess the health status of patients waiting for CABG. SF-36 V2 was developed to 
measure the health status among healthy people and several groups of people with 
chronic diseases. It covers two main dimensions of physical and mental health (Ware, 
2000). The SF-36 V2 was developed from the SF-36 V1 and was used to measure the 
physio-psychosocial well-being (Behavioral Epidemiology Unit {BEU}, 1995). The 
original SF-36 V2 was translated into Thai language by Methakanjanasak in 2005 
(Wongpiriyayothar, 2006). The reliability coefficient of the SF-36 V2 was tested for 
the well-being in 92 congestive heart failure patients and the obtained Cronbach’s 
alpha coefficient was 0.93 (Wongpiriyayothar).  
 The SF-36 V2 consists of 36 items which measure the eight dimensions of 
general health (GH: 5 items), physical functioning (PF: 10 items), role limitations due 
to physical health problems (RP: 4 items), role limitations due to emotional problems 
(RE: 3 items), bodily pain (BP: 2 items), social functioning (SF: 2 items), vitality 
(VT: 4 items to evaluate energy and fatigue), and mental health (MH: 5 items) (BEU, 
1995). 
The SF-36 V2 can be used for self-administration or administered by an 
interviewer. The response to the questions on each scale is summed to provide eight 
subscale scores ranged from 0 to 100. Total score ranges from 0 to 100. Person having 
a high score represents better health status than a person having a low score. There is 
a single unscaled item (Q2) which measures the changes in respondents’ health over 
the past year (BEU, 1995). It is a Likert-type scale which consists of a five-point scale 
(0, 25, 50, 75, 100) for item Q1, Q4a-4d, Q5a-5c, Q6, Q8, Q9a-9i, Q10, Q11a-11d, 
three-point scale (0, 50, 100) for item Q3a-3j, and six-point scale (0, 20, 40, 60, 80, 
100) for item Q7. Each response of a question is converted to 0 to 100. 
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In this study, the total score was classified into three levels using criteria 
identified by Wongpiriyayothar (2006). Scores of 0 to 33.33 indicates low perceived 
health status, 33.34 to 66.67 indicates moderate perceived health status, and 66.68 to 
100 indicates high perceived health status  
Validity of instruments   
 The contents of four instruments were validated by three experts. Among three 
experts one expert was lecturer in Faculty of Nursing at Maha sarakham University 
and the second expert was a cardiovascular nurse specialist at the Cardiac Care Unit 
of Ramathibodi Hospital, Mahidol University. Third expert was a cardiac surgeon 
from the Department of Surgery, Songklanagarind Hospital, Faculty of Medicine. The 
instruments were evaluated for relevance regarding symptom experiences, symptom 
managements, and symptom outcomes in patients waiting for CABG. The researcher 
then modified the contents based on the experts’ recommendations. 
Reliability of instruments 
The Thai version SF-36 was tested for its internal consistency in 20 patients 
waiting for CABG, who came for a follow up at Songklanagarind Hospital from 
which the Cronbach’ s alpha coefficient obtained was found to be 0.88. The internal 
consistency coefficient tested in a sample size of 60 subjects in this study was found 
to be 0.79.  
Ethical Considerations 
1. Approval from the Institutional Review Board of the Faculty of Nursing,  
Prince of Songkla University was obtained. 
 2. Permission to conduct this study was obtained from the Director of 
Songklanagarind Hospital. 
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3. Permission for data collection was obtained from the Heads of the surgical  
and medical OPD involved in the study.   
 4. The researcher explained the purpose of the study to eligible subjects. 
Subjects who were willing to participate in the study gave oral and written consent 
(Appendix A). They received further explanation about the study. They were also 
informed that they had a right to stop or continue from the study for any reason 
without fear of any negative consequences to the care provided to them. Researcher 
used the coding system to identify the subjects. Subjects were assured of anonymity, 
confidentiality of all information given, and that the use of such information was only 
for the purpose of this study.  
 5. After the subjects wrote the informed consent, the researcher started 
collecting data. 
Data Collection  
 Data were collected after the permission was obtained from the Director of 
Songklanagarind Hospital, and the Heads of the surgical and medical OPD. The 
researcher explained the objectives, design and duration of the study to the Heads 
Nurses in two OPDs. 
Data collection procedures   
1. The researcher assessed the patients from the waiting list for CABG of  
four cardiac surgeons according to the next follow up. The selected patients’ name, 
age, diagnosis, and date of follow up were recorded. 
2. The patients’ medical records were reviewed to obtain the primary  
information about their health profile. 
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3. Patients who felt comfortable and conscious were chosen. Subjects who  
met the inclusion criteria were approached to participate and were informed about the 
objectives and purpose of the study by the researcher. 
4. Patients who agreed to participate were then requested to give verbal  
consent and the researcher explained the components of the questionnaire. 
5. The subjects were interviewed by using the questionnaire. Symptom  
occurrence, symptom frequency, symptom severity, symptom management and 
symptom outcomes were asked in detail. Before completing the questionnaire, the 
subjects were asked to repeat and ensure their responses. The questionnaire would 
take about 30 to 40 minutes for person to be completed. 
6. Upon submission the researcher checked for completeness of the  
questionnaire; if any item was missing, subjects were asked to complete it.  
Data Analysis  
Data were processed by computer software. According to the objectives of the 
study and the level of measurement of the variables, the procedures of data analysis 
were as follows: 
1. Demographic and health related data were analyzed using frequency,  
percentage, mean, and standard deviation. 
2. Symptom occurrence, frequency, and severity of symptoms were analyzed  
using frequency and percentage. 
3. Symptom management was analyzed using simple content analysis. 
4. Symptom outcomes were analyzed into two parts. In part 1, the symptom  
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status resulting from symptom management was analyzed using frequency and 
percentage. In part 2, the health status was analyzed using mean and standard 
deviation.  
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CHAPTER 4 
RESULTS AND DISCUSSION 
Results 
The descriptive study was designed to study symptom experiences, symptom 
management and symptom outcomes of patients waiting for CABG. The results and 
discussion of this study were presented in two parts as follows:  
Part 1: Demographic and health related data 
Part 2: Symptom experiences, symptom management, and symptom outcomes 
of patients waiting for CABG  
Part 1: Demographic and Health Related Data 
 Most of the subjects in this study were men (73.3%) with a mean age of 62.92 
years old. Majority of them were Buddhist and married. About two-thirds of subjects 
had undergone primary school education, half of subjects were laborer and 
approximately one-fourth of them had income of 5,000 to 10,000 baht per month. 
More than half of the subjects used universal coverage scheme (30 baht) and lived out 
of Songkhla province. Most subjects stayed outside the Songkhla province with at 
least three members of the family (Table 3). 
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Table 3 
Frequency and percentage of subjects classified by demographic data (N = 60) 
Characteristics N %
Gender   
 Male 44 73.3
 Female 16 26.7
Age (year) (M = 62.92, SD = 8.1, Range = 42-80)  
 36-60 24 40.0
 > 60 36 60.0
Marital status   
 Single    3   5.0
 Married 46 76.7
 Divorced/widowed  11 18.3
Religion   
 Buddhist 51 85.0
 Muslim   9 15.0
Educational level  
 Primary school  38 63.3
 High school  14 23.3
 Diploma/bachelor    8 23.4
Occupation    
 Unemployed 21 35.0
 Retired   7 11.6
 Laborer/employee  
(farmer, gardener) 
30 50.0
 Government officer/ 
entrepreneurship 
  2   3.4
Income of family (baht per month)  
 < 5,000  13 21.7
 5,000-10,000 16 26.7
 10,001-20,000 11 18.3
 20,001-30,000 12 20.0
 > 30,000    8 13.3
Medical payment  
 Universal coverage scheme  
(30 baht)  
36 60.0
 Health insurance   4   6.7
 Self payment   1   1.7
 Government support 19 31.7
Residential area  
 Songkhla province 19 31.7
 Out of Songkhla province 38 63.3
Number of family members who stay with the 
patient 
 
 
 < 3 persons 22 36.7
 3 persons or more 38 63.3
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Most subjects (70.0%) had no family history of CAD. Nearly half of subjects 
(46.7%) stopped smoking, only 13.3% still smoked, and 96.7% does not drink 
alcohol. Most of the subjects have more than one underlying disease, the three most 
reported were hypertension (63.3%), dyslipidemia (51.7%), and diabetes (36.7%). 
According to duration of waiting for CABG, it was found that 31.7% of subjects 
waited for four to six months, followed by 25.0% waited for one to three months, and 
18.3% waited more than one year. The four mostly used medicines currently taken 
were Isosorbide dinitrate (ISDN), aspirin (ASA), anti-lipidemia, and beta-blockers. 
The majority of subjects was diagnosed with triple-vessel disease either proximal or 
non-proximal left anterior descending (LAD) involvement. For subjects who had 
ejection fraction (EF) test, it was found that the highest number of subjects had EF 50 
to 65% (n = 13), but the result of EF of 20 subjects was not specified in patients’ 
record. The least number of subjects had EF less than 30% (n = 8). More than half had 
no history of revascularization. By examination of cardiac function status at the first 
diagnosis to current status, it was found that half of subjects had increased New York 
Heart Association (NYHA), from class I to II (11.7%), from class I to III (1.7%), from 
class II to III (26.6%), and from class III to IV (10.0%), and only one subject had 
better NYHA (Table 4).   
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Table 4 
Frequency and percentage of subjects classified by health related data (N =60) 
Characteristics N %
Family history of CAD  
 No 42 70.0
 Yes 18 30.0
Smoking habits  
 
 
 
Non-smoking 
Stop smoking  
Smoking, but less now  
24 
28  
   8  
40.0 
  46.7 
23.3
Alcohol drinking habits   
 No  58 96.7
 Yes   2   3.3
Co-morbid disease  
 No    7 11.7
 Yes * 53 88.3
      Hypertension 38 63.3
      Dyslipidemia 31 51.7
      Diabetes  22 36.7
      Gout   9 15.0
      Renal insufficiency   9 15.0
      Valvular heart disease   5   8.3
      Congestive heart failure   3   5.0
      Others 18 34.0
Duration of waiting for CABG (months)  
 1-3  15 25.0
 4-6 19 31.7
 7-9   5   8.3
 10-12  10 16.7
 > 12 11 18.3
Medication currently taken * 
 Isosorbide dinitrate 58 96.7
 Aspirin 58 96.7
 Anti-lipidemia 56 93.3
 Beta-blockers 55 91.7
 Angiotensin-converting   
      enzyme inhibitor 
38 63.3
 Omeprazole 31 57.4
 Diuretic 26 43.3
 Calcium antagonists 22 36.7
 Anti-diabetic drugs 21 35.0
 Anti-ischemic drugs 10 16.7
 Isosorbide dinitrate 10 16.7
 Sedatives   7 11.7
 Others 28 46.7
* Patients reported more than one answer 
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Table 4 (Continued) 
Characteristics N %
Diagnosis  
 1-or 2-vessel disease   7 11.7
 3-vessel disease, no proximal 
LAD  involvement  
22 36.7
 3-vessel disease and proximal 
LAD involvement  
29 48.3
 Left main artery disease   2   3.3
Ejection Fraction (%)  
 < 30   8 13.3
 30-49 10 16.7
 50-65 13 21.7
 > 65 9 15.0
 No result 20 33.3
Revascularization  
 No 39 65.0
 Yes  21 35.0
      Thrombolysis   1   4.8
      Heparinization   2   9.5
      PTCA 18 85.7
NYHA Classification   
 At the first diagnosis ! Current status  
      Class II (no change) 21 35.0
      Class III (no change) 6 10.0
      Class IV (no change)   2 3.3
      Class I  ! Class II 7 11.7
      Class I  ! Class III 1 1.7
      Class II ! Class III 16 26.6
      Class III ! Class IV 6 10.0
      Class IV ! Class III 1 1.7
Note: LAD = left anterior descending  
      PTCA = percutaneous transluminal coronary angioplasty  
      NYHA = New York Heart Association 
Part 2: Symptom Experiences, Symptom Management and Symptom Outcomes of 
Patients Waiting for CABG 
Symptom experiences of patients waiting for CABG 
Twenty five symptoms, both physical and psychological symptoms were 
reported. The five top most common physical symptom occurrences were chest 
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pain/chest discomfort (80.0%), fatigue/weakness (66.7%), chest pain with referred 
pain (55.0%), indigestion/abdominal distension (51.7%), and dyspnea/shortness of 
breath/difficult breathing (50.0%). The five least reported symptom occurrences were 
constipation (18.3%), nausea/vomiting (15.0%), clammy limbs (13.3%), joint 
pain/muscle strain (8.4%), and diarrhea (1.7%). Most of the common physical 
symptom occurrences were reported as rarely occurred, except indigestion/abdominal 
distension that occurred almost all of the time (48.4%). Patients perceived these 
common symptom occurrences as being mild, but chest pain with referred pain were 
reported as being very severe (51.5%). Moreover, other physical symptoms such as 
nausea/vomiting (66.7%), sweating/diaphoresis (61.1%), and joint pain/muscle strain 
(60.0%) were reported as very severe (Table 5).  
Almost half of subjects reported psychological symptoms. The common 
psychological symptom occurrences were fear/fright (48.3%), stress/anxiety (48.3%), 
and uncertainty (46.7%). As some patients said “…I don’t want to get the cardiac 
surgery because I feel fear about the complications of cardiac surgery and death…”, 
“…I am worried  whether I can work due to chest pain…”, and “…I don’t know the 
future, when will I get the chance of undergoing cardiac surgery…”. Most of 
psychological symptoms occurred all the time. However, patients perceived them as 
mildly severe (Table 5). 
 From additional analysis, when each symptom experience was compared with 
gender by Chi-square Test, it was found that some of the symptoms were more 
significantly reported by male than female patients (p < .05). These symptoms were 
uncertainty and fear/fright (Table 6). In addition, chest pain with referred pain 
occurred more likely in patients aged over 60 years compared to those who aged less 
than 60 years (p < .05) (Table 7).  
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Symptom management of patients waiting for CABG 
The strategies used to manage symptoms were composed of three groups  
including (1) pharmacology, (2) non-pharmacology, and (3) combining both methods.  
The symptom management strategies that were used to manage chest pain/chest 
discomfort and chest pain with referred pain were quite similar. Most of subjects 
(79.1%,) used pharmacological management strategy to manage these symptoms such 
as taking ISDN. In addition, non-pharmacological management strategy was also used 
to manage the symptoms such as resting, chest thumbing, massaging/rubbing or 
moving the arms, and waiting and seeing/enduring. Only few subjects used the 
combination of both methods (Table 8). 
 Regarding fatigue/weakness, all subjects used non-pharmacological strategies 
to manage this symptom and the most common strategies were resting (82.5%) (Table 
9). For managing indigestion/abdominal distension, both pharmacological and non-
pharmacological management strategies were used. However, most of subjects 
(67.7%) used pharmacological strategies such as taking laxative, antacid, soothing 
medicine, and curcuma. In addition, some subjects (32.3%) used non-pharmacological 
strategies such as belching, abdominal compressing, waiting and seeing, and avoiding 
gas-inducing diet (Table 10). According to dyspnea, most subjects (80.0%) used non-
pharmacological management strategy and the highest number of subjects with 
dyspnea (40%) usually used relaxation technique (Table 11).      
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Table 5 
Frequency and percentage of symptom experiences reported by patients waiting for CABG (N = 60) 
   Frequency Severity 
 
Symptoms * 
 
N 
 
% 
Rarely Sometime Almost 
all  
the time 
All  
the time 
Mildly 
severe 
Moderately 
severe 
Very 
severe 
Extremely 
severe 
N % N % N % N % N % N % N % N % 
1. Chest pain/chest  
     discomfort 
48 80.0 20 42.6 12 25.5 15 31.9 - - 20 42.6 15 31.9 9 19.1 3 6.4 
2. Fatigue/weakness 40 66.7 13 32.5 20 50.0 5 12.5 2 5.0 23 57.5 8 20.0 9 22.5 - - 
3. Chest pain with   
     referred pain 
33 55.0 14 42.4 8 24.2 11 33.3 - - 7 21.2 7 21.2 17 51.5 2 6.1 
4. Indigestion/   
     abdominal    
     distension 
31 51.7 6 19.4 8 25.8 15 48.4 2 6.4 15 48.4 11 35.5 5 16.1 - - 
5. Dyspnea/shortness  
     of breath/difficult 
     breathing 
30 50.0 14 46.7 8 26.7 7 23.3 1 3.3 14 46.7 6 20.0 9 30.0 1 3.3 
6. Fear/fright 29 48.3 5 17.2 11 38.0 12 41.4 1 3.4 14 48.3 5 17.2 10 34.5 - - 
7. Stress/anxiety 29 48.3 7 24.1 8 27.6 14 48.3 - - 15 51.7 5 17.2 9 31.1 - - 
8. Uncertainty 28 46.7 4 14.3 12 42.9 10 35.7 2 7.1 18 64.3 2 7.1 7 25.0 1 3.6 
9. Tachyarrhythmia 27 45.0 15 55.6 8 29.6 4 14.8 - - 14 51.9 6 22.2 5 18.5 2 7.4 
10. Epigastric pain 25 41.7 12 48.0 7 28.0 6 24.0 - - 13 52.0 9 36.0 2 8.0 1 4.0 
11. Upper extremity  
       numbness 
25 41.7 9 36.0 8 32.0 4 16.0 4 16.0 21 84.0 1 4.0 3 12.0 - - 
*Patients reported more than one symptom 
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Table 5 (Continued) 
   Frequency Severity 
 
Symptoms * 
 
N 
 
 
% 
Rarely Sometime Almost 
all the 
time 
All  
the time 
Mildly 
severe 
Moderately 
severe 
Very 
severe 
Extremely 
severe 
N % N % N % N % N % N % N % N % 
12. Insomnia 25 41.7 3 12.0 11 44.0 11 44.0 - - 11 44.0 5 20.0 9 36.0 - - 
13. Palpitation 23 38.3 14 60.9 5 21.7 4 17.4 - - 13 56.5 5 21.8 2 8.7 3 13.0 
14. Dizziness/ 
       blackness/ 
       fainting/   
       lightheadedness 
22 36.7 8 36.4 7 31.8 7 31.8 - - 14 63.6 2 9.1 6 27.3 - - 
15. Coughing 22 36.7 5 22.7 9 40.9 8 36.4 - - 16 72.7 1 4.6 5 22.7 - - 
16. Sad 19 31.7 6 31.6 8 42.1 5 26.3 - - 12 63.2 4 21.1 3 15.7 - - 
17. Edema of the  
       extremities 
18 30.0 8 47.1 5 29.4 4 23.5 - - 11 64.7 5 29.4 1 5.9 - - 
18. Loss of appetite 18 30.0 1 5.6 15 83.3 2 11.1 - - 11 61.1 6 33.3 1 5.6 - - 
19. Sweating/ 
       diaphoresis 
15 27.8 14 77.8 1 5.6 3 16.6 - - 5 27.8 2 11.1 11 61.1 - - 
20. Heartburn 11 18.3 4 36.4 2 18.2 5 45.4 2 6.4 5 45.5 2 18.2 4 36.3 - - 
21. Constipation 11 18.3 1 9.1 4 36.4 6 54.5 - - 6 54.5 4 36.4 1 9.1 - - 
22. Nausea/vomiting   9 15.0 6 66.7 - - 3 33.3 - - 3 33.3 - - 6 66.7 - - 
23. Clammy limbs   8 13.3 5 62.5 1 12.5 2 25.0 - - 4 50.0 3 37.5 1 12.5 - - 
24. Joint pain/muscle  
       strain 
  5   8.4 - - 2 40.0 3 60.0 - - 1 20.0 1 20.0 3 60.0 - - 
25. Diarrhea   1   1.7 - - - - 1 100 - - - - - - 1 100 - - 
*Patients reported more than one symptom
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Table 6 
Comparison of the subjects’ experiences on symptom occurrences classified by 
gender (N = 60) 
 
Symptom occurrence 
         Gender X2
                Male  
           n (%)  
            Female 
        n (%)  
Uncertainty 20 (60.6%) 13 (39.4%) .014*
No uncertainty 24 (88.9%) 3(11.1%) 
Fear/fright 18 (60.0%) 12 (40.0%) .020*
No fear/fright 26 (86.7%) 4 (13.3%) 
*= p < .05  
Table 7 
Comparison of the subjects’ experiences on symptom occurrences classified by age  
(N = 60) 
 
Symptom occurrence 
     Age (years) X2
           36-60 
           n (%)     
                 > 60 
                n (%)  
Chest pain with referred pain 17 (51.5%) 16 (48.5%) .044*
No chest pain with referred pain 7 (25.9%) 20 (74.1%) 
*= p < .05  
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Table 8 
Frequency and percentage of subjects’ management strategies when experienced with 
chest pain and chest pain with referred pain  
 
Strategies 
      Chest pain 
      (n = 48) 
Chest pain with
          referred pain 
          (n = 33) 
N % N %
1. Pharmacological (ISDN) 38 79.1 15 45.5
2. Non-pharmacological  
   2.1 Resting 8 16.7 9 27.3
   2.2 Chest thumbing 1 2.1 - -
   2.3 Massaging/rubbing the  
         arms/moving the arms 
- - 4 12.1
   2.4 Waiting and seeing/enduring - - 4 12.1
3. Combination of  both the methods 
    (Pharmacological and 
resting/massaging) 
1 2.1 1 3.0
Table 9 
Frequency and percentage of subjects’ management strategies when experienced with 
fatigue/weakness (n = 40) 
 
Strategies 
       Fatigue/weakness  
N %
Non-pharmacological  
     1. Resting 33 82.5
     2. Waiting and seeing 5 12.5
     3. Consuming sweetie and sweet water 2 5.0
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Table 10 
Frequency and percentage of subjects’ management strategies when experienced with 
indigestion/abdominal distension (n = 31) 
 
Strategies 
Indigestion/abdominal 
distention 
N %
1. Pharmacological (laxative, antacid, soothing   
    medicine (Ya-Hom), curcuma (Ka-Min-Chan) 
21 67.7
2. Non-pharmacological  
    2.1 Belching, abdominal compressing 4 12.9
    2.2 Waiting and seeing 4 12.9
    2.3 Avoiding gas-inducing diet 2 6.5
Table 11 
 Frequency and percentage of subjects’ management strategies when experienced 
with dyspnea (n = 30) 
 
Strategies 
Dyspnea  
N %
1. Pharmacological (ISDN, inhalant) 6 20.0
2. Non-pharmacological  
    2.1 Relaxation (resting, deep breathing, meditation) 12 40.0
    2.2 Positioning (body straightening, turning over) 6 20.0
    2.3 Waiting and seeing 6 20.0
Regarding psychological symptoms (stress/anxiety, fear/frighten, uncertainty, 
and sadness), only non-pharmacological management strategy was applied to manage 
these symptom occurrences in patients waiting for CABG in this study. Non-
pharmacological strategies were classified into four groups including, religious 
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coping, positive thinking, distraction, and seeking information. The highest number of 
subjects used religious coping such as accepting/resigning, praying/reading religious 
books, meditation, and going temple for managing these psychological symptoms. 
Moreover, some subjects also seek information (Table 12).       
Table 12 
Frequency and percentage of subjects’ management strategies when experienced with 
psychological symptoms  
 
Strategies 
Stress/ 
anxiety 
(n = 29) 
Fear/ 
fright 
(n = 29) 
Uncertainty 
(n = 28) 
Sad 
(n = 19) 
N % N % N % N %
1. Religious coping   
    1.1 Accepting/  resigning  
          (Tham-Jai/Plong)  
13 44.9 14 48.3 14 50.0 5 26.3
1.2 Prayer/reading    
  dharma book 
5 17.3 8 27.6 5 17.9 5 26.3
    1.3 Meditation 1 3.4 4 13.8 3 10.6 2 10.5
    1.4 Going temple 1 3.4 - - 1 3.6 - -
2. Positive thinking 4 13.8 - - 1 3.6 1 5.3
3. Distraction  
    (meeting friends) 
4 13.8 1 3.4 - - 5 26.3
4. Seeking information 1 3.4 2 6.9 4 14.3 1 5.3
Many reasons for managing the symptoms were given by the subjects in this 
study. Most of the subjects (80.0%) takes sublingual ISDN that it is an effective way 
to manage chest pain in terms of its convenience and its fast action for relieving their 
chest pain. In addition, most of subjects (75.0%) also provided the reasons that those 
strategies are effective to manage their symptoms which they have learnt from the 
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past experience. For example, using body straightening and deep breathing to manage 
with dyspnea. Nearly half of subjects (45.0%) thought that the symptoms will 
disappear or become better with time and they were able to tolerate these symptoms. 
Some subjects (16.7%) were suggested to take medications by other persons such as a 
physician and friends. Moreover, other reasons that were reported by subjects in this 
study includes that the initial strategy is ineffective, thinking that a symptom comes 
from a co-morbid disease, being inconvenient for seeking health-care service (the 
symptoms occurred at night time and being afraid of offending their children), and 
perceiving some particular symptoms as very severe (Table 13). 
Most of the subjects (88.4%) managed the symptoms when the symptoms 
have already occurred, but some subjects (8.3%) managed the symptoms when they 
are expected to occur and was related to some activities such as working and taking a 
bath (Table 14). In addition, most symptoms were managed at home. However, some 
subjects made decision to go to a hospital when some symptoms does not improved 
after managing the symptoms such as chest pain/chest discomfort, chest pain with 
referred pain, dyspnea, and nausea/vomiting (Table 15).  
Even though, most of symptom occurrences were primarily managed by 
patients but some patients also asked for help from their relatives. The symptom 
management strategy that was commonly used by the relatives was accompanying 
patients to a hospital (47.4%). Moreover, the relatives assisted the patients to manage 
with their symptoms by massaging, back thumbing, seeking information, and soothing 
(Table 16). 
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Table 13 
Frequency and percentage of the subjects’ reasons for their symptom management 
used (N = 60)  
Reasons* N %
1. Taking sublingual ISDN is an effective way to manage chest 
pain (in terms of its convenience when used, its fast action for 
relieving chest pain) 
48 80.0
2. The strategy which was learnt from the past experience is 
effective to manage a symptom  
45 75.0
3. Thinking that a symptom would disappear / become better and 
the subject will be able to tolerate the symptoms 
27 45.0
4. The strategy which is suggested by someone is effective in 
symptom management 
10 16.7
5. Thinking that a symptom is not severe and there is no need to be 
cautious 
4 6.7
6. The initial strategy is ineffective and another strategy can be 
used 
4 6.7
7. Thinking that a symptom comes from a co-morbid disease 4 6.7
8. Being inconvenient for seeking health-care service  4 6.7
9. Perceiving some particular symptoms as very severe  4 6.7
*Patients reported more than one reason 
Table 14 
Frequency and percentage of the subjects’ reports of condition to be managed  
(N = 60) 
Conditions for symptom management N %
1. When a symptom has already occurred 53 88.4
2. When a symptom is expected to be occurred related to 
some activities (i.e. working, taking a bath)  
5 8.3
3. No specify 2 3.3
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Table 15 
Frequency and percentage of the subjects’ reports of the place for managing the 
symptoms (N = 60) 
Place N %
1. Home 43 71.7
2. Hospital/Primary Care Unit 11 18.3
3. Working place/garden 4 6.7
4. No specify 2 3.3
Table 16 
Frequency and percentage of the subjects’ reports of getting assistance from the 
relatives (n = 19) 
Symptom management by relatives N %
1. Accompanying patients to hospital 9 47.4
2. Massaging 5 26.3
3. Back thumbing 2 10.5
4. Seeking information 2 10.5
5. Soothing 1 5.3
Symptom outcomes of patients waiting for CABG 
Symptom outcomes of patients waiting for CABG were composed of two 
parts including, symptom status and health status. After managing the symptoms, 
most of subjects reported of getting better for all symptoms (Table 17). Levels of 
health status scores for overall health status and for each dimension of health in 
patients waiting for CABG are displayed in Table 18 and 19. Overall health status 
reported by subjects was at moderate level (M = 59.56, SD = 18.14). Regarding health 
status in each dimension, it was found that the scores for health status in each 
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dimension was at moderate level, except the dimension of mental health was at high 
level (M = 74.27, SD = 21.47). 
Table 17 
Frequency and percentage of symptom status reported by patients waiting for CABG 
after managing the symptoms  
Symptom Getting better No change Getting worse 
N % N % N %
1. Chest pain/chest discomfort  
    (n = 48)  
40 83.3 - - 8 16.7
2. Fatigue/weakness (n = 40) 35 87.5 3 7.5 2 5.0
3. Chest pain with referred pain 
    (n = 33) 
31 94.0 1 3.0 1 3.0
4. Indigestion/abdominal   
    distension (n = 31)  
28 90.3 3 9.7 - -
5. Dyspnea/shortness of     
     breath/difficult breathing  
     (n = 30) 
27 90.0 - - 3 10.0
6. Fear/frighten (n = 29) 26 89.7 3 10.3 - -
7. Stress/anxiety (n = 29) 27 93.2 1 3.4 1 3.4
8. Uncertainty (n = 28) 26 92.9 2 7.1 - -
9. Sad (n = 19) 16 84.2 3 15.8 - -
Table 18 
Frequency and percentage of level of health status reported by patients waiting for 
CABG after managing their symptoms (N = 60) 
Level of health status N %
Low 4 6.7
Moderate 32 53.3
High 24 40.0
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Table 19 
Mean and standard deviation of health status reported by patients waiting for CABG 
(N = 60) 
Variables Possible 
scores 
M SD Level of 
health status 
General health 0-100 64.33 21.44 Moderate
   
Physical functioning 0-100 36.15 33.11 Moderate
   
Role limitations due to physical problems 0-100 66.42 29.98 Moderate
   
Role limitations due to emotional problems 0-100 49.17 24.91 Moderate
   
Social functioning 0-100 60.83 22.52 Moderate
   
Bodily pain 0-100 66.04 30.89 Moderate
   
Vitality 0-100 59.31 31.86 Moderate
   
Mental health 0-100 74.27 21.47 High
   
Overall health status 0-100 59.56 18.14 Moderate
Discussion 
The discussion of the results is presented in two parts as follows:  
Part 1: Demographic and health related data 
Part 2: Symptom experiences, symptom management, and symptom outcomes 
of patients waiting for CABG  
Part 1: Demographic and Health Related Data 
Sixty subjects were recruited as the samples in this study. Most subjects were 
male (73.3%) and nearly half of male patients have history of smoking. The higher 
proportion of males was congruent with the literature that shows the number of male 
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patients is higher than female patients among patients waiting for CABG (Levy et al., 
2007). This might be due to the fact that men have more risky behaviors such as 
smoking than women (Koivula et al., 2002).  
 In addition, the age of most subjects in this study was more than 60 years 
(60.0%). By the age of 60 years, CAD is a degenerative disease which is commonly 
occurs as a clinical problem (Pearlman et al., 2007). This finding is similar to the 
study conducted by Levy et al. (2007) who found that most patients waiting for 
CABG were above the age of 60. 
 The majority of subjects were married and stayed with family members 
consisting of at least three persons. This may be due to the fact that most subjects 
were elders and were having families. Regarding Thai culture, most of the elders 
usually live with their spouses and children because Thai people believe in the 
repayment for their parents’ goodness and usually live with their parents even after 
getting married (Choowattanapakorn, 1999). Parents are the supporters to the patients’ 
while the patients get sick. Koivula et al. (2002) also found that most patients waiting 
for CABG had four or more supporters. Their spouses and children are their social 
network. Spouse is one of the social network that is the best supporter for emotional 
and tangible aid because it is emotionally close in patients waiting for CABG 
(Koivula et al.).  
About two-third of subjects (63.3%) had primary school education which was 
a compulsory education in the previous time. Half of subjects were laborer/employee 
and the most of the subjects had monthly income of around 5,000 to 10,000 baht. 
With those occupation and income, they may not be able to cover their health care 
cost. However, their health care can be supported by government. In this study, most 
of the subjects (60.0%) used medical payment of universal health coverage scheme 
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(30 baht). According to the Thai government policy, the 30-baht scheme covers 
everyone who is not covered by other government-sponsored forms of insurance. It 
allows patients from different areas to gain access to the quality health service 
(NaRanong & NaRanong, 2006). This provides more health care opportunity for 
patients with CAD to get CABG procedure.   
 Nearly all the subjects (88.3%) had co-morbid disease and the top three co-
morbid diseases were hypertension (63.3%), dyslipidemia (51.75), and diabetes 
(36.7%). These diseases were common co-morbid medical conditions in patients with 
CAD (Hassan et al., 2005). In addition, during waiting for CABG the co-morbid 
disease can be developed (Levy et al., 2007).  
All the subjects in this study were accepted for elective CABG and were onto 
the waiting list for CABG. The highest number of subjects (31.7%) had waiting 
period for four to six months. Cesena et al. (2004) reported, waiting time for CABG 
surgery is around four months. In fact, waiting time for CABG should not be more 
than one week after diagnostic coronary angiography (CAG). Because the 
complications can always occur within four weeks after diagnostic CAG or early in 
the queuing process (Ray et al., 2001; Stott, 2002). However, there was no 
complication or death during the period of this study. Moreover, subjects were on the 
waiting list for elective CABG for at least one month due to the limited available 
facilities, for instance, shortage of cardiac surgeons and shortage of ICU bed. 
According to Songklanagarind Hospital, the proportion of cardiac surgeons and 
cardiac patient are imbalanced. There are only four cardiac surgeons whereas the 
numbers of cardiac patients are more than a hundred (V. Chittitaworn, personal 
communication, July 9, 2008). These findings are similar to Fox et al. (1998). In 
addition, it was found that the shortage of surgical and financial resources and the 
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shortage of ICU bed are the reasons for patients waiting for cardiac surgery (Cesena et 
al., 2004; Jonsdottir & Baldursdottir, 1998). Not only the dominant long waiting time 
comes from limited facilities, but it also comes from patients’ factors such as feeling 
of fear, feeling better after taking medication, being unready to have cardiac surgery, 
or lacking of family support. As one of the patient said that “…I don’t want to get the 
operation because my children are not available to take care of me during 
hospitalization…”. These findings were congruent with the literature that reported that 
the patients refused for the cardiac surgery because some felt fear about the 
complications after surgery, some are not ready at the time it is offered because of 
lack of social support, and some thought that they still healthy (NHS Trust, 2008).  
Medications prescribed for the subjects in this study varied according to the 
severity of the disease, the location of any blockages in the blood vessels, the 
presence of any risk factors (abnormal cholesterol profile or high blood pressure) and 
the overall health status of the patient (Elhendy et al., n.d.). According to this study, 
ISDN (96.7%) and ASA (96.7%) were the most common medications for the patients 
with CAD. Both medications are considered as the major medications of patient with 
CAD for relaxing or dilating the vessels and inhibiting the formation of blood clots to 
improve blood flow to the heart (Elhendy et al.; Grogan, 2008). Additionally, anti-
lipidemia, beta-blockers, ACE inhibitors and calcium antagonists were also 
prescribed. These medications were bused to control the risk factors as arising from 
the use of anti-lipidemia (Statins) to decrease the amount of cholesterol in the blood, 
especially LDL or bad cholesterol (Grogan). Moreover, beta-blockers, ACE inhibitors 
and calcium antagonists were prescribed to control high blood pressure for preventing 
the progression of CAD and reducing the risk of future heart attacks (Grogan). From 
the observation, another medication that was commonly prescribed to the subjects is 
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omeprazole (66.7%). It was usually prescribed together with ASA. Omeprazole is the 
most widely used anti-ulcer drugs and is known to be effective inhibitors of gastric 
acid secretion by preventing of the gastric mucosal damage caused by ASA 
(Nefesoglu, Ayanoglu-Dulger, Ulusoy, & Imeryuz, 1998).   
Most of the subjects (83.3%) who were diagnosed for triple-vessel disease, 
36.7% had triple-vessel disease with no proximal LAD involvement and 48.3% had 
triple-vessel disease with proximal LAD involvement. The CABG surgery is usually 
performed in patients with multi-vessel CAD (Fox et al., 1998). At least one of 
following indications will be included (1) significant (more than 50%) stenosis of the 
left main stem; (2) significant proximal stenosis of the three major coronary arteries; 
and (3) significant stenosis of two major coronary arteries, including high grade 
stenosis of the proximal LAD (Schofield, 2003). 
In addition, the impaired left ventricular function using EF needs to be 
accessed for surgical revascularization (Levy et al., 2005). EF is classified in four 
categories including normal (EF more than 65%), slightly diminished (EF 50 to 65%), 
diminished (EF 30 to 49%), and poor (EF less than 30%) (Koomen et al., 2001). The 
left ventricular function of subjects was slightly diminished which may be due to 
several factors. These are 1) having early detection and receiving medical treatment 
timely and 2) lifestyle modification from risk behavior. It was shown that 46.7% of 
subjects stopped smoking and 23.3% of subjects decreased smoking after they were 
diagnosed of CAD which can prevent further risks or complications during waiting 
for CABG (McHugh et al., 2001; Stott, 2002).   
Only 38.3% of subjects had experienced revascularization, 85.7% of them 
undergone revascularization by PTCA. PTCA is a procedure for treatment of 
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symptomatic CAD and acute occlusion of the coronary arteries, which is aimed to 
restore or improve perfusion of heart muscle tissue (Grogan, 2008).  
Half of the subjects have been found with worsening of NYHA. It may be due 
to the progression of CAD and co-morbid disease during waiting period. The co-
morbid conditions can be developed at the time of waiting for CABG that increased 
risks of worsening symptoms (Levy et al., 2007; Ray et al., 2001). During waiting 
time for CABG, severe left ventricular dysfunction, advanced angina, heart failure 
functional classes and high triglyceride level are developed (Cesena et al., 2004). 
However, nearly half of subjects had unchanged NYHA, it may be due to the fact that 
their conditions were not severe and their co-morbid diseases and CAD can be 
effectively controlled by medications.   
Part 2: Symptom Experiences, Symptom Management, and Symptom Outcomes of 
Patients Waiting for CABG 
Symptom experiences of patients waiting for CABG 
In this study, 25 symptoms, both physical and psychological symptoms were 
reported. From top five common physical symptoms, chest pain/chest discomfort 
(80.0%) was the most common symptom that was reported by the patients waiting for 
CABG. These findings are similar to a previous study which reports that the chest 
pain is a dominant physical symptom appearing among patients waiting for CABG 
(Arslanian-Engoren, 2005; Canto et al., 2007; Horne et al., 2000; Omran & Al-
Hassan, 2006). In addition, chest pain is the hallmark symptom of cardiac symptom in 
patients with CAD (Canto et al.). Chest pain is caused by narrowing of the coronary 
arteries because of ischemia of the cardiac muscle. Subsequently, when the heart tries 
to perform at a high level (such as during exercise or hard work), the narrowed artery 
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is incapable of delivering the required blood volume to the working muscle resulting 
chest pain (Warnica, 2007).  
Moreover, in this study other physical symptoms such as fatigue/weakness, 
chest pain with referred pain, indigestion/abdominal distention, and dyspnea/shortness 
of breath/difficult breathing were among the most common physical symptoms in 
patients waiting for CABG. It is possible that in CAD patients, their heart cannot 
pump enough blood to meet the need of their body, and thus shortness of breath or 
extreme fatigue on exertion are developed (Pearlman et al., 2007). The findings are 
congruent with a previous study which reports that the chest pain can be accompanied 
by shortness of breath, weakness, fatigue, nausea, sweating, or dizziness (Fogoros, 
2006). Moreover, chest pain with referred pain in this study occurred more likely in 
patients aged over 60 years compared to those who aged less than 60 years. It is 
possible that elderly patients in this study rarely took medications to manage their 
chest pain. Another reason may be because elderly patients with CAD tend to receive 
less aggressive medical therapy and fewer revascularization procedures than do 
younger patients (Kelly, 2007).     
The five least reported symptom occurrences were constipation, 
nausea/vomiting, clammy limbs, joint pain/muscle strain, and diarrhea. Even though 
these symptoms may not accurately associate with CAD, but they can be found in 
patients waiting for CABG. It may be due to the fact that most of the subjects were 
older in age (60.0%). Constipation is a very commonly reported among elderly 
patients (Harari, Gurwitz, Minaker, 1993) because of age-related physiologic changes 
and polypharmacy (Ginsberg, Phillips, Wallace, & Josephson, 2007). In addition, the 
constipation may relate to psychological symptoms such as stress/anxiety (Haug, 
Mykletun, & Dahl, 2002). In the present study, nearly half of the subjects reported 
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stress/anxiety. Distress and anxiety are associated with slow colonic transit as a 
possible etiological factor in constipation (Towers et al., 1994). Other symptoms, such 
as nausea/vomiting, clammy limbs, and diarrhea can be found in CAD patients which 
is similar to the findings of present study (Fogoros, 2006). Moreover 8.4% of the 
subjects in this study reported joint pain/muscle strain, it may be due to these subjects 
had co-morbid disease of Gout (15.0%).  
Moreover, various psychological symptoms also occurred during waiting for 
CABG, such as fear/frighten, stress/anxiety, and uncertainty. These psychological 
symptoms are consistent with the findings of previous studies (Bengtson et al., 1996; 
Ivarsson et al., 2004). Patients feel fear/fright about the cardiac surgery, complications 
of cardiac surgery, and death. Regarding additional interview, a patient said that “…I 
don’t want to undergo the surgery because I feel fear about the complications of 
cardiac surgery such as pain, inability to work and death…”. It may be due to lacking 
of information among the patient about cardiac surgery or misunderstanding about 
this procedure. The findings are congruent with a previous study conducted by 
Bengtson et al.  
Stress/anxiety was also presented as psychological symptoms during waiting 
for CABG. It may be due to the effect of symptoms or diseases on patients’ daily lives 
and jobs. In the present study, more than half of subjects (65%) were occupied on 
working role and they were the responsible person in making money for their family. 
But these subjects were unable to work due to their illness and physical incapacity 
which results in a decreased productivity. These situations caused economic burdens 
and stress.  Regarding additional interview, a patient said that “…I am worried, since 
I have got the disease and I can’t work due to the chest pain…”. The findings are not 
different from previous studies (Fitzsimons et al., 2003; Haddad et al., 2002; 
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Jonsdottir & Baldursdottir, 1998). Moreover, stress is associated with the severity of 
symptoms, especially chest pain (Bengtson et al., 2000; Canto, 2007). Stress can also 
affect coronary blood flow (Stone as cited in Jonsdottir & Baldursdottir, 1998).  
Moreover during waiting for CABG, patients may feel uncertainty about the 
future of their lives. As one patient said that “…I don’t know the future. What will 
happen next with my life?…”. It may be due to the subjects did not receive accurate 
information regarding the ongoing treatment. As a patient said that “…a physician 
doesn’t tell anything about my further treatment and my condition…”. This is 
consistent with the findings of the previous study which found uncertainty is the 
common psychological symptom in patients waiting for CABG (Bengtson et al., 
2000). Moreover, the patients waiting for CABG feel uncertainty due to their 
concerns about whether their symptoms will be treated in time or not, their financial 
situation, and the future of their families (Bengtson et al., 1996).   
Fear/fright and uncertainty in male were found significantly more than in 
female patients. It is possible that men hold the responsibility of being the head of 
family and they typically have multiple roles of responsibilities to their family as 
mentioned above, due to male patients feel more fear/fright while waiting for CABG. 
These findings are similar to Thai context that man is the head of the family and being 
ultimately responsible for the home and most authority in home belonged to men 
(Yoddumnern-Attig, Richter, Soonthorndhada, Sethaput, & Pramualratana, 1992). 
Those subjects who are unable to work due to physical incapacity, they may feel fear 
and uncertainty about how they and their family’s lives would be. Moreover, most 
psychological symptoms were found in higher proportion in female than male 
patients. It may be due to the ways the male patients used to cope up with stress such 
as alcohol drinking and cigarette smoking. 
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 Most physical and psychological symptoms were reported to occur rarely and 
as mildly severe, particularly chest pain/chest discomfort. Even though, chest pain is a 
dominant symptom in patients with CAD (Canto et al., 2007). Most subjects in this 
study reported that the symptoms occurred rarely and were mildly severe. This differs 
from a previous study which found the chest pain to occur frequently and as pretty 
severe (Dej-adisai, 2006). It is possible that nearly all the subjects in this study 
continuously took cardiac medication, particularly ISDN (96.7%) and ASA (96.7%). 
Both medications are the major medications for treating CAD patients. They are used 
for relaxing and dilating the vessels (Elhendy et al., n.d.) and inhibiting the formation 
of blood clots (Grogan, 2008) to improve blood flow in the arteries that encircle and 
supplies the heart leading to reduced chest pain (Elhendy et al.). Some patients took 
anti-lipidemia, beta-blocker, and ACE-inhibitors to control the risk factors of the 
progression of atherosclerosis (Grogan). In addition, approximately one-third of 
subjects in this study had undergone revascularization during waiting for CABG, 
including thrombolysis, heparinization, and PTCA. These procedures increase blood 
to flow into the heart muscle which may help to reduce the chest pain (AHA, 2008). 
Moreover, it is possible that the long period of waiting time was associated with 
perception of mildly severe symptoms.  Patients with a long-term history of a specific 
symptom often learn to catalogue various, discrete, and subtle sensations associated 
with the symptom (Dodd et al., 2001). Further half of subjects were laborer/employee 
(i.e. farmer, gardener, and carpenter) who may tolerate the symptom occurrences. 
 However, there were some symptoms that patients perceived as rarely 
occurred but were severe. Those symptoms included chest pain with referred pain 
(51.5%), sweating/diaphoresis (61.1%), and nausea/vomiting (66.7%). Even though 
these symptoms rarely occur, but most subjects perceived them as very severe. It may 
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be the reasons that these symptoms were presented as the concurrent symptoms of 
chest pain. Patients who reported chest pain with referred pain as very severe or 
extremely severe usually reported along with palpitation, nausea/vomiting, 
dizziness/blackness/fainting/ lightheadedness, and sweating/diaphoresis. These 
findings are similar to the findings of previous study (Kerry, Marjorie, Amy, & Viola, 
2002). These findings are supported by Dodd et al. (2001) who reported that the 
patients experienced symptom clusters perceiving the symptoms as more severe than 
patients experience single symptom.  
Symptom management of patients waiting for CABG. 
The occurrence and severity of symptoms have influence on patients waiting 
for CABG in seeking treatment and/or mange symptoms because of the impact of 
symptoms on the patients’ daily life. Dodd et al. (2001) stated that the goal of 
symptom management is overt or to delay a negative outcome through self-
management. However, management depends on the individual’s perception of the 
symptom experience, whether their symptoms affect their life or not by interaction of 
three components (symptom occurrence, symptom perception, and symptom 
evaluation) of symptom experience. Symptom management begins with assessment of 
the symptom experience from the individual’s perspective, followed by identifying 
the focus for intervention strategies (Dodd et al.). The management of symptoms may 
differ from an individual’s symptom management (Barsevick et al., 2002). In this 
study, there were three major symptom management strategies for managing the 
symptoms of patients waiting for CABG including pharmacological management 
strategy, non-pharmacological management strategy, and combining both methods. 
The discussion of symptom management in this study was classified on the basis of 
symptom experience.  
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In this study, the pattern of symptom management strategies that were used to 
manage the chest pain/chest discomfort and chest pain with referred pain were quite 
similar. It may be due to the fact that both symptoms were the typical symptoms that 
may have similar symptom characteristic. Patients perceived both symptoms as 
associated with cardiac problems (Horne et al., 2000). Most subjects usually managed 
by using pharmacological management strategies such as taking ISDN. ISDN is 
indicated for relieving or preventing the chest pain due to CAD. The mode of action 
of ISDN is to relax vascular smooth muscle and consequent dilation of peripheral 
arteries and veins, especially the latter one. Dilation of the veins promotes peripheral 
pooling of blood and decreases the venous blood to return to the heart, thereby 
reducing preload. Afterload is reduced due to arteriolar relaxation and thus dilation of 
the coronary arteries occur (Fung et al., 1981). The subjects in this study used ISDN 
because it is convenient to use and effective and rapid for relieving chest pain. 
Sublingual ISDN is used for instant relief in case of brief episodes of chest pain. It 
acts within five minutes (Soroka University Medical Center, 2008).  
The individual pattern of taking ISDN in this study was different. It depends 
on the experience of patients. In this study, some subjects took ISDN when the chest 
pain had occurred and some subjects took it before doing some kind of activities, for 
example, before working or taking a bath. Subjects provided the reasons that they 
learnt from their past experience and some subjects followed the suggestions given by 
the physician. The findings of present study support the fact that experience and 
interpretation of symptoms are the important sources of symptom management to 
encourage the patients for managing their symptoms (Horne et al., 2000).  
Additionally, non-pharmacological management strategies, including resting, 
chest thumbing, massaging/rubbing or moving the arms, and waiting and 
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seeing/enduring were also used to manage chest pain/chest discomfort and chest pain 
with referred pain in this study. Subjects provided the reasons that these strategies 
made them to relax and feel more comfortable. Resting helps the patients to relax and 
reduces the oxygen consumption by the cardiac muscle (Convertino, 1997). Only one 
subject used chest thumbing to relax the pain in chest muscle. Some patients used 
massaging at local area/rubbing or moving the arms to relax the arm muscles, which 
are similar to the findings of the study conducted by Dej-adisai (2006). Moreover, few 
subjects used pharmacological management strategies combined with resting and 
massage for relief chest pain. Combining both methods helped subjects to feel more 
comfortable than using only pharmacological method. This finding is similar to the 
previous study (Perry et al., 2001). 
Resting was the most common strategy for managing fatigue/weakness. It is 
possible that this strategy was effective in managing this symptom in the past 
experience. Resting is necessary for patients with heart disease. Energy conservation 
can be accomplished by resting (Redeker, Ruggiero, & Hedges, 2004). Some patients 
used waiting and seeing due to which they thought that this symptom was not severe 
and it will disappear. Moreover, two subjects consumed sweets and sweet water when 
they feel fatigue/weakness. Regarding health related data in this study, more than half 
of subjects had co-morbidity disease of diabetes. It is possible that these two subjects 
perceived fatigue/weakness as hypoglycemic symptom. Fatigue/weakness is a 
symptom of neuroglycopenic group in hypoglycemic patients (Towler, Havlin, Craft, 
& Cryer, 1993).  
For managing indigestion/abdominal distension, both pharmacological and 
non-pharmacological management strategies were used by the subjects. Most of the 
subjects used pharmacological management strategies including taking laxative, 
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antacid, Ya-Hom, and Ka-Min-Chan. Subjects used laxative and antacid because these 
medications made them feel more comfortable. Laxative induces bowel movements. It 
works to hasten the elimination of un-indigested remains of food and gas in the large 
intestine (Rang, Dale, & Ritter, 2003). In addition, antacids are a type of medicine 
that can provide immediate relief for mild to moderate symptoms of indigestion. They 
are commonly used as self-prescribed medications. They consist of calcium carbonate 
and magnesium and aluminum salts in various concentrations. The effect of antacids 
on the stomach is due to partial neutralization of gastric hydrochloric acid and 
inhibition of the proteolytic enzyme, pepsin, so that it no longer irritates the mucosa 
of digestive system (Maton & Burton, 1999).  
Additionally, Ya-Hom was also used by the subjects to manage indigestion in 
this study. Mostly, it was used by elderly patients who experienced abdominal 
distention, dizziness, and nausea/vomiting, which is similar to the findings of previous 
study (Dej-adisai, 2006). Furthermore some patients used herbal medicine, such as 
Ka-Min-Chan, to manage indigestion as they were suggested by their friends. Ka-
Min-Chan is traditional medicine that has been used in many conditions, such as anti-
bacterial, anti-fungal, anti-oxidant, and anti-ulcer effects. A hot water extract of the 
dried rhizome has been taken orally as a tonic and to calm the stomach. Additionally, 
the fresh juice taken regularly on an empty stomach has been used to prevent stomach 
disorders (Scartezzini & Speroni, 2000).  
Non-pharmacological management strategies including belching and 
abdominal compressing, waiting and seeing, and avoiding gas-inducing diet were 
used by approximately one-third of subjects in this study. Subjects reported that 
belching and abdominal compressing could help them to release gas in their abdomen. 
These strategies made the patients to relieve the symptom and feel more comfortable, 
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which are similar to the findings of previous study (Dej-adisai, 2006). However, four 
subjects (12.9%) used waiting and seeing strategy due to which symptom frequently 
occurred and they can tolerate it. In addition, some of the subjects reported that their 
symptoms were not perceived as serious symptoms and the symptoms did not threaten 
their daily lives. Patients who perceived their symptoms as not serious, they try to 
manage their symptoms by waiting and seeing until the symptoms disappeared 
(Finnegan et al., 2000; Moser et al., 2006), or they try to tolerate or ignore them 
initially (Sobolev et al., 2006).        
 Dyspnea was managed by both pharmacological and non-pharmacological 
management strategies. Pharmacological strategy used to manage dyspnea includes 
ISDN and inhalant. Some subjects in this study used ISDN as they suffer from both 
dyspnea and chest pain. In addition, the subjects who had co-morbidity of asthma 
managed dyspnea by using inhalant. However, most subjects used non-
pharmacological management strategies including relaxation, positioning, and waiting 
and seeing to control dyspnea. Subjects reported that these strategies could relieve 
dyspnea more effectively and almost all subjects with dyspnea reported that the 
symptom get better after managing them non-pharmocology. Relaxation techniques, 
such as resting, deep breathing, and meditation were practiced by subjects in this 
study. Subjects believed that these strategies controlled their breathing to be smooth 
and comfortable. Deep breathing is a relaxation technique that helps the patients to 
breathe fully and deeply. Deep breathing makes the diaphragm to move far down into 
the abdomen, and lungs are able to expand more completely into the chest cavity. 
More oxygen is taken in and more carbon dioxide is released with each breathe which 
help the patient to relieve dyspnea (Davis, Eshelman, & McKay, 1982). In addition, 
another strategy was positioning, including body straightening and turning the body 
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over. One subject reported that dyspnea always occurred at night time, turning the 
body over made him feel better and more comfortable. Moreover, another possible 
reason could be that the body straightening and turning over of the body helps in chest 
expansion (Dej-adisai, 2006).  
 Religious coping (both Buddhist and Muslim) was usually used when subjects 
in this study confronted psychological symptoms (stress/anxiety, fear/frighten, 
uncertainty, and sad). It may be due to 60% of subjects were elderly. Thai elderly 
people have a good practice on religious activities (Othaganont, Sinthuvorakan, & 
Jensupakarn, 2002). Subjects usually performed the religious activity to cope up with 
their psychological symptoms by holding onto religious principle for a cure and a 
longer life. Religious coping was appraised with reference to the individual, culture, 
beliefs, and religion.  
In this study, Buddhist subjects often used accepting/resigning (Tham-
Jai/Plong), prayer/reading dharma book, meditation, and going to temple while they 
were confronting with psychological problems. Integrating Buddha’s teaching into 
their lives was a crucial way of patients’ to rearranging their life for alleviating their 
suffering from inevitable and uncontrolled events. Following Buddha’s teachings, the 
patients have well adjusted to living with people with happiness and have the right 
understanding of the truth of human life. The findings of the present study support 
culture and values notions about Buddhist concepts and religious ritual. The Buddhist 
notion expresses that all things and experiences are inconsistent, unsteady, and 
impermanent. Human life embodies this flux in the aging process, the cycle of rebirth 
(samsara), and in any experience of loss. Buddhist teaching teaches human beings to 
accept the human life (Minarik, 1996).  
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In addition, prayer/reading dharma book and meditation was performed by 
patients waiting for CABG in this study. Some patients performed prayer (Buddhist 
prayer) because they believed in supernatural powers. They hope that the sacred 
prayers could help their circumstances to be cured. Moreover, using religious coping 
by performing meditation to manage their symptoms was also reported by patients 
waiting for CABG in this study. Meditation commonly was practiced by Buddhists to 
achieve a peaceful mind. The behavioral components of meditation are relaxation, 
concentration, an altered state of awareness, a suspension of logical thought and the 
maintenance of self-observing attitude (Perez-De-Albeniz & Holmes, 2000). In 
addition, meditation has been used as a method of stress reduction (Davidson et al., 
2003). Although this strategy makes the patients comfort but it may not be effective 
enough to relieve all psychological symptoms (Dej-adisai, 2006).    
In addition, Islamic patients also used religious coping to manage their 
psychological symptoms by putting trust in God and prayer (La-Mad). They believed 
that sickness is a test from God (Allah). Islamic teaching teaches human beings how 
to face difficulty in life, such as illness, suffering and death. Muslims view these 
problems as tests from God, which should be handled with patience and prayers. They 
consider an illness, as well as other tests, as atonement for their sins to achieve the 
best life in the hereafter. Despair, hopeless and frustration are not considered good in 
Islamic belief because everything that happens on the earth is with God’s supervision. 
Hope and optimism for the best life in the future is embedded in Islamic philosophy 
(Mills, as cited in Ibrahim, 2004). Therefore, integrating the right understanding, right 
thought, right effort, right mindfulness, and right concentration into their experiences 
lead the patients to understand or insight the true nature of human life and to prepare 
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their mind to accept or reject the uncertainty (impermanence) of their illness. 
Consequently, the patients’ suffering was found to be diminished.  
Additionally, other strategies, such as distraction and seeking information 
were also used for managing the psychological symptoms. In this study, distraction 
used by subjects was meeting their friends. These strategies may temporarily distract 
the patients’ attention away from the psychological problems. Seeking information 
was another alternative strategy reported by patients waiting for CABG to reduce the 
level of psychological symptoms. Information about the disease, operation date, 
ongoing treatment, cardiac surgery, and complications of surgery were shown to be 
the patients’ needs which were also reported in the previous study (Linsey, Sherrard, 
& Bickerton, 1997). Accurate information about what will be the outcome of the 
surgery can reduce fear and anxiety of the unknown situation (Maltas, 2003).  
 Mostly, symptom management was performed by patients waiting for CABG 
in this study when the symptoms had already occurred. It may be due to the fact that 
when the symptoms occur, the physical nature of the symptoms stimulates the patients 
to manage those symptoms (Horne et al., 2000). However, some subjects managed the 
symptoms when the symptoms were expected to occur. The subjects can feel it during 
some daily activities such as working and taking a bath which they learnt from their 
past experiences. For example, chest pain was observed after taking a bath, so taking 
sublingual ISDN was used to prevent chest pain effectively. In general, patients 
waiting for CABG in this study performed symptom management by themselves at 
home before consulting for help from others. However, when the symptoms were not 
found to be improved after managing by the first strategy, the patients preferred to 
visit the hospital. The findings of this study are congruent with a previous study 
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which reported that the patient takes the decision to visit hospital when they perceive 
the symptoms as severe (Horne et al.).  
Even though, most of patients waiting for CABG in this study usually 
managed their symptoms by themselves. Social network (family members or 
relatives) is an important resource to assist the patients in managing their symptoms 
(Koivula et al., 2002). After symptom onset, some patients in this study usually 
consult with their family members about their acute symptoms. This finding was 
similar to the study of Lovlien et al. (2006). The family members being the co-
sufferers while they were caring for their ill loved ones suffering from severe illness 
was perceived as being very important by the relatives of this study. In this study, 
symptom management strategies provided by the relatives includes massaging, back 
thumbing, seeking information, and soothing. Going to hospital was the most 
common strategy applied by the relatives. It is possible that the elderly patients were 
most likely unable to go to the hospital by themselves when severe symptoms 
occurred and thus they had to rely on their children or others.        
Symptom outcomes of patients waiting for CABG 
In this study, symptom outcomes of patients waiting for CABG were 
composed of two parts including, symptom status and health status. Symptoms were 
generally better after managing them. It is possible that most symptom management 
strategies were effective to manage the symptoms. In addition, it may also be due to 
the fact that most subjects took the medications to control their symptoms and co-
morbid diseases. Regarding to ISDN and ASA, they were generally prescribed for 
almost all of subjects. ISDN is considered as the most effective symptom 
management strategy for managing chest pain (Dej-adisai, 2006). Moreover, another 
possible reason could be that the most of the subjects in this study perceived the 
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symptoms as being mild. It may be due to the prognosis of subjects was not quite poor 
and more than one-third of subjects had EF > 50% (Table 4). EF value between 50% 
and 65% indicated that the healthy heart which has effective ability to eject blood 
(Cotran et al., 2005). Additionally, EF is one of the most important predictors of 
prognosis; with significantly reduced EF typically indicates the poorer prognoses 
(Owan et al., 2006).         
Most subjects received the scores of overall health status at moderate level 
(53.3%) and high level (40.0%). The subjects had scores of overall health status in 
each dimension at moderate level, except the score of mental health was at high level 
(M = 74.27, SD = 21.47). It is possible that psychological symptoms typically were 
managed by non-pharmacological management strategies by the subjects themselves. 
In addition, most of the subjects used religious coping to manage the psychological 
symptoms which were reported as getting better, especially among elderly patients. 
Patients who used these symptom management strategies could control their 
psychological symptoms and relieve the severity of symptoms. Thereby, increased 
mental health will lead to increased overall health status. Another reason could be that 
most of the symptoms could be managed at home and the health status was reported 
to be moderate to high.  
In addition, subjects may have good social support. Most of the subjects lived 
with their spouses and children and other family members consisting of at least three 
persons as mentioned above. In this study, when patients experienced the symptoms, 
the relatives assisted the patients by helping in managing the patients’ symptoms both 
physical and psychological symptoms. For example, when the patients experienced 
very severe symptoms, their relatives took control by promptly taking them to a 
hospital. In addition, the relatives assisted the patients to manage their symptom 
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occurrences by massaging and back thumbing. With respect to receiving 
informational support and emotional support, some patients who displayed 
psychological symptoms received related information and soothing from their 
relatives. It is in accordance with Thai context that family members or relatives take 
the responsibility for taking care of the patients while patients get sick. Thai people 
believe in repayment for their goodness and helping nature for their parents’ 
(Choowattanapakorn, 1999). The family members may provide high emotional 
support for their loved ones. Emotional support that the patients received possibly 
produces a positive effect on mental health in these patients (Koivula et al., 2002). 
The findings from this study are consistent with the study of Koivula et al. (2002) 
who found that emotional support from social network, particularly from family 
members and relatives are the important source to reduce psychological symptom.  
 In summary, various symptoms including physical and psychological 
symptoms can occur in patients while waiting for CABG. Chest pain was the most 
common symptom reported. However, most symptoms were perceived as being 
infrequent and their severity was perceived as mild. The perception and evaluation of 
symptoms may be associated with some demographic and health-related data such as 
gender, age, and medications. Both pharmacological and non-pharmacological 
management strategies were used to manage the symptoms by the patients waiting for 
CABG. Those strategies were demonstrated as effective for managing the symptom 
occurrences. The individual symptom management strategy was different depending 
on the individual, culture, beliefs, and religion. In the study, patients waiting for 
CABG usually managed their symptoms by themselves rather than asking for help 
from others. Moreover, the findings of this study are in accordance with the Symptom 
Management Model (Dodd et al., 2001) which states that the symptom experiences, 
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symptom management, and symptoms outcomes are interrelated. In addition, some 
factors including person domain (gender, age, and occupation), health and illness 
domain (disease, cigarette smoking, co-morbid disease, duration of waiting for 
CABG, and medications), and environment domain (culture, beliefs, and religion) 
could influence these three dimensions. 
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CHAPTER 5 
CONCLUSIONS AND RECOMMENDATIONS 
This chapter presents three parts including summary, limitations of the study, 
and implications and recommendations for further. 
Summary  
This study was a descriptive study aimed to study symptom experiences, 
symptom management, and symptom outcomes of the patients waiting for CABG. 
The 60 purposive subjects were recruited at Songklanagarind Hospital from January 
2009 to May 2009. The symptom experiences, symptom management, and symptom 
outcomes of the patients waiting for CABG were examined based on the Symptom 
Management Model (Dodd et al., 2001).  
Four parts of the instrument were used to obtain demographic and health-
related data, symptom experiences, symptom management, and symptom outcomes of 
patients waiting for CABG. The content validity was validated by three experts and 
the internal consistency in 20 patients waiting for CABG who came for a follow up at 
Songklanagarind Hospital from which the Cronbach’ s alpha coefficient obtained was 
found to be 0.88. The internal consistency coefficient tested in a sample of 60 subjects 
in this study was found to be 0.79.  
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The main findings of the study were summarized as follows: 
1. Symptom experiences. Both physical and psychological symptoms were  
reported from the patients. The common physical and psychological symptoms of 
patients waiting for CABG were chest pain/chest discomfort (80.0%), 
fatigue/weakness (66.7%), chest pain with referred pain (55.0%), indigestion/ 
abdominal distension (51.7%), dyspnea/shortness of breath/difficulty in breathing 
(50.0%), fear/fright (48.3%), stress/anxiety (48.3%), and uncertainty (46.7%). Each 
symptom was differently perceived in terms of its frequency and severity. These 
symptoms were reported as being infrequent and their severity was perceived as being 
mild.  
2. Symptom management strategies. Various strategies were used to manage  
the symptoms and they included: (1) using pharmacological strategies such as 
isosorbide dinitrate, inhalant, laxative, antacid, and herbs, (2) using non-
pharmacological strategies such as resting, massaging, chest thumbing, abdominal 
compressing, positioning, avoiding gas-inducing diet, using relaxation and religious 
coping, and (3) combining both strategies.  The symptoms were primarily managed by 
patients at home rather than asking for help from other persons.  
3. Symptom outcomes. After performing symptom management strategies,  
most subjects reported that their symptoms were improved and their overall health 
status during waiting for CABG was at moderate level.  
Limitations of the Study 
The limitations of this study were as follows: 
1. This study was a cross-sectional design which did not reflect change  
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overtime of symptom status and health status and could not capture the ongoing 
process of symptom experiences.  
2. This study was conducted only at Songklanagarind Hospital and the  
convenience sampling was used. The lack of random sampling may contribute to the 
bias in sample selection and limits the generalization of the findings. Moreover, the 
number of the large sample in this study is small. Therefore, the findings were based 
on small numbers in subgroups and must be viewed with caution.  
3. Most subjects in this study were elder. Therefore, they might be unable to  
recall all symptom occurrences over the past month. 
Implications and Recommendations 
The findings of this study provide several important implications for nursing 
practice, nursing administration, and nursing research as follows: 
1. Nursing practice 
 The results of this study provide the nurses with knowledge regarding 
symptom experiences, symptom management, and symptom outcomes in patients 
waiting for CABG. Psychological symptoms frequently occurred during waiting for 
CABG. Nurses can use the results of this study to make some interventions such as 
self-help group for patients waiting for CABG, which may be beneficial for the 
patients in supporting them and managing their symptom occurrences.  
2.  Nursing administration 
The nurse administrators can use the results of this study to create a policy for 
improving health care personnel and quality of nursing care. The nurse administrators 
may create a training program to teach the medical and surgical OPD nurses to gain 
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advanced knowledge about CAD, its treatment and symptom management for 
providing nursing care to the patients waiting for CABG and improving their health 
status. 
3. Nursing research 
Based on the limitations and the findings of this present study, several 
recommendations for future study are presented as follows: 
1. A longitudinal-prospective study is recommended because symptom  
occurrence is a dynamic process. 
2. Future studies should be conducted with various age groups and settings in  
order to increase the generalization of the research findings.  
3. The number of women subjects in future studies should be increased to  
compare and discuss regarding gender differences. 
4. Canadian Cardiovascular Society Angina Grading Scale should be used  
combined with New York Heart Association functional classification to evaluate the 
condition of CAD patients in terms of classification of severity of angina. 
5. Since the findings of the present study indicated that demographic and  
health related data may relate to symptom experiences, symptoms management, and 
symptom outcomes, the factors influencing symptom experiences, symptom 
management, and symptom outcomes in patients waiting for CABG are worth to 
investigate and may contribute to a better understanding of them. Moreover, 
psychological symptoms frequently occurred during waiting for CABG, thus the 
coping strategies of patients waiting for CABG should be further studied.  
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INFORMED CONSENT FORM 
คําชี้แจงและการพิทักษสิทธิของผูปวยในการเขารวมวิจัย 
ขาพเจานางสาวสุกานดา บุญคง ขณะนี้กําลังศึกษาระดับปริญญาโท สาขาการพยาบาล
ผูใหญ หลักสูตรนานชาติ คณะพยาบาลศาสตร มหาวิทยาลัยสงขลานครินทร และทําวิทยานิพนธ
เร่ือง ประสบการณอาการ การจัดการอาการ และผลลัพธการจัดการอาการในผูปวยท่ีรอผาตัดทาง
เบี่ยงหลอดเลือดหัวใจ การศึกษานี้มีวัตถุประสงคเพื่อศึกษาประสบการณอาการ การจัดการอาการ 
และผลลัพธท่ีเกิดจากการจัดการอาการในผูปวยท่ีรอผาตัดทางเบ่ียงหลอดเลือดหัวใจ 
 ทานเปนผูปวยกลุมเปาหมาย จึงไดรับการติดตอใหเปนผูใหขอมูลในการวิจัย โดยทาน
สามารถตอบรับเขารวมวจิัยหรือปฏิเสธการเขารวมวิจัยไดตามความสมัครใจ การวิจัยในคร้ังนี้ไมได
ใหประโยชนตอทานโดยตรง แตจะเปนประโยชนตอไปในการพัฒนารูปแบบการบริการสุขภาพ
สําหรับผูปวยท่ีรอผาตัดทางเบ่ียงหลอดเลือดหัวใจคนอ่ืนๆ ตอการรักษาพยาบาล การบริการ หรือ
สวัสดิการตางๆ ท่ีทานจะไดรับจากโรงพยาบาล ทานยังคงไดรับบริการตางๆตามมาตรฐานปกติของ
โรงพยาบาล 
หากทานตอบรับเขารวมวิจัย ทานจะไดรับการสัมภาษณและบันทึกขอมูลตอไปนี้ ไดแก 
ขอมูลสวนบุคคล ขอมูลเกี่ยวกับความเจ็บปวย ประสบการณอาการ การจัดการอาการ และผลลัพธท่ี
เกิดจากการจัดการอาการในขณะรอผาตัดทางเบ่ียงหลอดเลือดหัวใจ โดยใชเวลาสัมภาษณประมาณ 
30-40 นาที ในสถานท่ีที่ผูวิจัยเตรียมไว หรือสถานท่ีอ่ืนตามท่ีทานสะดวก โดยทานเปนผูเลือกเวลา
ท่ีสะดวกในการใหสัมภาษณ  
 การศึกษาคร้ังนี้ไดผานการพิจารณาอนุมัติจากคณะกรรมการควบคุมวิทยานิพนธ และ
คณะกรรมการพิจารณาจริยธรรมในการวิจัย คณะพยาบาลศาสตร มหาวิทยาลัยสงขลานครินทร 
การเขารวมวิจัยของทานในคร้ังนี้ ไมมีความเส่ียงรุนแรงท่ีทําใหเกิดอันตรายตอรางกายและชีวิตของ
ทาน ไมมีการใหยา ไมมีการใหสารเคมี และไมมีการใหการรักษาอ่ืนใดท่ีกระทําตอรางกายของทาน 
นอกเหนือจากการรักษาท่ีทานไดรับตามปกติ อยางไรก็ตาม ในระหวางการสัมภาษณทานอาจจะมี
อาการเหน่ือย หรืออาการไมสบายอ่ืนๆเกิดข้ึนได หากมีอาการดังกลาวขอใหทานแจงใหผูวิจัยทราบ
โดยทันที เพื่อหยุดการสัมภาษณ และผูวิจัยจะใหการชวยเหลือทาน และ/หรือปรึกษาแพทยผูรักษา
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ทันที ท้ังนี้เม่ือทานมีอาการดีข้ึนทานจะยังคงใหขอมูลตอ หรือหยุดเขารวมวิจัยไดตามความสมัครใจ 
หรือนัดหมายวัน เวลาในการสัมภาษณคร้ังตอไปตามความพรอมของทาน 
ในการเขารวมวิจัย หากทานมีขอสงสัยเกี่ยวกับการวิจัย ทานสามารถสอบถามผูวิจัยไดทันที 
ทานสามารถยกเลิกการเขารวมวิจัยไดตลอดเวลาแมวาทานจะลงนามใหคํายินยอมเขารวมวิจัยแลวก็
ตาม ในระหวางการสัมภาษณ ทานอาจมีขอสงสัยเกี่ยวกับการดูแลรักษาตนเอง หรือขอมูลเกี่ยวกับ
ความเจ็บปวยของตนเอง ผูวิจัยจะตอบขอคําถามของทาน หรือติดตอแพทยหรือพยาบาลเจาของไข
เพื่อใหขอมูลแกทานในภายหลังเม่ือเสร็จส้ินการสัมภาษณ 
ขอมูลของทานจะถูกเก็บเปนความลับ ในแบบสอบถามจะบันทึกเฉพาะหมายเลขประจําตัว
โรงพยาบาลของทานเทานั้น จะไมมีการบันทึกช่ือ นามสกุล และท่ีอยูของทาน ขอมูลของทานจะถูก
เก็บอยูในรูปของเอกสารและฐานขอมูลคอมพิวเตอร ขอมูลในเอกสารจะเก็บไวในท่ีเฉพาะ มีเพียง
ผูวิจัยเทานั้นท่ีสามารถเขาถึงขอมูลของทาน ผูวิจัยจะดําเนินการทําลายขอมูลในเอกสารการ
สัมภาษณทันทีท่ีเสร็จส้ินการวิจัย สวนฐานขอมูลคอมพิวเตอรจะเก็บไวเพื่อการศึกษาวิจัยตอไป ซ่ึง
จะเก็บบันทึกเปนภาพรวมของผูปวยท้ังหมด โดยไมมีการบันทึกช่ือ นามสกุล และท่ีอยูของทาน 
การเสนอรายงานผลการวิจัยในวิทยานิพนธ การตีพิมพบทความวิจัย และการเสนอผลการวิจัยในท่ี
ประชุมตางๆ จะนําเสนอในทางวิชาการเทานั้น และเสนอเปนภาพรวมของผูเขารวมวิจัยท้ังหมด 
โดยไมมีการระบุหลักฐานใดๆที่เปนขอมูลเฉพาะตัวบุคคล 
 หากทานมีขอสงสัยใดๆเก่ียวกับการศึกษาวิจัยคร้ังนี้ หรือหากทานตองการขอมูลเพิ่มเติม 
ทานสามารถสอบถามผูวิจัยไดท่ีหมายเลขโทรศัพท 086-9463162 หรือติดตอในเวลาราชการที่คณะ
พยาบาลศาสตร มหาวิทยาลัยสงขลานครินทร และขอขอบคุณท่ีกรุณาใหความรวมมือในการวิจัยใน
คร้ังนี้ 
 
        สุกานดา บุญคง 
                                        ผูวิจัย 
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หนังสือแสดงเจตจํานงของผูปวยในการตอบรับหรือปฏิเสธการเขารวมวิจัย 
(สําหรับผูเขารวมวิจัย) 
ขาพเจา นาย/นาง/นางสาว.. (ช่ือ-สกุลผูปวย) ไดรับการติดตอจาก
ผูวิจัยเพื่อขอความรวมมือในการใหขอมูลในการทําวิทยานิพนธ เร่ืองประสบการณอาการ การ
จัดการอาการ และผลลัพธการจัดการอาการในผูปวยท่ีรอผาตัดทางเบ่ียงหลอดเลือดหัวใจ ของ
นางสาวสุกานดา บุญคง นักศึกษาพยาบาล ระดับปริญญาโท คณะพยาบาลศาสตร สาขาการ
พยาบาลผูใหญ หลักสูตรนานชาติ มหาวิทยาลัยสงขลานครินทร  
  ขาพเจาไดรับการช้ีแจงถึงวัตถุประสงคของการวิจัย สิทธิในการตอบรับเขารวมหรือ
ปฏิเสธการเขารวมในการวิจัยไดตามความสมัครใจ โดยไมมีผลใดๆตอการรักษาพยาบาล การ
บริการ หรือสวัสดิการตางๆท่ีขาพเจาจะไดรับจากโรงพยาบาล ขาพเจายังคงไดรับการบริการตางๆ
ตามมาตรฐานปกติของโรงพยาบาล ไมวาจะเขารวมหรือไมเขารวมการวิจัยก็ตาม และการวิจัยคร้ังนี้
ไมไดใหประโยชนตอขาพเจาโดยตรง แตจะเปนขอมูลในการพัฒนารูปแบบการบริการสุขภาพ
สําหรับผูปวยท่ีรอผาตัดทางเบ่ียงหลอดเลือดหัวใจตอไป 
 ขาพเจาทราบวา การศึกษาวิจัยคร้ังนี้ไดผานการพิจารณาอนุมัติจากคณะกรรมการควบคุม
วิทยานิพนธและคณะกรรมการพิจารณาจริยธรรมในการวิจัย คณะพยาบาลศาสตร มหาวิทยาลัย  
สงขลานครินทร ขาพเจาทราบดีวาตนเองจะไดรับการปกปองจากอันตรายหรือความเส่ียงท่ีจะทําให
เกิดอันตรายตอรางกายและชีวิต โดยผูวิจัยจะไมใหยา ไมใหสารเคมี และไมใหการรักษาอ่ืนใดท่ี
กระทําตอรางกายของทาน นอกเหนือจากการรักษาท่ีทานไดรับตามปกติ ขาพเจาทราบวาการให
ขอมูลสัมภาษณอาจทําใหมีอาการเหนื่อยหรือไมสบายอ่ืนๆเกิดข้ึนได ซ่ึงขาพเจาสามารถแจงให
ผูวิจัยทราบโดยทันที เพื่อหยุดการสัมภาษณ และผูวิจัยจะใหการชวยเหลือตามหลักวิชาหรือปรึกษา
แพทยผูรักษาทันที ขาพเจาสามารถใหขอมูลตอเม่ืออาการดีข้ึน หรือหยุดเขารวมวิจัยไดตามความ
สมัครใจ หรือนัดหมายวัน เวลาในการสัมภาษณคร้ังตอไปตามขาพเจาจะเห็นสมควร 
 ขาพเจาทราบวา ในการเขารวมวิจัยนั้น ขาพเจาจะไดรับการสัมภาษณประมาณ 30-40 นาที 
และผูวิจัยจะบันทึกขอมูลสวนบุคคล ขอมูลเกี่ยวกับความเจ็บปวย ประสบการณอาการ การจัดการ
อาการ และผลลัพธท่ีเกิดจากการจัดการอาการในขณะรอผาตัดทางเบ่ียงหลอดเลือดหัวใจ ขาพเจา
สามารถเลือกสถานท่ีและเวลาในการใหสัมภาษณตามความพรอมของตนเอง เม่ือเสร็จส้ินการ
สัมภาษณ ขาพเจาสามารถสอบถามและมีสิทธิท่ีจะทราบขอมูลตางๆเก่ียวกับการดูแลตนเองและการ
รักษาตางๆไดจากผูวิจัย หรือผูวิจัยจะติดตอประสานงานกับแพทยและพยาบาลเจาของไขเพื่อให
ขอมูลแกขาพเจา 
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ขาพเจาทราบวา ผูวิจัยจะเก็บขอมูลของขาพเจาเปนความลับ การสัมภาษณจะไมบันทึกช่ือ 
นามสกุลและท่ีอยูของขาพเจา มีเฉพาะหมายเลขประจําตัวโรงพยาบาลของทานเทานั้นท่ีจะถูก
บันทึกไว เอกสารการสัมภาษณจะเก็บไวในท่ีเฉพาะและถูกทําลายทันทีท่ีเสร็จส้ินการวิจัย ขอมูล
จากการสัมภาษณจะถูกนําไปใชในทางวิชาการเทานั้นโดยจะเสนอในภาพรวมของผูปวยท้ังหมด  
ขาพเจาทราบวาขอมูลท่ีเก็บอยูในฐานขอมูลคอมพิวเตอรจะนําไปใชเฉพาะการศึกษาทางวิชาการ
เทานั้น 
 ขาพเจาทราบวา ตนเองสามารถติดตอสอบถามขอมูลเกี่ยวกับการวิจัยไดท่ีหมายเลขโทร 
ศัพท 086-9463162 หรือติดตอในเวลาราชการที่คณะพยาบาลศาสตรมหาวิทยาลัยสงขลานครินทร 
 ขาพเจาขอรับรองวาขาพเจาทราบถึงสิทธิในการตัดสินใจเขารวม หรือไมเขารวมการวิจัย
ไดตามความสมัครใจ และสามารถยกเลิกการเขารวมวิจัยไดตลอดเวลาแมวาจะลงนามใหความ
ยินยอมเขารวมวิจัยแลวก็ตาม ท้ังนี้ขาพเจารับทราบขอมูลและเขาใจถึงวัตถุประสงคของการวิจัย 
ความเส่ียง และประโยชนในการเขารวมวิจัยตลอดจนบุคคลท่ีสามารถติดตอขอขอมูลเพิ่มเติม 
 ในการนี้ ขาพเจา  [   ]   ยินยอมเขารวมในการวิจัย 
                                     [   ]    ไมยินยอมเขารวมในการวิจัย 
 
 
ลงนาม .... (ผูปวย)   ลงนามผูวิจัย... 
วันท่ี ...               วันท่ี .. 
 
ลงนาม . (ผูแทนของผูปวย) 
วันท่ี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APPENDIX B 
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INSTRUMENTS 
Symptom Experiences, Symptom Management and Symptom Outcomes in 
Patients Waiting for Coronary Artery Bypass Graft 
                       Code…………………. 
                       Date………………….  
           HN…………………... 
Introduction: This instrument is divided into four parts. Part 1 is related to 
demographic and health-related data form. Part 2 is related to symptom experiences 
questionnaire. Part 3 is related to symptom management questionnaire. Part 4 is 
related to symptom outcomes questionnaire. 
Part 1: Demographic and Health-Related Data Form 
Direction: Please mark “√” or write the appropriate sections. There is no right or 
wrong answer. If you do not understand or not clear about these questions you can ask 
the investigator. 
 
1. Gender  !  1. Male  ! 2. Female 
2. Age ………. years old 
3. Marital status ! 1. Single  ! 2. Married  
   ! 3. Divorced  ! 4. Widowed 
4. Religion  ! 1. Buddhist  ! 2. Muslim 
   ! 3. Christian  ! 4. Others………. 
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5. Educational level ! 1. None   ! 2. Primary School 
   ! 3. Junior High School ! 4. Senior High School 
! 5. Diploma   ! 6. Bachelor Degree or higher 
6. Occupation  ! 1. None   ! 2. Retired  
   ! 3. Farmer or gardener ! 4. Private employee 
   ! 5. Government employee ! 6. Entrepreneurship 
   ! 7. Housewife   ! 8. Others………. 
7. Income of family (baht/ month) 
  ! 1. < 5,000 ! 2. 5,000-10,000 ! 3. 10,000-20,000 
  ! 4. 20,000-30,000 ! 5. > 30,000 
8. Medical payment   
! 1. Universal coverage scheme (30 baht) ! 2. Social insurance 
 ! 3. Health insurance    ! 4. Self payment  
! 5. Government support   ! 6. Others………….... 
9. Residential area ! 1. Songkhla province 
! 1.1 Rural   ! 1.2 Urban 
   ! 2. Out of Songkhla province 
! 2.1 Rural   ! 2.2 Urban 
10. Number of family members ………. persons 
11. Family history of CAD  ! 1. No ! 2. Yes…………… 
12. Smoking habits ! 1. Non-smokers/ stop smoking……….month ago   
! 2. Smokers, but less now……….rolls/ day 
   ! 3. Smokers, unchanged……….rolls/ day   
! 4. Smokers, more……….rolls/ day 
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13. Drinking habits ! 1. Not using alcohol/ stop drinking……….month ago   
! 2. Using alcohol, but less now  
! 3. Using alcohol, unchanged  
! 4. Using alcohol, more 
14. Co-morbid disease 
       ! 1. No   ! 2. Yes  
       If yes  ! 2.1 Valve disease   …….year…….month  
   ! 2.2 Congestive heart failure …….year…….month 
   ! 2.3 Hypertension    …….year…….month 
   ! 2.4 Diabetic mellitus   …….year…….month 
   ! 2.5 Hyperlipidemia   .……year…….month 
   ! 2.6 Kidney disease   …….year…….month 
! 2.7 COPD    …….year…….month 
 ! 2.8 Gout     …….year…….month 
! 2.9 Others……….    …….year…….month 
15. Length of waiting for CABG 
  ! 1. 1 - 3 months ! 2. 4 - 6 months ! 3. 7 - 9 months  
! 4. 10 -12 months ! 5. > 1 year 
16. Medication currently taken (For researcher)  
! 1. Long and short acting nitrates ! 2. Beta-blockers 
  ! 3. Aspirin    ! 4. Calcium antagonists 
  ! 5. Diuretics    ! 6. ACE inhibitors 
  ! 7. Antidiabetic treatment  ! 8. Antihyperlipidemic med.   
  ! 9. Sedative (incl. sleeping pill) ! 10. 2-3 anti-ischemic med. 
! 11. Others…………………… 
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17. Clinical examination 
       Diagnosis  
! 1. 1-or 2-vessel disease  
! 2. 3-vessel disease, no proximal left anterior descending  
        (LAD) involvement 
! 3. 3-vessel disease and proximal LAD 
! 4. Left main artery disease 
EF = ! 1. < 30% ! 2. 30-49%       ! 3. 50-65%       ! 4. > 65% 
Revascularization 
! 1. No  ! 2. Yes 
If yes  ! 2.1 Thrombolytic strategy 
! 2.2 Heparinization 
! 2.3 Percutaneous Transluminal Coronary Angioplasty 
 New York Heart Association  
1. At the first time  
! 1.1 Class I      ! 1.2 Class II       
! 1.3 Class III      ! 1.4 Class IV 
2. At current  
! 2.1 Class I      ! 2.2 Class II      
! 2.3 Class III      ! 2.4 Class IV 
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Part 2: Symptom Experiences Questionnaire 
Direction: The following items are symptom occurrences in patients waiting for 
CABG. Please mark “√” in the blank that indicates the frequency and severity of 
symptoms over the last month. There is no right or wrong answer. If you do not 
understand or are not clear about these questions you can ask the researcher. 
 The frequency of symptoms was described as follows:  
 Rarely  =  Symptoms occur once a month or more but less  
than sometime. 
 Sometime =  Symptoms occur once a week or more but less  
than almost all of the time. 
Almost all the time =   Symptoms occur everyday or more than once a 
day or almost all of the time. 
All the time   =            Symptoms occur all of the time.  
The severity of symptoms was described at four levels including mildly 
severe, moderately severe, very severe, and extremely severe. 
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Symptom 
 
No 
 
Yes 
Frequency Severity 
Rarely Sometime Almost all 
the time 
All the 
time 
Mildly 
severe 
Moderately
severe 
Very 
severe 
Extremely 
severe 
1. Chest pain/chest discomfort           
2. Chest pain with referred pain 
identify………………………… 
          
3. Epigastric pain           
4. Dyspnea/shortness of breath/ 
difficult breathing 
          
5. Dizziness/blackness/fainting/ 
lightheadedness 
          
6. Upper extremity numbness            
7. Edema of the extremities           
8. Sweating/diaphoresis           
9. Clammy limbs           
10. Heartburn           
11. Indigestion/abdominal 
distension 
          
12. Nausea/vomiting           
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Symptom 
 
No 
 
 
Yes 
Frequency Severity 
Rarely Sometime Almost all 
the time 
All the 
time 
Mildly 
severe 
Moderately 
severe 
Very 
severe 
Extremely 
severe 
13. Fatigue/weakness           
14. Palpitation           
15. Tachyarrhythmia           
16. Coughing           
17. Loss of appetite           
18. Uncertainty           
19. Fear/frighten           
20. Stress/anxiety           
21. Sad           
22. Insomnia           
23. Others……….................................... 
......................................................................
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Part 3: Symptom Managements Questionnaire 
Direction: Please describe your symptom management strategies that you use to 
manage with each symptom experience.  
" chest pain/chest discomfort " chest pain with referred pain  
" epigastric pain  " dyspnea/shortness of breath/difficult breathing  
" dizziness/blackness/fainting/lightheadedness " upper extremity numbness 
" edema of the extremities " sweating/diaphoresis   " clammy limbs  
" heartburn   " indigestion/abdominal distension 
" nausea/vomiting     " fatigue/weakness  " palpitation    
" tachyarrhythmia  " coughing    " loss of appetite 
" uncertainty     " fear/frighten  " stress/anxiety  
"  sad   " insomnia   " others……………. 
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Question 
1. How do you manage your symptom occurrences? (what, when, where, why, 
how much, to whom, and how) 
**For chest pain, how do you feel? 
" No change (stable)  
" Change 
 If change " More frequency " More severe    " More duration  
Taking sublingual medication " 1 tab and getting better 
     " 1 tab and no change 
 
After taking sublingual medication and no change, how do you do? 


 
 
 Other symptoms, please describe 



 
 2. According to your symptom management, what is the most effective 
symptom management for each symptom? 
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3. What are your symptom outcomes after using symptom management? 
 
Symptom 
Symptom outcome  
Symptom 
Symptom outcome 
Getting 
better 
No 
change 
Getting 
worse 
Getting 
better 
No 
change 
Getting 
worse 
1. Chest pain/ 
chest discomfort 
   12. Nausea/ 
vomiting 
   
2. Chest pain 
with referred 
pain identify 
……………….. 
   13. Fatigue/ 
weakness 
   
3. Epigastric 
pain 
   14. Palpitation    
4. Dyspnea/ 
shortness of 
breath/ difficult 
breathing 
   15.Tachyarrhyth
-mia 
   
5. Dizziness/ 
blackness/ 
fainting/ 
lightheadedness 
   16. Coughing    
6. Upper 
extremity 
numbness 
   17. Bored with 
food 
   
7. Edema of the 
extremities 
   18. Uncertainty    
8. Sweating/ 
diaphoresis 
   19. Fear/ 
frighten 
   
9. Clammy 
limbs 
   20. Stress/ 
Anxiety 
   
10. Heartburn    21. Sad    
11.Indigestion/ 
abdominal 
distension 
   22. Insomnia    
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Part 4: Symptom Outcomes Questionnaire (SF-36 V2) 
This survey asks for your views about your health. This information will help you 
keep track of how you feel and how well you are able to do your usual activities. 
Direction: Please answer every question by selecting the answer as indicated. If you 
are unusual about how to answer a question, please give the best answer you can.  
1. In general, would you say your health is: 
     (   )      (   )    (   )  (   )  (   ) 
Excellent      Very good          Good               Fair                 Poor 
2. Compared to one year ago, how would you rate your health in general now? 
        (   )                  (   )                  (   )                 (   )         (   ) 
 Much better     Somewhat       About the       Somewhat        Much worse 
now than one    better now     same as one     worse now        now than one 
   year ago           than one         year ago         than one              year ago 
                            year ago                               year ago 
3……………………………………………………………………………………….... 
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แบบประเมินอาการ การจัดการอาการ และผลลัพธการจัดการอาการ 
ในผูปวยท่ีกําลังรอผาตัดทางเบ่ียงหลอดเลือดหัวใจ 
เลขท่ีแบบสอบถาม 
วันท่ี 
HN. 
แบบสอบถามนี้ประกอบดวย 4 สวน ดังนี ้
สวนท่ี 1 แบบบันทึกขอมูลสวนบุคคลและขอมูลเกี่ยวกับความเจ็บปวยในผูปวยท่ีรอผาตัดทาง 
เบ่ียงหลอดเลือดหัวใจ 
สวนท่ี 2 แบบประเมินประสบการณอาการในผูปวยท่ีรอผาตัดทางเบ่ียงหลอดเลือดหัวใจ 
สวนท่ี 3 แบบสัมภาษณการจัดการอาการในผูปวยท่ีรอผาตัดทางเบ่ียงหลอดเลือดหัวใจ 
สวนท่ี 4 แบบประเมินผลลัพธของการจัดการอาการในผูปวยท่ีรอผาตัดทางเบ่ียงหลอดเลือดหัวใจ 
สวนท่ี 1 แบบบันทึกขอมูลสวนบุคคลและขอมูลเก่ียวกับความเจ็บปวยในผูปวยท่ีรอผาตัดทางเบี่ยง 
                หลอดเลือดหัวใจ 
คําชี้แจง ในการตอบแบบสอบถามน้ีตองการทราบขอมูลสวนบุคคลและขอมูลเกี่ยวกับความ
เจ็บปวยของทาน โปรดเติมขอความในชองวาง และ/หรือขีดเครื่องหมาย  √ ในชอง ! 
หนาขอความท่ีตรงตามความเปนจริง โดยแตละขอขอใหทานเลือกตอบตรงตามความจริงท่ีทาน
เปนอยู 
 
1. เพศ  ! 1. ชาย ! 2. หญิง 
2. อายุ.ป 
3. สถานภาพสมรส ! 1. โสด  ! 2. คู 
   ! 3. หยาราง  ! 4. หมาย 
4. ศาสนา  ! 1. พุทธ  ! 2. อิสลาม 
   ! 3. คริสต  ! 4. อ่ืนๆ ระบุ 
5. ระดับการศึกษาช้ันสูงสุด 
  ! 1. ไมไดรับการศึกษา  ! 2. ประถมศึกษา 
  ! 3. มัธยมศึกษาตอนตน ! 4. มัธยมศึกษาตอนปลาย 
  ! 5. อนุปริญญาหรือเทียบเทา ! 6. ปริญญาตรีหรือสูงกวา
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6. อาชีพ 
  ! 1. ไมไดประกอบอาชีพ ! 2. เกษยีณ 
  ! 3. เกษตรกรรม  ! 4. ลูกจางบริษัทเอกชน  
! 5. ขาราชการ  ! 6. รัฐวิสาหกิจ 
! 7. งานบาน   ! 8. อ่ืนๆ (ระบุ). 
7. รายไดของครอบครัวบาท/เดือน 
8. การจายคารักษา ! 1. สิทธิบัตรประกันสุขภาพถวนหนา (30 บาท) 
 ! 2. ประกันสังคม ! 3. ประกันสุขภาพ 
 ! 4. จายเอง  ! 5. เบิกได 
 ! 6. อ่ืนๆ (ระบุ). 
9. พื้นท่ีอาศัย 
 ! 1. จ. สงขลา 
  ! 1.1 ในตัวเมือง ! 1.2 ชานเมือง 
 ! 2. นอก จ. สงขลา 
  ! 2.1 ในตัวเมือง ! 2.2 ชานเมือง 
10. จํานวนสมาชิกในครอบครัว....................คน 
11. ประวัติการเจ็บปวยดวยโรคหลอดเลือดหัวใจของคนในครอบครัว 
 ! 1. ไมมี ! 2. มี (ระบุ) 
12. การสูบบุหร่ี ! 1. ไมสูบ หรือ เลิกสูบ......................เดือน! 2. สูบ แตลดปริมาณลง
 ! 3. สูบ เทาเดิม      ! 4. สูบ มากข้ึน 
13. การดื่มสุรา ! 1. ไมดื่ม หรือ เลิกดื่ม......................เดือน ! 2. ดื่ม แตลดปริมาณลง 
 ! 3. ดื่ม เทาเดิม      ! 4. ดื่ม มากข้ึน 
14. การเจ็บปวยรวม 
 ! 1. ไมมี ! 2. มี 
 ถามี ! 2.1 กลามเนื้อหัวใจขาดเลือด...........ป..........เดือน 
  ! 2.2 หัวใจวาย...........ป..........เดือน 
  ! 2.3 ความดันโลหิตสูง...........ป..........เดือน 
  ! 2.4 เบาหวาน...........ป..........เดือน 
  ! 2.5 ไขมันในโลหิตสูง...........ป..........เดือน 
  ! 2.6 โรคไต...........ป..........เดือน 
  ! 2.7 โรคปอดอุดกั้นเร้ือรัง...........ป..........เดือน 
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  ! 2.8 อ่ืนๆ (ระบุ). 
15. ระยะเวลาที่รอผาตัดทางเบ่ียงหลอดเลือดหัวใจ 
  ! 1. 1-3 เดือน  ! 2. 4-6 เดือน  ! 3. 7-9 เดือน   
  ! 4. 10-12 เดือน ! 5. > 1 ป 
16. ยาท่ีรับประทานอยูในปจจุบัน (จายโดยแพทย) (สําหรับผูวิจัย) 
! 1. Long and short acting nitrates ! 2. Beta-blockers 
! 3. Salicylates   ! 4. Calcium antagonists 
  ! 5. Diuretics    ! 6. ACE inhibitors 
  ! 7. Antidiabetic treatment  ! 8. Antihyperlipidemic                       
                                                                                                        treatment 
  ! 9. Sedative (incl. sleeping pill) ! 10. 2-3 anti-ischemic medications 
  ! 11. อ่ืนๆ (ระบุ) 
17. ผลการตรวจทางคลินิก  
การวินิจฉัย 
! 1. 1-or 2-vessel disease  
! 2. 3-vessel disease, no proximal left anterior descending  
(LAD) involvement 
! 3. 3-vessel disease and proximal LAD 
! 4. Left main artery disease 
EF = ! 1. < 30%     ! 2. 30-40%     ! 3. 50-65%     ! 4. > 65% 
 Revascularization 
! 1. ไมมี  ! 2. มี  
ถามี  ! 2.1 Thrombolytic strategy 
! 2.2 Heparinization 
! 2.3 Percutaneous Transluminal Coronary Angioplasty 
 New York Heart Association  
1. คร้ังแรกท่ีไดรับการวินจิฉัยวาตองรักษาโดยการผาตัดทําทางเบ่ียงหลอดเลือดหัวใจ  
! 1.1 Class I     ! 1.2 Class II      ! 1.3 Class III     ! 1.4 Class IV 
2. คร้ังลาสุด  
! 2.1 Class I     ! 2.2 Class II      ! 2.3 Class III     ! 2.4 Class IV 
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สวนท่ี 2 แบบประเมินประสบการณอาการในผูปวยท่ีรอผาตดัทางเบี่ยงหลอดเลือดหัวใจ 
 
คําชี้แจง ขอความที่จะถามทานตอไปนี้เปนการถามเกี่ยวกับประสบการณอาการในผูปวยท่ีรอผาตัด
ทางเบ่ียงหลอดเลือดหัวใจ ขอใหทานบอกความรูสึกของทานวาในชวงหนึ่งเดือนท่ีผานมา ทานมี
อาการตามท่ีถามหรือไม ถาไมมีไมตองประเมินความถ่ีและความรุนแรงของอาการในขอนั้น แตถา
มีอาการนั้นใหบอกวาอาการแตละอาการมีความถ่ีและความรุนแรงตอทานมากนอยเพียงใดตาม
วิธีการประเมินท่ีใหไว คําตอบท่ีทานใหมาจะไมมีคาคะแนนใหวาทานตอบถูกหรือผิด แตจะเปนคา
คะแนนท่ีเกิดจากความรูสึกของทานจริงๆ 
 โปรดตอบทุกขอตามความเปนจริงโดยกาเคร่ืองหมาย √ ลงในชองท่ีตรงกับความรูสึกของ
ทาน เพื่อตองการทราบประสบการณอาการ ความถ่ีและความรุนแรงของอาการท่ีมีและเกิดข้ึนกับ
ทานดังนี้ 
ทานสามารถประเมินความถ่ีของอาการตามความรูสึกตอไปนี ้
  นานๆคร้ัง หมายถึง มีอาการเกิดข้ึนประมาณเดือนละ 1 คร้ังหรือ 
 มากกวา 1 คร้ังแตนอยกวาเปนบางคร้ัง 
  บางคร้ัง  หมายถึง มีอาการเกิดข้ึนประมาณสัปดาหละ 1 คร้ังหรือ 
 มากกวา 1 คร้ังแตนอยกวาเกือบตลอดเวลา 
  เกือบตลอดเวลา หมายถึง มีอาการเกิดข้ึนทุกวัน อาจจะเปนวันละคร้ัง 
 หรือมากกวา 1 คร้ังแตนอยกวาตลอดเวลา 
ตลอดเวลา หมายถึง มีอาการเกิดข้ึนวันละหลายคร้ังหรือเกือบตลอดเวลา 
ทานสามารถประเมินความรุนแรงของอาการตามความรูสึก 4 ระดับ ตอไปนี ้
1. มีความรุนแรงนอย 
2. มีความรุนแรงปานกลาง 
3. มีความรุนแรงมาก 
4. มีความรุนแรงมากท่ีสุด 
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อาการ 
 
ไมมี 
 
มี 
ความถี่ ความรุนแรง 
นานๆครั้ง บางครั้ง เกือบตลอด 
เวลา 
ตลอดเวลา นอย ปานกลาง มาก มากที่สุด 
1. เจ็บหนาอก/แนนหนาอก           
2. ปวดราวไปอวัยวะตางๆ 
ระบุ......................................... 
          
3. ปวดยอดอก/ลิ้นป           
4. หอบเหนื่อย/หายใจลําบาก/ 
หายใจขัด 
          
5. วิงเวยีนศีรษะ/ตาลาย/หนา
มืด/เปนลม 
          
6. ชาปลายมือปลายเทา           
7. บวมที่แขน/ขา           
8. เหงื่อออก           
9. แขนขาเยน็ชื้น/ซีด           
10. แสบยอดอก           
11. อาหารไมยอย/ทองอืด 
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อาการ 
 
 
ไมมี 
 
 
มี 
ความถี่ ความรุนแรง 
นานๆครั้ง บางครั้ง เกือบตลอด 
เวลา 
ตลอดเวลา นอย ปานกลาง มาก มากที่สุด 
12. คลื่นไส/อาเจียน           
13. เหนื่อยลา/ออนเพลีย           
14. ใจสั่น           
15. หัวใจเตนเร็วผิดปกติ           
16. ไอ           
17. เบื่ออาหาร           
18. รูสึกไมแนนอน/ไมมั่นคง           
19. กลัว/ตกใจกลัว           
20. เครียด/วิตกกังวล           
21. เศรา           
22. นอนไมหลับ           
23. อื่นๆ.................................. 
................................................ 
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สวนท่ี 3 แบบสัมภาษณการจัดการอาการในผูปวยท่ีรอผาตัดทางเบี่ยงหลอดเลือดหัวใจ 
คําชี้แจง ใหทานชวยเลาการจดัการอาการในขณะท่ีรอผาตัดทางเบ่ียงหลอดเลือดหัวใจท่ีทานได
ปฏิบัติเพื่อจัดการอาการดังกลาว 
" เจ็บหนาอก/แนนหนาอก " ปวดราวไปอวัยวะตางๆ " ปวดยอดอก/ล้ินป 
" หอบเหนื่อย/หายใจลําบาก/หายใจขัด " วิงเวียนศีรษะ/ตาลาย/หนามืด/เปนลม 
" ชาปลายมือปลายเทา  " บวมท่ีแขน/ ขา    " เหง่ือออก   
" แขนขาเย็นช้ืน/ซีด  " แสบยอดอก    " อาหารไมยอย /ทองอืด  
" คล่ืนไส/อาเจียน    " เหนื่อยลา/ออนเพลีย  " ใจส่ัน   
" หัวใจเตนเร็วผิดปกติ   " ไอ      " รูสึกไมแนนอน/ไมม่ันคง  
" วิตกกังวล   " เครียด   " กลัว/ตกใจกลัว   
" หายใจลําบาก/หายใจไมอ่ิม   " อ่ืนๆ ระบุ. 
แนวคําถาม 
 1. ทานมีวิธีการจัดการหรือแกไขอาการอยางไร ท่ีทานคิดวาเปนวิธีการจัดการท่ีไดผลใน
การแกไขอาการดังกลาวท่ีเกดิข้ึน 


 
 2. วิธีการจัดการหรือแกไขอาการดังกลาวทานมีวิธีการปฏิบัติอยางไร (วิธีท่ีใชคืออะไร ทํา
อยางไร ท่ีไหน เม่ือไหร นานเพียงใด บอยแคไหน ทําไม ใครเปนคนทําให) 





 
 3. ผลลัพธท่ีเกิดข้ึนจากวิธีการจัดการอาการของทานดังกลาวขางตนเปนอยางไร 
" ดีข้ึน  " คงเดิม  " แยลง 
อยางไร............................................................................................................................................... 
. 
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สวนท่ี 4 แบบประเมินผลลัพธของการจัดการอาการในผูปวยท่ีรอผาตดัทางเบี่ยงหลอดเลือดหัวใจ 
คําชี้แจง แบบสอบถามนี้เปนแบบสอบถามท่ีสํารวจความคิดเห็นตอภาวะสุขภาพของทานในดาน
ตางๆ โปรดตอบคําถามทุกคําถาม โดยการขีดเคร่ืองหมายถูกตองลงใน (     ) ในขอท่ีทานเห็นดวย
มากท่ีสุด 
1. โดยท่ัวไปทานคิดวาสุขภาพของทานเปนอยางไร  
       (     ) ดีเลิศ              (     ) ดีมาก              (     ) ดี                (     ) พอใช             (     ) ไมด ี
2. เม่ือเทียบกับปท่ีแลวทานคิดวาสุขภาพทานเปนอยางไร 
       (     ) ดีกวาปท่ีแลวมาก            (     ) คอนขางดีกวาปท่ีแลว         (     ) เหมือนกับปท่ีแลว    
       (     ) คอนขางแยกวาปท่ีแลว   (     ) แยกวาปท่ีแลวมาก
3...
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TABLES 
Table C-1 
Frequency and percentage of subjects classified by demographic data (N = 60) 
Characteristics N %
Gender   
 Male 44 73.3
 Female 16 26.7
Age (year)(M = 62.92, SD = 8.1, Range = 42-80)  
 60 or less  24 40.0
 More than 60 36 60.0
Marital status   
 Single  3 5.0
 Married 46 76.7
 Divorced 3 5.0
 Widowed 8 13.3
Religion   
 Buddhist 51 85.0
 Muslim 9 15.0
Educational level  
 Primary  38 63.3
 Junior high  6 10.0
 Senior high  8 13.3
 Diploma 1 1.7
 Bachelor or higher 7 11.7
Occupation    
 None 18 30.0
 Retired 7 11.7
 Farmer or gardener 16 26.7
 Government employee 1 1.7
 Entrepreneurship 1 1.7
 Housewife 3 5.0
 Others 14 23.3
Income of family (baht)  
 < 5,000  13 21.7
 5,000-10,000 16 26.7
 10,001-20,000 11 18.3
 20,001-30,000 12 20.0
 > 30,000  8 13.3
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Table C-1 (Continued) 
Characteristics N %
Medical payment  
 Universal coverage scheme  
(30 baht)  
36 60.0
 Health insurance 4 6.7
 Self payment 1 1.7
 Government support 19 31.7
Residential area  
 Songkhla province 19 31.7
      Rural     11 57.9
      Urban 8 42.1
 Out of Songkhla province 41 68.3
      Rural 13 31.7
      Urban 28 68.3
Number of family members who stay with the 
patient 
 
 < 3 persons 22 36.7
 3 persons or more 38 63.3
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Table C-2 
Frequency and percentage of subjects classified by health-related data (N = 60) 
Characteristics N %
Family history of CAD  
 No 42 70.0
 Yes 18 30.0
Smoking habits  
 No 53 88.3
 Yes 7 11.7
Alcohol drinking habits  
 No 58 96.7
 Yes 2 3.3
Co-morbidity   
 No 7 11.7
 Yes 53 88.3
      Valvular heart disease 5 8.3
      CHF 3 5.0
      HT 38 63.3
      DM 22 36.7
      Dyslipidemia 31 51.7
      Renal insufficiency 9 15.0
      COPD 1 1.7
      Gout 9 15.0
      Cardiomegaly  3 5.0
      Cerebrovascular accident 1 1.7
      Asthma 3 5.0
      Tuberculosis 1 1.7
      Abdominal aortic aneurism 1 1.7
      Gall stone 3 5.0
      Peptic ulcer 2 3.3
      Psoriasis 1 1.7
      Cord compression 1 1.7
Duration of waiting for CABG (month)  
 1-3  15 25.0
 4-6  19 31.7
 7-9  5 8.3
 10-12 10 16.7
 > 12 11 18.3
Medication currently taken * 
 Long and short acting nitrates 58 96.7
 Acetyl salicylic acid 58 96.7
 Anti-lipidemia 56 93.3
 Beta-blockers 55 90.7
 ACE inhibitor 38 63.3
 Diuretic 26 43.3
*Patients reported more than one answer 
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Table C-2 (Continued) 
Characteristics N %
 Calcium antagonists 38 63.3
 Anti-diabetic 21 35.0
 Plavix 15 25.0
 Anti-ischemic drugs 10 16.7
 Sedatives 10 16.7
 Isosorbide dinitrate 10 16.7
 Digitalis glycosides 3 5.0
 Co-diovan 1 1.7
 Omeprazole 40 66.7
 Ranitidine 1 1.7
 Laxative 4 6.7
 Gout medications 5 8.3
 Antihistamine 1 1.7
 Folic acid 2 3.3
 Vitamin B2 2 3.3
 Bronchodilator 4 6.6
 Muscle relaxant 4 6.6
Diagnosis  
 1-or 2-vessel disease 7 11.7
 3-vessel disease, no proximal 
LAD involvement 
21 35.0
 3-vessel disease and proximal 
LAD 
29 48.3
 Left main artery disease 2 3.3
Ejection fraction (%)  
 < 30 8 13.3
 30-49 10 16.7
 50-65 13 21.7
 > 65 9 15.0
 No result 18 33.3
Revascularization  
 No 39 65.0
 Yes 21 35.0
      Thrombolytic therapy 1 4.8
      Heparinization 2 9.5
      PTCA 18 85.7
New York Hear Association 
 At the first time  
      Class I 8 13.3
      Class II 32 53.3
      Class III 16 26.7
      Class IV 4 6.7
 At current  
      Class II 27 45.0
      Class III 25 41.7
      Class IV 8 13.3
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Table C-3 
Frequency and percentage of symptom experiences reported by patients waiting for 
CABG (N =60) 
Symptoms N %
Chest pain/chest discomfort  48 80.0
Chest pain with referred pain 33 55.0
 Head 7 21.2
 Molar or jawbone 2 6.1
 Neck 4 12.1
 Shoulder 9 27.3
 Arms 14 42.4
 Back 7 21.2
 Legs 2 6.1
 Flanks 1 3.0
Epigastric pain 25 41.7
Dyspnea/shortness of breath/difficult breathing 30 50.0
Dizziness/blackness/fainting/lightheadedness 22 36.7
Upper extremity numbness 25 41.7
Edema of the extremities 17 28.3
Sweating/diaphoresis 18 30.0
Clammy limbs  8 13.3
Heartburn  11 18.3
Indigestion/abdominal distension 31 51.7
Nausea/vomiting 9 15.0
Fatigue/weakness 40 66.7
Palpitation  23 38.3
Tachyarrhythmia  27 45.0
Coughing  22 36.7
Loss of appetite  18 30.0
Uncertainty  28 46.7
Fear/frighten  29 48.3
Stress/anxiety  29 48.3
Sad  19 31.7
Insomnia  25 41.7
Constipation  11 18.3
Joint pain/muscle strain 5 8.3
Diarrhea  1 1.7
*Patients reported more than one symptom 
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Table C-4 
Frequency and percentage of symptom experiences reported by patients waiting for 
CABG classified by gender (N =60) 
Symptoms * Frequency 
(N) 
Percentage 
(%) 
Male Female 
N % N % 
1. Chest pain/ chest    
    discomfort 
47 78.3 37 78.7 10 21.3 
2. Fatigue/ weakness 40 66.7 30 75.0 10 25.0 
3. Chest pain with referred    
    pain 
33 55.0 27 81.8 6 18.2 
4. Indigestion/ abdominal  
    distension 
31 51.7 25 80.6 6 19.4 
5. Dyspnea/ shortness of    
    breath/ difficult breathing 
30 50.0 25 83.3 5 16.7 
6. Fear/ frighten 29 48.3 19 65.5 10 34.5 
7. Stress/ anxiety 29 48.3 20 69.0 9 31.0 
8. Uncertainty 28 46.7 19 67.9 9 32.1 
9. Tachyarrhythmia 27 45.0 20 74.1 7 25.9 
10. Epigastric pain 25 41.7 18 72.0 7 28.0 
11. Upper extremity    
      numbness 
25 41.7 16 64.0 9 36.0 
12. Insomnia 25 41.7 20 80.0 5 20.0 
13. Palpitation 23 38.3 19 82.6 4 17.4 
14. Dizziness/ blackness/   
      fainting/ lightheadedness
22 36.7 18 81.8 4 18.2 
15. Coughing 22 36.7 16 72.7 6 27.3 
16. Sad 19 31.7 15 78.9 4 21.1 
17. Edema of the extremities 18 30.0 13 72.2 5 27.8 
18. Bored with food 18 30.0 15 83.3 3 16.7 
19. Sweating/ diaphoresis 15 27.8 10 66.7 5 33.3 
20. Heartburn 11 18.3 8 72.7 3 27.3 
21. Constipation 11 18.3 9 81.8 2 18.2 
22. Nausea/ vomiting 9 15.0 6 66.7 3 33.3 
23. Clammy limbs 8 13.3 7 87.5 1 12.5 
24. Joint pain/ muscle strain 5 8.4 4 80.0 1 20.0 
25. Diarrhea 1 1.7 1 100 - - 
*Patients reported more than one symptom 
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Table C-5 
Frequency and percentage of symptom frequency reported by patients waiting for 
CABG (N = 60) 
 
Symptoms 
Rarely Sometime Almost all 
the time 
All the time 
N % N % N % N %
Chest pain/chest discomfort 20 42.6 12 25.5 15 31.9 - -
Chest pain with referred pain 14 42.4 8 24.2 11 33.3 - -
Epigastric pain 12 48.0 7 28.0 6 24.0 - -
Dyspnea/shortness of breath/ 
difficult breathing 
14 46.7 8 26.7 7 23.3 1 3.3
Dizziness/blackness/fainting/ 
lightheadedness 
8 36.4 7 31.8 7 31.8 - -
Upper extremity numbness 9 36.0 8 32.0 4 16.0 4 16.0
Edema of the extremities 8 47.1 5 29.4 4 23.5 - -
Sweating/diaphoresis 14 77.8 1 5.6 3 16.6 - -
Clammy limbs 5 62.5 1 12.5 2 25 - -
Heartburn 4 36.4 2 18.2 5 45.4 - -
Indigestion/abdominal 
distension 
6 19.4 8 25.8 15 48.4 2 6.4
Nausea/vomiting 6 66.7 - - 3 33.3 - -
Fatigue/weakness 13 32.5 20 50.0 5 12.5 2 5.0
Palpitation 14 60.9 5 21.7 4 17.4 - -
Tachyarrhythmia 15 55.6 8 29.6 4 14.8 - -
Coughing 5 22.7 9 40.9 8 36.4 - -
Loss of appetite 1 5.6 15 83.3 2 11.1 - -
Uncertainty 4 12.5 15 46.8 11 34.4 2 6.3
Fear/frighten 5 17.2 11 38.0 12 41.4 1 3.4
Stress/anxiety 7 24.1 8 27.6 14 48.3 - -
Sad 6 31.6 8 42.1 5 26.3 - -
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Table C-5 (Continued) 
 
Symptoms 
Rarely Sometime Almost all 
the time 
All the time 
N % N % N % N %
Insomnia 3 12.0 11 44.0 11 44.0 - -
Constipation 1 9.1 4 36.4 6 54.5 - -
Joint pain/muscle strain - - 2 40.0 3 60.0 - -
Diarrhea - - - - 1 100 - -
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Table C-6 
Frequency and percentage of symptom severity reported by patients waiting for 
CABG (N = 60) 
 
Symptoms 
Mildly 
severe 
Moderately 
severe 
Very  
severe 
Extremely 
severe 
N % N % N % N %
Chest pain/chest discomfort 20 42.6 15 31.9 9 19.1 3 6.4
Chest pain with referred pain 7 21.2 7 21.2 17 51.5 2 6.1
Epigastric pain 13 52.0 9 36.0 2 8.0 1 4.0
Dyspnea/shortness of breath/ 
difficult breathing 
14 46.7 6 20.0 9 30.0 1 3.3
Dizziness/blackness/fainting/ 
lightheadedness 
14 63.6 2 9.1 6 27.3 - -
Upper extremity numbness 21 84.0 1 4.0 3 12.0 - -
Edema of the extremities 11 64.7 5 29.4 1 5.9 - -
Sweating/diaphoresis 5 27.8 2 11.1 11 61.1 - -
Clammy limbs 4 50.0 3 37.5 1 12.5 - -
Heartburn 5 45.5 2 18.2 4 36.3 - -
Indigestion/abdominal 
distension 
15 48.4 11 35.5 5 16.1 - -
Nausea/vomiting 3 33.3 - - 6 66.7 - -
Fatigue/weakness 23 57.5 8 20.0 9 22.5 - -
Palpitation 13 56.5 5 21.8 2 8.7 3 13.0
Tachyarrhythmia 14 51.9 6 22.2 5 18.5 2 7.4
Coughing 16 72.7 1 4.6 5 22.7 - -
Loss of appetite 11 61.1 6 33.3 1 5.6 - -
Uncertainty 20 6.3 3 9.4 7 22.0 2 6.3
Fear/fright 14 48.3 5 17.2 10 34.5 - -
Stress/anxiety 15 51.7 5 17.2 9 31.1 - -
Sad 12 63.2 4 21.1 3 15.8 - -
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Table C-6 (Continued) 
 
Symptoms 
Mildly 
severe 
Moderately 
severe 
Very  
severe 
Extremely 
severe 
N % N % N % N %
Insomnia 11 44.0 5  20.0 9 36.0 - -
Constipation 6 54.5 4 36.4 1 9.1 - -
Joint pain/muscle strain 1 20.0 1 20.0 3 60.0 - -
Diarrhea - - - - 1 100 - -
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Table C-7 
Frequency and percentage of the top three strategies managed by patients waiting for 
CABG (N = 60) 
Symptom management N %
Chest pain/chest discomfort Taking ISDN 40 85.1
 Resting 4 8.5
 Stop doing activity 2 4.3
 Going to hospital 2 4.3
Chest pain with referred pain Taking ISDN 15 45.5
 Resting 9 27.3
 Massaging/rubbing 
the arms/moving the 
arms 
4 12.1
 Waiting and 
seeing/enduring 
4 12.1
 Taking ISDN with 
massaging  
1 3.0
Epigastric pain Chest compressing 6 24.0
 Waiting and seeing  4 16.0
 Body straightening 4 16.0
 Taking ISDN 3 12.0
Dyspnea/shortness of breath/ 
difficult breathing 
Body straightening 6 20.0
Waiting and seeing 4 13.3
 Deep breathing 4 13.3
 Using inhalant 4 13.3
 Resting  2 6.7
Dizziness/blackness/fainting/ 
lightheadedness 
 
Waiting and seeing 6 27.3
Going to hospital 4 18.2
Using inhalant/ 
borneol 
3 13.6
 Resting 3 13.6
Upper extremity numbness Massaging  15 60.0
 Waiting and seeing 3 12.0
 Enduring 2 8.0
 Hands fisting 2 8.0
 Hand moving 2 8.0
Edema of the extremities Waiting and seeing 10 58.8
 Arms or legs 
straightening 
3 17.6
 Leg raising 2 11.8
Sweating/diaphoresis Going to hospital 5 27.8
 Blowing the fan 5 27.8
 Resting 3 16.7
 Taking Ya-Hom 2 11.1
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Table C-7 (Continued) 
Symptom management N %
Clammy limbs Sponging 2 25.0
 Waiting and seeing 2 25.0
 Wearing the socks 2 25.0
 Massaging 2 25.0
Heartburn Taking antacid 5 45.5
 Waiting and seeing 2 18.2
 Belching 2 18.2
 Drinking sweet/ cold 
water 
1 9.1
 Resting 1 9.1
Indigestion/abdominal 
distension 
Taking laxative 14 45.1
Taking antacid 6 19.3
 Waiting and seeing 4 12.9
 Belching 2 6.5
 Abdominal 
compressing 
2 6.5
 Avoiding gas-
inducing diet 
2 6.5
 Taking Ka-Min-Chan 1 3.2
Nausea/vomiting Waiting and seeing 2 22.2
 Using inhalant 2 22.2
 Rinsing the mouth 
with warm water 
2 22.2
 Trying to vomit 1 11.1
 Sponging 1 11.1
 Going to hospital 1 11.1
Fatigue/weakness Resting 31 77.5
 Waiting and seeing 5 12.5
 Consuming sweetie/ 
drinking sweet water 
2 5.0
Palpitation Waiting and seeing 8 34.8
 Resting 5 21.7
 Taking ISDN 3 13.0
Tachyarrhythmia Taking a sit 7 25.9
 Waiting and seeing 7 25.9
 Resting  4 14.8
 Going to hospital 3 11.1
Coughing Waiting and seeing 8 36.4
 Taking cough-syrup 5 22.7
 Drinking warm water 4 18.2
Loss of appetite Food modification 7 38.9
 Drinking soft drinks 3 16.7
 Waiting and seeing 3 16.7
 Eating meal 1 5.6
Uncertainty Letting it go 7 21.9
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Table C-7 (Continued) 
Symptom management N %
 Laying down 4 12.5
 Meditation 3 9.4
 Prayer 3 9.4
Fear/fright Laying down 12 41.4
 Putting trust in God 3 10.3
 Seeking information 
related to operation 
2 6.9
 Positive thinking 2 6.9
Stress/anxiety Laying down 8 27.6
 Letting it go 4 13.8
 Positive thinking 4 13.8
 Prayer 2 6.9
 Putting trust in God 2 6.9
Sad Distraction 4 21.1
 Letting it go 3 15.8
 Prayer 2 10.5
Insomnia Sleeping and turning 
over 
8 32.0
 Watching TV 7 28.0
 Taking sedatives 3 12.0
 Letting it go 3 12.0
Constipation Taking laxatives 6 54.5
 Drinking plenty of 
water 
2 18.2
 Eating sour fruit 1 9.1
 Letting it go 1 9.1
Joint pain/muscle strain Taking Gout 
medications 
3 60.0
 Massaging with 
analgesic cream 
2 40.0
Diarrhea Going to hospital 1 100.0
Table C-8 
Comparison of the subjects’ smoking classified by gender (N = 60) 
Smoking        Gender X2
           Male         Female 
No 10 (38.5%)  16 (61.5%)  .000*
Yes 34 (100%) -   
*= p < .05  
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Table C-9 
Comparison of the subjects’ experiences on symptom occurrences classified by 
gender (N = 60) 
Symptom occurrences Gender X2
Male Female 
  Chest pain/chest discomfort    
     No 9 (75.0%) 3 (25.0%) .884ns
     Yes 35 (72.9%) 13 (27.1%) 
Chest pain with referred pain  
     No 20 (74.1%) 7 (25.9%) .907 ns
     Yes 24 (72.75) 9 (27.3%) 
Dyspnea/shortness of breathe/ 
difficult breathing 
 
     No 21 (70.0%) 9 (30.0%) .559 ns
     Yes 23 (76.7%) 7 (23.3%) 
Fear/frighten  
     No  26 (86.7%) 4 (13.3%) .020*
     Yes 18 (60.0%) 12 (40.0%) 
Stress/anxiety  
     No 24 (77.4%) 7 (22.6%) .459ns
     Yes 20 (69.0%) 9 (31.0%) 
Uncertainty  
     No 24 (88.9%) 3 (11.1%) .014*
     Yes 20 (60.6%) 13 (39.4%) 
Sad  
     No 30 (73.2%) 11 (26.8%) .967 ns
     Yes 14 (73.7%) 5 (26.3%) 
ns = non-significant *= p < .05  
 
 
162 
 
Table C-10 
Comparison of the subjects’ experiences on symptom occurrences classified by age  
(N = 60) 
Symptom occurrences Age (years) X2
      36-60 >60 
Chest pain/chest discomfort    
     No 4 (33.3%) 8 (66.7%) .598ns
     Yes 20 (41.7%) 28 (58.3%) 
Chest pain with referred pain  
     No 7 (25.9%) 20 (74.1%) .044*
     Yes 17 (51.5%) 16 (48.5%) 
Dyspnea/shortness of breathe/ 
difficult breathing 
 
     No 12 (40.0%) 18 (60.0%) 1.00ns
     Yes 12 (40.0%) 18 (60.0%) 
Fear/frighten  
     No  10 (33.3%) 20 (66.7%) .292ns
     Yes 14 (46.7%) 16 (53.3%) 
Stress/anxiety  
     No 11 (35.5%) 20 (64.5%) .460ns
     Yes 13 (44.8%) 16 (55.2%) 
Uncertainty  
     No 9 (33.3%) 18 (66.7%) .340ns
     Yes 15 (45.5%) 18 (54.5%) 
Sad  
     No 16 (39.0%) 25 (61.0%) .821ns
     Yes 8 (42.1%) 11 (57.9%) 
ns = non-significant *= p < .05  
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Table C-11 
Comparison of the subjects’ experiences on symptom occurrences classified by 
smoking (N = 60) 
Symptom occurrences Smoking X2
       No      Yes 
Chest pain/chest discomfort    
     No 3 (25.0%) 9 (75.0%) .147ns
     Yes 23 (47.9%) 25 (52.1%) 
Chest pain with referred pain  
     No 7 (25.9%) 20 (74.1%) .199ns
     Yes 19 (57.6%) 14 (42.4%) 
Dyspnea/shortness of breathe/ 
difficult breathing 
 
     No 14 (46.7%) 16 (53.3%)  .601ns
     Yes 12 (40.0%) 18 (60.0%) 
ns = non-significant 
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Table C-12 
Comparison of the subjects’ experiences on symptom occurrences classified by co-
morbidity (N = 60) 
Symptom occurrences Co-morbidity X2
      No      Yes 
Chest pain/chest discomfort    
     No 2 (16.7%) 10 (83.3%) .542ns
     Yes 12 (25.0%) 36 (75.0%) 
Chest pain with referred pain  
     No 7 (25.9%) 20 (74.1%) .668ns
     Yes 7 (21.2%) 26 (78.8%) 
Dyspnea/shortness of breathe/ 
difficult breathing 
 
     No 8 (26.7%) 22 (73.3%) .542ns
     Yes 6 (20.0%) 24 (80.0%) 
ns = non-significant 
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LIST OF EXPERTS 
The content validity of research instrument (SEQ, SMQ, SOQ, and SF-36) 
was assessed by three panels of experts: 
Vorawit Chittitaworn, MD., Dip Thai Board of Surgery, 
 Dip. Thai Board of Cardiology,  
 Assistant Professor,  
 Department of Surgery, Faculty of Medicine,  
Prince of Songkla University, Hat Yai, Songkhla 
Apinya Wongpiriyayothar, PhD, MNS, RN 
Lecturer 
Faculty of Nursing, Maha sarakham University, Maha sarakham 
Sineenat Likhitratchareon, MNS, RN, 
Cardiovascular Nurse Specialist, 
Cardiac Care Unit, Ramathibodi Hospital, Mahidol University, Bangkok 
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